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Abstract 
 
The focus of this study is proteins from the ArAE family, specifically two 
subfamilies: firstly, the ALMT family of plant membrane channels, which have 
numerous vital roles in plants, and secondly, the bacterial family first described 
as PET inner membrane exporters. Constructs were created for expression of 
firstly, the C-terminal domain (CTD) of wheat ALMT1 in E. coli and secondly, 
three full-length ALMTs (ALMT from wheat and ALMT5, ALMT9 from 
Arabidopsis) in Nicotiana benthamiana for structural and biochemical studies. 
Unfortunately, it appears that the CTD is not an independent soluble domain as 
originally thought, and this domain is now predicted to contain transmembrane 
helices, making it unsuitable for study in the manner planned. Similarly, 
production of full length ALMTs was unsuccessful as when extraction and 
purification was attempted, the protein degraded. Thirdly, a bacterial member of 
the ArAE family was expressed and characterised: AaeB from E. coli, along with 
its putative binding partner, AaeA. This was shown to form a complex with and 
be vital for the stability of AaeB. A strategy was devised for expression, 
solubilisation, and purification of these proteins and once they were obtained in 
pure form they were subjected to a range of biochemical and structural 
experiments. Microcrystals of AaeA were produced, towards a strategy for 
structural determination by X-ray crystallography. The first Electron Microscopy 
examination was performed on complexes of AaeB, and negative stain classes 
were produced. The first in silico homology model of AaeA has been produced 
and validated by CD spectroscopy, providing a range of insights. The complex 
formed by AaeA and AaeB has also been probed by crosslinking and SEC-
MALLS analysis, suggesting a 6:2 or 6:3 stoichiometry. Together this has 
furthered our understanding of this poorly characterised membrane protein 
family and provided a set of clones and protocols for future studies.   
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1  
1.1 Compartmentalisation and Membranes 
1.1.1   Biological membranes and membrane proteins 
All cells are surrounded by a membrane, and in many ways it is the membrane 
that defines the boundary of life: whatever is inside the plasma membrane is 
part of a living organism and whatever is outside is not. This phospholipid 
bilayer has a hydrophobic core that only permits small, uncharged molecules 
such as CO2 to cross, while molecules such as water, charged inorganic ions, 
and large polar molecules are impermeable. Thus, membranes perform a vital 
role for any organism or cell, allowing cells to contain and control their DNA, 
proteins, and metabolic activity, while permitting vital chemicals to be contained 
at useful concentrations and keeping out undesirable compounds. A plasma 
membrane surrounds every cell of every organism and eukaryotes also contain 
additional intracellular compartments separated by membranes. This 
compartmentalisation enables a single cell to have several different 
environments within it. For example, lysosomes are maintained at an acidic pH 
to enable efficient degradation1, and separate organelles are available for 
photosynthesis, in the case of chloroplasts2, or respiration in the case of 
mitochondria3, enabling each to have controlled conditions, prevent futile cycles 
of opposing pathways, and to keep reactive oxygen species contained. 
However, while separation and compartmentalisation brings many benefits, 
cells and organelles also require contact with their immediate environment in a 
controlled way that does not compromise the integrity of the membrane and for 
this task they have a specialised group of transport proteins embedded in their 
membranes.  
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Membrane proteins are involved with many vital roles within cells including 
bioenergetics, signal transduction, ion and solute transmission, and catalysis. 
There are many such proteins: the human genome has over 1000 transporters 
alone (http://www.membranetransport.org). Consequently, and unsurprisingly, 
they are key targets for medical research, chiefly because dysfunction in 
membrane proteins is the basis of many diseases4–6. For example, cystic 
fibrosis is known to be caused by deficiency in control of chloride transport7, 
and membrane transporters are the target for many pharmacological therapies 
such as proton pump inhibitors to treat gastro-intestinal problems 8, and current 
research is attempting to target bacterial transporters are involved with removal 
of antibiotics in order to reduce multidrug resistance 9. A commonly used drug 
class is “beta blockers”, which bind to the β-Adrenergic G-protein-coupled 
receptor (GPCR) to protect the heart against heart attacks and cardiac 
arrhythmias, and the first human GPCR crystal structure was of the β2 
Adrenergic Receptor bound to the inverse agonist carazolol10. Another drug 
class that targets a GPCR is serotonin-specific reuptake inhibitors (SSRIs), 
which bind to the serotonin transporter SERT11 and are used to treat 
depression. Of course, drugs are not the sole driver of membrane protein 
research, with the notable area of plant membrane biology being important to 
the understanding and generation of improved crops, whether by conventional 
breeding or bioengineering12.   
Membrane proteins are an important target for study: they comprise up to one 
third of genes in the genomes of sequenced organisms,13 over two thirds of 
current drugs target membrane proteins14, and even outside of the context of 
drug development they are involved in numerous vital processes. However, 
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despite this importance there have been relatively few membrane protein 
structures solved15. This is largely due to the fact that membrane proteins are 
inherently hard to produce, stabilise, and characterise structurally4. The 
membrane volume is only a small fraction of a cell, and so they are usually 
expressed at lower levels than their soluble counterparts. They are hard to 
purify, and in the native state require a lipid environment to remain in their 
stable three-dimensional structure but these lipids can interfere with 
biochemical experiments as well as structural studies. We still lack a detailed 
understanding of the structure and function of most membrane protein families, 
how they work, how they move, and how they are regulated. This understanding 
will require the determination of many more high-resolution structures to 
develop a more complete understanding of the structure-function relationships 
encoded within membrane protein sequences.    
 
1.1.2  Transport across membranes  
Membranes are essential to contain and define a cell and its organelles and, 
conversely, transport across these membranes is vital to enable metabolites to 
enter, waste products to be removed, and signals to be transmitted. Some 
molecules, such as urea and steroid hormones such as testosterone, are 
sufficiently hydrophobic to permit them to cross the membrane un-aided, by 
simple diffusion16. This takes place down a concentration gradient by the 
process of random movement of molecules, towards equilibrium, as seen in 
Figure 1.1. This process requires no external energy input, and will continue to 
happen until equilibrium is reached, but cannot move solutes up a concentration 
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gradient, and does not permit the transport of hydrophilic substrates. For these 
tasks, specialised membrane proteins are required.  
 
Figure 1.1 - Diffusion of lipid-soluble compounds across membranes 
takes place with a net flux from regions of high concentration to regions 
of low concentration. 
 
1.1.3  Channels and transporters 
Channels and transporters are required for cells to mediate the movement of 
hydrophilic compounds across membranes and to move compounds up a 
concentration gradient. There are many such molecules that are important to 
cross into or out of the cell, for example signalling molecules17, metabolites 
such as glucose18 and nucleosides19, and equilibration of water content in 
cells20. Thus, these channels and transporters are important for growth, 
metabolic processes, and sensory perception.  
1.1.3.1 Channels 
Channels, seen in Figure 1.2A, act as gates within the membrane; they have a 
hollow, hydrophilic core that forms the channel pore and permits ions, water, 
and other small molecules to pass through them into the cell by a process of 
facilitated diffusion, which takes place down the electrochemical gradient in the 
same manner as simple diffusion. They generally have a relatively simple 
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mechanism with a central gated pore to allow transport and often have very 
high rates of transfer (up to 108 molecules per second21) as when they are in 
the open state they are limited only by the rate of diffusion. Aquaporins, for 
example, enable an almost instantaneous equilibration of water across 
membranes. Flux is determined by two factors, the chemical potential, resulting 
from a difference in concentration across the membrane, and, for charged 
particles, the membrane potential, or electrical potential, resulting from the 
distribution of charge across a membrane. These factors combined are called 
the electrochemical potential.   
While the overall mechanism of action of channels is conceptually simple, the 
details of individual channels are more complex. Channel opening and closing 
can be stimulated by three stimuli, firstly, ligand binding22 (which may be a non-
covalent ligand such as acetylcholine or a covalent modification such as 
phosphorylation); secondly, changes in membrane potential in the case of 
voltage-gated channels23, which contain a charged domain that moves in 
response to voltage changes and causes a conformational change in the pore; 
and thirdly, mechanical tension may activate channels, for example those found 
in smooth muscle or that control turgor in plants24.  
Whatever the method of activation and de-activation, the process of gating itself 
can take place in one of three general ways. Firstly, gating can be via a small 
discrete area, for example at the selectivity filter, secondly, it can come about 
from a larger, general conformational change, or thirdly a channel may contain 
a blocking domain that moves into the pore to seal it in a closed state25. This 
gating control is vital for the cell, as without it channels would permanently 
dissipate electrochemical gradients established across the membrane.  
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Figure 1.2 - Diagrammatic representation of the action of channels and 
transporters.  
A) Channels switch from a closed state to an open state to allow transport 
down a concentration gradient. B) uniporters permit facilitated diffusion in a 
similar manner to channels, but transport is via several conformational 
changes. C) Co-transport and D) antiport is shown with proteins cycling 
through different states in order to transport their substrate. This can be a case 
of both substrates moving down a concentration gradient but also enables 
secondary active transport against an electrochemical gradient.  E) ABC-
driven Transporter. Hydrolysis of ATP drives transport of substrate up a 
concentration gradient. ATPase domain hydrolyses ATP and this energy is 
used to drive transport, leading to primary active transport, for example in the 
V-ATPase or ABC transporters.   
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An example of such channels is aquaporins. These proteins serve as channels 
in the transfer of water across the membrane and conserved in bacteria, plants, 
and animals20. Channel gating has been investigated in the spinach aquaporin 
PIP2;1 protein, with crystallography revealing both open and closed 
conformations, with large loops moving to occlude the pore in the closed state 
and phosphorylation promoting closing of the pore during drought stress26 and 
this tight control of water loss plays a large role in survival during drought 
stress.  
1.1.3.2 Transporters 
Transporters are also used by cells to move solutes from one side of a 
membrane to the other, but often have a more complicated mechanism of 
action than channels. These proteins often have two “gates” within their 
structure, one at either side of the membrane, which are never both open at the 
same time, but can be both closed resulting in an occluded state whereby the 
substrate is located in an internal cavity with no access to either side of the 
membrane. These gates sequentially open and close as the protein shifts 
through several intermediate states. These states allow substrate binding, 
movement through the membrane, and substrate release.  
1.1.3.2.1 Facilitated diffusion by uniporters 
Facilitated diffusion through uniporters is conceptually similar to transport by 
channels. It does not require energy input to move ions or molecules across the 
membrane and the membrane proteins merely provide a path across the 
membrane through which the substrate can travel down the electrochemical 
gradient. Uniporters, seen in Figure 1.2B, can provide this type of transport to 
their specific substrates. For example, GLUT1 transports glucose across 
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mammalian plasma membranes27 as a Michaelis-Menten enzyme relying on the 
specific binding of the substrate to the protein. Transport is driven by 
conformational changes between three states, one state open to the outside, 
allowing it to pick up glucose, an occluded state, which is closed to both sides of 
the membrane, and a third state open to the inside allowing it to release the 
glucose into the cell27. Like a channel, transport still depends on the 
concentration gradient, but unlike a channel transport is saturable due to the 
mechanism which requires multiple conformational state changes, and thus 
there is a limited maximum flux per protein.  
1.1.3.2.2 Active transport  
While channels and facilitative transporters only permit substrates to move 
across membranes down their electrochemical gradients, active transporters 
can move a substrate against its concentration gradient, using an external 
source of energy. This can be achieved by primary active transport – that is, 
coupling transport to the hydrolysis of ATP. This is the case, for example, in 
ABC transporters28: where ATP hydrolysis drives conformational changes in the 
molecule to allow the transport of substrate against its own electrochemical 
gradient, or in the V-ATPase, which is involved in pumping protons to acidify 
compartments29, depicted in Figure 1.2E. This enables transport to be 
concentrative, rather than equilibrative, so that a chemical species can be 
accumulated to much higher concentrations that found in the environment in 
order to, for example, scavenge precious nucleosides from the environment30, 
or to maintain the vital metabolite glutamine concentrations in the cytoplasm at 
~2-20 mM against an external concentration of 0.2-0.8 mM31. A unique 
transport system in bacteria is the Phosphotransferase System (PTS) which is 
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used for uptake of carbohydrates and uses a set of interconnected enzymes to 
couple translocation and phosphorylation of carbohydrates and the energy for 
this is provided by hydrolysis of phosphoenolpyruvate32.  
A second method is secondary active transport: coupling the transport of the 
substrate up a concentration gradient to transport of another molecule down its 
concentration gradient, which is used in the case of co-transporters and 
antiporters, seen in Figure 1.2C-D. This relies on the initial generation of an 
electrochemical gradient for the second species, which is generally established 
by a transporter coupled directly to ATP hydrolysis, and so the transport is 
indirectly coupled to ATP hydrolysis. Generally, the energy source for 
secondary active transport is the electrochemical gradient of either protons or 
sodium ions33.  
Transporters generally have several states through which they move during the 
transport cycle, and because of this rates of translocation are lower than the 
rate for channels, typically around 1000 molecules per second but sometimes  
as low as one molecule per second34. These changes in conformation involve 
alternately opening gates at either side of the membrane and it is vital that both 
gates are never both open at the same time, as this would, in effect, produce an 
open channel and thus a current in the opposite direction with several orders of 
magnitude higher than the active transport. The transport kinetics of 
transporters are again Michaelis-Menten meaning that increased substrate 
concentration leads to increased rate of transport only up to the point that the 
transporter is saturated and then the transport rate reaches a plateau. However, 
a cell can add more capacity by upregulating expression, if a higher rate of 
transfer is required. 
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An example of a transporter is the NRT1.1 from Arabidopsis thaliana, belonging 
to the Major Facilitator Superfamily (MFS) of proton-driven antiporters. This 
protein provides nitrate uptake from the soil and has two modes, a low-affinity 
mode that is used in times when nitrate is plentiful and a high-affinity mode that 
is used in low-nitrate conditions, allowing for rapid response to changing nitrate 
levels35. A combination of crystallographic and binding studies suggested that 
the switch is driven by phosphorylation, which drives the protein into a more-
flexible conformation, allowing for faster transfer rates35. Additionally, binding of 
the herbicide chlorate was seen, an important commercial implication in addition 
to the fundamental structural biology. 
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1.2 ArAE Family of Acid Exporters (including plant ALMTs) 
The Aromatic Acid Exporter (ArAE) family of membrane proteins is found 
throughout plants, and bacteria, and also in yeast and protozoa and were first 
identified in 200036. The most important members of this family so far 
characterised include the ALMT family of anion channels found ubiquitously in 
plants37 as well as bacterial members, which were initially described as Putative 
Efflux Transporters (PETs)38. Since their identification, the Transporter 
Classification Database39 has classified these proteins as “2.A.85 The Aromatic 
Acid Exporter (ArAE) Family”.   The plant ALMTs are a family of ion channels, 
predicted to contain six TM helices followed by a large soluble domain, while 
the bacterial members are predicted to contain an internal repeat, and thus be 
comprised of two sequential sections of six TM helices each followed by soluble 
domains (shown in Figure 1.3). As such, plant ALMTs can perhaps be 
considered ‘half transporter’ versions of bacterial PETs and it has been 
postulated that if bacterial PETs act as monomers then ALMTs are likely to form 
dimers36. A similar situation can be found in the SWEET transporters. Plant 
members of this family contain a pair of 3-TM helices in their structure, joined by 
a linker, while bacterial members (so-called semiSWEETs) contain a single 3-
TM bundle and require homo-dimerization40,41.  
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Figure 1.3 - Predicted overall architecture of ArAE family members from 
plants and bacteria.  
The plant ArAE family members (ALMTs) were predicted to contain six TM 
helices and a soluble C-terminal domain (CTD), while the bacterial genes were 
predicted to be formed of a duplication with two sets of six TM helices each 
followed by a soluble domain (S). 
  
Specifically, the Arabidopsis ALMTs that were identified in the initial paper 
concerning PETs were: ALMT6 and 12, whose functions are described in the 
following section, and ALMT5, 7, 10, and 11, whose functions have not yet been 
studied. The ALMTs have been more widely characterised, but remain poorly 
understood at a structural level. The bacterial PETs, similarly to ALMTs, have 
not been well studied and no structural studies have been performed. One 
bacterial family members has been characterised as an aromatic carboxylic 
acid efflux pump38, and a second is identified as a sulfa-drug efflux pump42 but 
otherwise the bacterial family members remain poorly studied.  
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1.3 ALMT Family Members in Plants, Function, Topology, 
Mechanism, and Structure 
The first protein family studied here is the Aluminium activated Malate 
Transporter (ALMT) family of ion channels, found ubiquitously within plants. 
Family members have been shown to have a wide variety of vital roles in the 
plant (reviewed in detail below) and there is a growing appreciation for their 
central role in many processes, but structural and mechanistic data are scarce 
and often conflicting. Thus, the ALMT family represents a high value but as-yet 
under-studied family of plant membrane proteins that are in particular need of 
high-quality structural data. The following section will review the physiological 
importance of ALMTs, and give an overview of the current state of biochemical, 
topological, and structural data for ALMTs.  
The ALMT family is found ubiquitously in genomes throughout the plant 
kingdom and was named after the first member of the family to be characterised 
(TaALMT1) was found to be involved in aluminium resistance in wheat, Triticum 
aestivum43. The first characterised homologue in Arabidopsis thaliana, 
AtALMT1, was similarly found to be involved in Al-resistance44. However, the 
gene family in this species contains 13 other members, some of which have 
already shown to have a wide range of other roles37. Indeed, the fact that 
species have so many homologues was the first indication that the ALMT family 
was of high importance – for example poplar contains 22 members45, rice has 
nine members45, and soybean has 31 members46. To date, the ALMT family 
has been shown be central to processes such as control of stomatal 
aperture47,48 and anion homeostasis49. Furthermore, increasing attention is 
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being paid due to their potential role in economically valuable traits such as fruit 
flavour50 and grain filling51, and more recently they have been shown to be key 
mediators of GABA signalling52 and in supplying carbon to symbiotic soil 
bacteria46. Identification of the molecular actors in these processes is already 
helping guide marker-assisted breeding53. 
 
1.3.1  Food security 
The issue of food security is of current importance as the world faces what the 
UN describes as “an unprecedented convergence of pressures”54. Namely, a 
growing world population, with demand for food expected to double by 2050; 
pressures for alternative land use including production of biofuels and 
urbanisation; a changing climate with varying water availability; and declining 
stocks of available resources such as oil and phosphate rock55. A further 
constraint on yields is the presence of acid soils and the aluminium toxicity 
provoked by these. As ALMTs have emerged as key molecular actors in vital 
processes linked to this and other aspects of plant physiology, their importance 
to potential food security issues and GM crops has grown, including current 
research that is examining the potential for transgenic crops to combat acid 
soils56. A brief survey of their importance to the trait of Aluminium Resistance 
will now be given as an example.  
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1.3.2  Aluminium Resistance 
1.3.2.1 Overcoming aluminium toxicity on acid soils 
Acid soils are prevalent worldwide, comprising around half of all potentially 
arable land57. In these soils, aluminium ions become solubilised and damage 
crops via root growth inhibition58 and, to compound the problem, nutrients such 
as phosphate become less available59. Several plant species have been 
identified as aluminium-resistant and they use a variety of mechanisms 
including thickening of cell walls60, active transport of aluminium away from 
sensitive organs61, or, more prominently, organic acid exudation, chiefly either 
by release of malate, citrate, or oxalate62,63, which will now be discussed in the 
following section. 
1.3.2.2 TaALMT1 in Aluminium Resistance 
Studies on crosses of near isogenic Al-resistant and Al-sensitive wheat 
(Triticum aestivum) cultivars identified a gene responsible for malate exudation 
from root tips, providing the primary mechanism of aluminium resistance. 
Subsequent electrophysiological studies using Xenopus oocytes43,64,65 first 
characterised TaALMT1 as a malate channel activated by Al. TaALMT1 is 
constitutively expressed in the root apices of Al-resistant wheat and malate 
chelates Al3+ forming a 2:2 complex with the trivalent aluminium ions (seen in 
Figure 1.4), thus encasing the ions and rendering them non-toxic66. This 
enables longer root growth and greater yields compared to a sensitive cultivar 
grown on acid soils. In addition to protection from Al3+ toxicity, malate extrusion 
has the benefit of increasing phosphate availability in the soil – since Al3+ binds 
and complexes phosphate67. This is part of a host of processes activated in 
plants for improved phosphorus usage59,68. Heterologous expression of 
TaALMT1 in cultured tobacco cells, Xenopus oocytes, and transgenic rice 
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plants has shown efflux of malate activated by the presence of Al3+ and 
expression confers Al-resistance to tobacco cells43. Importantly, transgenic 
expression of TaALMT1 in Al-sensitive barley plants rendered them resistant to 
aluminium toxicity69. The transgenic plants grown on acid soil displayed root 
growth similar to that seen in neutral soils and a doubling in yield when 
expressing just the single gene68, making it a powerful tool for transgenic crop 
development.  
 
Figure 1.4 - Structure of malate and aluminium complexed by malate. 
Structure of the complex from Tashiro et al.66.  
 
1.3.2.3 Other ALMTs involved in aluminium-resistance  
Since the characterisation of TaALMT1, several ALMTs from other species 
including oilseed rape, Arabidopsis, rye, and soybean have been shown to be 
vital for Al-resistance and characterised (see Table 1 and Figure 1.5). These 
channels are activated by Al3+ and in some cases their expression is also 
upregulated upon sensing Al3+ 70. 
AtALMT1 is a malate channel critical for Al-resistance in Arabidopsis, expressed 
at the plasma membrane of the epidermal cells of the root tip44. This protein 
shows 41% sequence identity and 63% similarity to TaALMT1. However, in 
contrast, AtALMT1 is not constitutively expressed; instead, expression is 
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upregulated by aluminium70,71, mediated by the transcription factors STOP1, 
STOP2 and WRKY46, which also regulate other genes critical for tolerance of 
acid soils72–74. A recent showed that a chimeric protein made from the N-
terminal half of TaALMT1 and the C-terminal half of AtALMT1 was functional, 
and actually showed higher malate export than either of the native channels75. 
Their study also noted that there were significant differences between 
expression of ALMTs in Xenopus oocytes76 as compared to in tobacco BY-2 
cells and cautioned that heterologous expression in animal cells may not be a 
faithful representation of reality75. 
In addition, two genes with 95% sequence identity to one another (BnALMT1, 
BnALMT2) were identified in oilseed rape (Brassica napus)77,78, as well as 
GmALMT1 in soybean (Glycene max), and ScALMT1 in rye (Secale 
cereale)79,80. These genes are expressed at root tip plasma membranes, and 
the corresponding proteins are permeable to malate and are activated by 
aluminium, showing a widespread mechanism for Al-resistance among plant 
species. In addition, GmALMT1 channel activity has also been shown to be 
regulated by pH changes and phosphorous concentration81. It is expected that 
as more species are studied more Al-responsive genes will be found.  
1.3.3  Structural and topological studies of TaALMT1 and AtALMT1 
Although a sizable and growing number of ALMTs have been physiologically 
and functionally characterised (as discussed throughout this section), much less 
is understood about their structure and mechanism, with even aspects of their 
basic topology remaining controversial. AtALMT1 and TaALMT1 remain the 
most comprehensively characterised of ALMTs, with studies covering 
mutagenesis of individual residues, deletion of various sections, swapping of 
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domains, fusions with YFP, and pharmacological approaches taken. A 
discussion of these studies will now be given.  
 
1.3.3.1 C-terminal domain 
The C-terminal domain (CTD) is the most studied region of ALMT1 and is 
known to be involved in regulation of ALMTs and truncation of it in TaALMT1 
and AtALMT1 abolishes both basal and Al3+-activated anion currents, indicating 
this domain is vital for channel function82. It has been speculated that the CTD 
may be involved in oligomerisation vital for channel function; and it is likely be 
involved in gating the channel, although this requires further study to confirm. 
The CTD contains conserved motifs including a sequence “F-(X)4-W-(X)2-E-X-L” 
at the very start (residues 213-223 in TaALMT1), which has been identified to 
be crucial for GABA-binding (discussed in more detail below); and the “WEP” 
motif (residues 282-284 in TaALMT1) whose function has not been established, 
but is likely to be important in the formation of tertiary structure. In addition, the 
T323A mutant has significantly higher basal and aluminium-activated activity82. 
Threonine, uniquely, has a secondary βC making it conformationally restricted 
and it was speculated that perhaps the increased flexibility caused by mutation 
leads to this enhancement in malate currents. Discovering the structural basis 
for this will be important in enabling future genetic engineering to optimise the 
development of transgenic species. 
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1.3.3.2 Al-binding 
Three specific acidic residues (E274, D275 and E284) in the CTD of TaALMT1 
were shown by mutagenesis to be essential for channel activation by Al3+83. The 
authors speculated that Al3+ binds directly to this domain via these three 
residues, causing a conformational change that leads to channel activation. 
However, later studies have cast significant doubt on this hypothesis. The final 
glutamate of the proposed binding site (E284) is present in another homologue, 
AtALMT12, as E276. Mutagenesis of this residue in AtALMT12 led to a loss of 
channel function, and as AtALMT12 is not Al-activated this suggests that this 
residue is unlikely to have a specific role in Al-sensing in TaALMT1 either. 
Indeed, a later study involving a comprehensive mutagenesis of 43 acidic 
residues within TaALMT1 showed that it was possible to generate an identical 
phenotype by mutagenesis at many different locations including residues 
predicted to be within the transmembrane region and located at either side of 
the membrane, and even mutagenesis of neutral residues can produce a 
protein that lacks Al-responsiveness84. This suggests that the change in activity 
that is brought about by mutagenesis, rather than being a specific diminishment 
in the binding of Al, is likely to cause a more fundamental structural change. 
Indeed, the final Glu identified in the original study is part of the highly 
conserved WEP motif that is present throughout all ALMTs, including those that 
show no activation by Al it is therefore implausible for this residue to be vital to 
the specific activation by Al.  
A second potential binding motif was identified near the N-terminus. It was 
discovered that Al-responsive homologues contain a motif with the sequence 
[D,E]-[H,K,R]-X-[K,R]-[D,E]-X-X-X-[D,E] (residues 4-12 in TaALMT1) that is not 
present in those homologues that do not interact with Al and mutation of 
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individual residues led to a loss of Al-responsiveness84. However, when the 
entire region was deleted in another study Al activation was only reduced rather 
than removed, showing this region is not essential75. The binding site for Al 
remains uncharacterised, and it is likely that Al-activation requires several 
regions of the protein in both the N- and C-terminal halves.  
 
1.3.3.3 Phosphorylation  
Kinase inhibitors have been shown to inhibit the activation of TaALMT1 by Al3+ 
and mutation of putative phosphorylation site S384 within the CTD has been 
shown to abolish transport by the channel when expressed in Xenopus oocytes 
for both basal and activated currents suggesting that phosphorylation is a 
prerequisite for any transport82. Depending on what topology (discussed below) 
is chosen, this residue is alternately placed either inside or outside the cell, 
prompting speculation about how this could be phosphorylated if it were indeed 
extracellular. Were the topology of ALMT1 shown to place this residue outside 
of the cell, phosphorylation could possibly be mediated by cell wall associated 
kinase WAK1, which has been shown to be upregulated by Al3+ treatment in 
Arabidopsis 85, although this would not account for activity of TaALMT1 in 
Xenopus, which necessarily do not contain such a kinase. Conversely, mutation 
of the three serine residues that constitute putative phosphorylation sites in a 
homologue AtALMT12 does not affect transport, suggesting that 
phosphorylation is not universally required for ALMT activity86.  
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1.3.4  Other roles of ALMTs 
As mentioned above, ALMTs are a multigenic family and have many diverse 
roles in addition to acid soil tolerance.  A review of the current understanding of 
these roles beyond Al-tolerance, and the structural and mechanistic basis of 
channel activity will now be given. 
1.3.4.1 Other root related functions 
A large number of ALMTs have been shown to be root-localised and Al-
responsive, but other homologues have been linked with wider roles, even 
within the root.  ZmALMT2 from maize (Zea mays) has been shown to be root 
localised and to release malate into the soil. Unlike AtALMT1 and TaALMT1, 
however, this is not correlated with Al-resistance, but instead is likely to provide 
solubilisation for soil nutrients, such as phosphate, as discussed above for 
TaALMT1. As it is also found in vascular tissue, ZmALMT2 could also play a 
role in the transport of organic acids or mineral anions in the xylem.87 
Another recently-revealed role of ALMTs is in providing carbon to symbionts 
such as rhizobia that form root nodules. LjALMT4 is expressed at the 
parenchyma cells at root vascular bundles and releases dicarboxylic acids such 
as malate, fumarate, and succinate plus other inorganic anions which are then 
available for the bacteria to take up in exchange of fixed nitrogen46. This finding 
raises the possibility that ALMTs may be responsible for other nutrient 
exchange with other symbiotic organisms such as mycorrhiza, as the molecular 
actors in carbon-nitrogen exchange remain unidentified. Mycorrhizal 
associations are formed very widely with 80% of surveyed plant species having 
mycorrhizal associations88 and thus ALMTs, which are found ubiquitously and 
have many homologues with as-yet unknown function, are plausible candidates.  
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Table 1 - Summary of known functions and localisation of ALMTs from 
several species 
Gene Organism Localisation Al-
activated? 
Function 
AtALMT1 Arabidopsis 
thaliana 
Root cell plasma 
membranes 
Y Aluminium resistance 
AtALMT6 Arabidopsis 
thaliana 
Tonoplast N Guard cell malate 
currents 
AtALMT9 Arabidopsis 
thaliana 
Tonoplast N Chloride currents in 
guard cells and 
malate homeostasis 
AtALMT12 Arabidopsis 
thaliana 
Plasma 
membrane of 
guard cells 
N Stomatal closing 
TaALMT1 Wheat, 
Triticum 
aestivum 
Root cell plasma 
membranes 
Y Aluminium resistance 
VvALMT9 Grape, Vitis 
vinifrera 
Tonoplast of 
berry mesocarp 
N Fruit flavour/vacuolar 
malate uptake 
MdMA1 Apple, Malus 
domestica 
Tonoplast N Fruit flavour/vacuolar 
malate uptake 
BnALMT1 Oilseed 
rape, 
Brassica 
napus 
Root cell plasma 
membranes 
Y Aluminium resistance 
 
BnALMT2 Oilseed 
rape, 
Brassica 
napus 
Root cell plasma 
membranes 
Y Aluminium resistance 
 
ScALMT1 Rye, Secale 
cereale 
Root cell plasma 
membranes 
Y Aluminium resistance 
 
GmALMT1 Soybean, 
Glycine max 
Root cell plasma 
membranes 
Y Aluminium resistance 
 
HvALMT1 Barley, 
Hordeum 
vulgare 
Root cell plasma 
membranes and 
guard cells 
N Maintaining turgor in 
growing cells, guard 
cell movements 
ZmALMT1 Maize, Zea 
mays 
Plasma 
membranes 
throughout plant 
N Inorganic anion 
homeostasis 
ZmALMT2 Maize, Zea 
mays 
Root plasma 
membrane 
N Constitutive malate 
efflux, not Al-related 
LJALMT4 Lotus, Lotus 
japonicus 
Root nodules N Symbiosis with 
rhizobia 
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Figure 1.5 - Phylogenetic tree of ALMTs with known functions plus family 
members from Arabidopsis with unknown function.  
Numbers on nodes denote likelihood of correctness. Tree made using MEGA6 
software89, sequences were aligned by the inbuilt MUSCLE functionality, and 
constructed with the Maximum Likelihood method and 500 iterations of 
bootstrapping. Taken from Palmer et al. (2016) 
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1.3.5  Guard Cell Movements  
Another vital role played by some ALMT family members is found far away from 
the roots, within the leaves. Several homologues are molecular components of 
the guard cell movements that regulate gas exchange across leaf surfaces. 
Plants control CO2 uptake and water loss by regulating the aperture of the 
stomatal pores. Three family members from Arabidopsis, AtALMT6, AtALMT9, 
and AtALMT12, are involved in opening and closing of stomata, with movement 
driven by osmotically active inorganic and organic ions90. An overview of the 
process is seen in Figure 1.6.  Upon stomatal opening, K+ enters the guard cell 
via voltage-gated inward rectifying potassium channels, driven by the 
electrochemical gradient maintained by ATP-driven proton pumping. Malate 
synthesis from stored starch provides a charge-balancing ion, and is taken up 
into the vacuole via AtALMT6, and similarly AtALMT9 acts to permit entry of 
chloride counterions into the vacuole. The increase in solutes draws water into 
the cell down the water potential gradient, swelling the cell. The process is 
inverted during stomatal closing. The membrane is depolarised, prompted by 
the action of AtALMT12/QUAC1 (Quick Anion Channel1) releasing malate 
rapidly, this allows K+ to flow out of the cell, accompanied by Cl- and NO3- 
anions via SLAC1 (Slow Anion Channel1). In addition, AtALMT6 activity is 
regulated in part by the cytosolic malate concentration, and so malate can flow 
out of the vacuole to either be lost via AtALMT12/QUAC1 or used in 
metabolism. This loss of osmotica drives a loss of water and closing of the 
stomata.  
26 
 
 
Figure 1.6 - Schematic of ion currents in stomatal opening and closing. 
 K+ ions enter the cell during opening, and the charge is balanced by malate 
synthesis from starch, which is then taken up into the vacuole via ALMT6 and 
activates ALMT9 to permit Cl- uptake into the vacuole. This increase in osmotic 
potential draws water into the cell, leading to swelling and stomatal opening. 
Stomatal closing, conversely, is driven by release of K+ ions, which is permitted 
during membrane depolarisation and driven by ALMT12. Additionally, anions 
are released by SLAC1 over a longer period of time. Loss of osmolytes leads to 
concomitant loss of water and thus stomatal closing. Taken from Palmer et al. 
(2016) 
 
AtALMT6 is expressed in guard cell vacuoles and is a malate channel, specific 
for divalent malate involved in stomatal movements. It is not aluminium 
activated but instead is controlled by light, ABA91, pH, and cytosolic malate 
concentration92. As transport is dependent on the concentration of malate in the 
cytosol and the tonoplast membrane potential, AtALMT6 can mediate both 
malate uptake into and release from the vacuole in guard cells, with uptake 
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during stomatal opening, and release during stomatal closing as shown in 
Figure 1.6. Interestingly, in Arabidopsis thaliana expression is also seen in 
floral organs, suggesting another role yet to be elucidated. Knockout plants did 
not show phenotypic differences, indicating functional redundancy in vacuolar 
malate channels, perhaps from the action of AtALMT9 and perhaps also 
AtALMT5, which has been shown to be expressed in guard cells, and to be 
closely related to AtALMT6 as seen in the phylogenetic analysis in Figure 1.5.  
AtALMT9 is a vacuolar chloride channel in guard cells and knockouts show 
impaired stomatal opening48. It permits chloride to enter the vacuole, providing a 
charge-balance for K+ in the same way as malate. Malate in the cytosol 
(synthesised from starch) activates the channel, meaning malate can act both 
as an osmolyte and as a signalling molecule in guard cells. Interestingly, kinetic 
data suggest AtALMT9 is multimeric, with a number of subunits >2.5 with more 
recent work based on co-expressing WT and mutated AtALMT9 suggesting that 
it is forms a tetramer93. Furthermore, cytosolic nucleotides such as ATP block 
the activity of AtALMT9, competing with malate for a binding site94. This 
provides a level of regulation based on the activity of the H+-V-ATPases that 
maintain a hyperpolarised tonoplast. These consume ATP, provoking lowered 
cytosolic ATP concentrations, removing this block and thus permitting currents 
via AtALMT9 and facilitating anion uptake into the vacuole. Mutagenesis studies 
identified the positively-charged Lys193, Arg200, and Arg215 in the fifth TM 
helix as being vital for channel function93 but, similar to studies of ALMT1, the 
mechanistic relevance of these residues is unclear although they are 
speculated to be part of the permeation pathway, putatively formed by TM5. 
Indeed, AtALMT9 is the only member whose N-terminal transmembrane domain 
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has been studied in detail by mutagenesis studies and a conserved pair of 
residues (Lys93 and Glu130), found in the first two helices were found to form a 
salt bridge vital for formation of a functional channel. The N-terminal domain of 
ALMTs are well conserved, with sometimes >50% identity, and many residues 
(such as the pair involved in a salt bridge) being strictly conserved and so 
findings such as this are likely to be widely applicable across all family 
members.  
AtALMT12 (also known as QUAC1) is expressed in guard cell plasma 
membranes and operates as an R-type (Rapid-type) channel crucial for 
stomatal closing47, allowing rapid malate release. One study also found 
localisation to endomembranes, although this is possibly an artefact of 
overexpression or evidence of regulation of the channel95. The channel opens 
with fast kinetics upon membrane depolarisation, releasing malate into the 
apoplasm in parallel with K+ release through potassium channels to maintain 
the depolarisation. Moreover, both cytoplasmic malate and external malate 
causes increased activation of the channel and thus may represent a positive-
feedback loop.  Loss-of function mutants confer a wilty phenotype due to their 
impaired stomatal closing. Rather than being ligand-gated, as seen in ALMT1, 
ALMT12 activity is voltage gated; however, the voltage sensor is yet to be 
identified, although it is likely in the CTD, which has been shown to be vital for 
regulation, but eleven deletion mutants missing sections of the CTD were all 
non-functional and so could not help locate the voltage sensing domain86. A 
GFP fusion at the C-terminus also prevented voltage-gated deactivation of the 
channel, suggesting that the CTD is involved in closing the channel.  
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1.3.6  Other Roles  
1.3.6.1  Malate storage and homeostasis 
AtALMT9, in addition to its role in guard cells has been shown to be permeable 
to both chloride and malate and expressed strongly throughout leaf mesophyll 
tissue. It is proposed to have a role in homeostasis: ensuring that the 
concentration of malate – which plays an essential role in metabolism as part of 
the citric acid cycle – remains stable within the cytoplasm. Similar to AtALMT6, 
the channel is likely to work in both directions, by storing excess in the vacuole 
and releasing it when required to regulate osmotic potential and C-
metabolism96.  
1.3.6.2 Cell elongation and nutrient storage 
Barley (Hordeum vulgare) HvALMT1 is a malate channel expressed in guard 
cells and in the root elongation zone, as well as in floral tissues and seeds97. 
Although it has the greatest sequence similarity to TaALMT1 in the barley 
genome and localises to the plasma membrane, it is not involved in Al-
resistance but seems to have several distinct roles within the plant. HvALMT1 
over-expressing lines take longer to close their stomata98 and RNAi knockouts 
show a similar wilty phenotype to Atamlt12 knockouts51, so HvALMT1 is 
proposed to be a functional homologue of AtALMT12, transporting malate from 
the guard cell. In expanding cells HvALMT1 may help provide an osmotic 
balance and regulate turgor. Additionally, later studies have shown that this 
channel plays a role in seed development during acidification of the starchy 
endosperm, which is required for enzyme activity51. Rather than directly causing 
acidification itself (this is most plausibly caused by a H+-ATPase pumping 
protons from the surrounding aleurone layer) release of malate is suggested to 
act as a counterion for H+ and other positively charged nutrients such as K+, 
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helping to maintain electroneutrality and osmotic balance in a similar manner to 
the role of malate in guard cell movements. The significant difference in function 
between HvALMT1 and TaALMT1 despite strong sequence similarity again 
highlights that small differences in sequence can underlie large changes in 
function.  
1.3.6.3 Fruit Flavour 
Malic acid is an important component of apple taste, grape quality, and wine 
production: an economically-significant set of traits. A malic acid channel 
homologous to AtALMT genes has been shown to be responsible for the acidity 
of apples, and functions to accumulate malic acid in the vacuole: 90% of acid 
content of apples is malic acid. 50,99. Similarly, grape berries contain an ALMT 
family member expressed in the tonoplast of berry mesocarp tissue responsible 
for malate and tartrate accumulation100. Understanding of the action of these 
genes could be valuable for fruit and wine development99. Interestingly, one 
allele has been found containing a premature stop codon within the CTD, 
causing a loss of function. This protein localises to the plasma membrane rather 
than tonoplast, suggesting that localisation is at least partly controlled by the 
CTD99.  
1.3.6.4 Inorganic Anion Homeostasis 
ZmALMT1 from maize was one of the first family members to be described that 
did not have a role in aluminium resistance. It localises to plasma membranes 
throughout the plant, but is less permeable to organic anions and instead is 
likely involved in inorganic anion homeostasis and mineral nutrition49. 
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1.3.6.5 GABA Signalling  
A recently-discovered role of ALMTs is in mediating γ-aminobutyric acid (GABA) 
signalling in plants. This is the first evidence for GABA signalling in plants in 
addition to its established role as a metabolite within the TCA cycle52. GABA is 
a non-protein amino acid that accumulates in plant tissues in response to biotic 
and abiotic stresses, and has a central role in pollen tube growth and the 
regulation of root growth101. Recently, it has been shown that GABA’s influence 
is exerted by interaction with ALMT proteins, and a putative GABA-binding motif 
has been identified in the CTD, falling just after the sixth transmembrane helix, 
on the extracellular face. GABA binding negatively regulates ion flux through the 
channel, i.e. decreasing carbon flux from roots in the case of TaALMT1. 
Additionally, as plant anion equilibrium potentials are strongly positive and plant 
action potentials are generated by voltage gated ion channels, GABA inhibition 
of ALMTs will hyperpolarise membranes and decrease excitability. And as 
ALMTs can control membrane voltages, they indirectly control transport of other 
ions that rely on the membrane potential. A mechanism of long-distance 
electrical signalling in plants has been proposed to act via ALMTs. Malate and 
GABA regulate ALMT activity in opposite directions and can both be transported 
out of a cell to affect the activity of ALMTs in adjacent cells. This could mediate 
signalling in times of increased stress that produces ROS, as in these 
conditions 2-oxoglutarate is transported out of the mitochondria, and converted 
to GABA in the cytoplasm which is free to be released, or can otherwise re-
enter the mitochondria to re-join the TCA cycle.  
This new understanding of the role of GABA, like many other discoveries made 
relating to ALMTs raises even more questions. By what mechanism does GABA 
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regulate ALMTs? Where is the GABA binding site located in the ALMT 
structure, is it on the inside or outside of the cell? What implications does this 
have for ALMT topology? Are ALMTs functional multimers, and if so are these 
homomers-or heteromers? Mammalian GABA-receptors are heteromers with 
the GABA binding site found at the junction between proteins, is this reflected in 
ALMTs?   
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1.4 Bacterial members of the ArAE family (PETs)  
The second sub-family of the AeAE family of interest within this study is the 
bacterial clade, seven members of which were initially identified as part of the 
PET family in 200036, alongside the plant ALMTs. The best studied of these 
bacterial members is AaeB, with the only other protein with an identified 
function being SdsQ. These two were first identified as part of a novel family of 
inner-membrane bacterial transporters, named Putative Efflux Transporters 
(PETs) in 200036, since classified as Aromatic Acid Exporters (ArAE). These 
two characterised proteins will be discussed below.  
1.4.1 AaeA and AaeB – the aromatic acid exporter  
AaeB is one of only two members of the PET family that has been characterised 
at all, albeit in a limited way, and its role has been  described as a “metabolic 
relief valve”, involved in exporting aromatic acids such as p-hydroxybenzoic 
acid (pHBA) (shown in Figure 1.7), leading to the naming of it as Aromatic Acid 
Exporter B (AaeB)38. In addition to this protective role, AaeB may also have a 
function in biofilm formation102. The gene is expressed when the cell is under 
some metabolic upset which makes it a target for biotechnological development 
as a sensor for build-up of toxic metabolites, for example in biofuel 
production103–105. 
 
Figure 1.7 The primary substrate of AaeB, p-hydroxybenzoic acid. 
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AaeB is predicted to contain a duplicated repeat of six transmembrane helices, 
each followed by a soluble cytoplasmic domain, as previously mentioned, 
shown in Figure 1.8B. It is likely to form an inner-membrane efflux pump.  
 
 
Figure 1.8 – Hydrophobicity plots for AaeA and AaeB.  
A) hydrophobicity plot calculated by the Kyte and Doolittle method for AaeA. 
The predicted transmemebrane helix is annotated. B) Hydrophobicity plot for 
AaeB. The two transmembrane domains are annotated. 
 
Also expressed from the same operon as AaeB is a second protein, designated 
AaeA. From its sequence this is predicted to be part of the Membrane Fusion 
Protein (MFP) class, also called the Periplasmic Adaptor Proteins (PAPs)106. 
Several of these (which associate with other IM transporters from families such 
as the RND or MFS families) have had crystal structures solved. These 
MFP/PAPs have a conserved overall architecture, shown in Figure 1.9 with 
typically four domains, which extend out from the inner membrane: membrane 
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proximal domain (MPD), the β-barrel domain, the lipoyl domain, and the α-
hairpin domain107. They are anchored into the inner membrane either by a 
single hydrophobic transmembrane helix, indicated in Figure 1.8A, or by a lipid 
anchor.  
 
Figure 1.9 - Schematic representation of a range of MFP crystal 
structures.  
Structures of MFPs that form complexes with three families of exporters, 
Resistance-Nodulation-Division (RND) Major Facilitator Superfamily (MFS), and 
ATP-Binding Cassette (ABC) are shown. The four canonical domains are: the 
membrane proximal domain (MPD), coloured orange; the β-barrel domain, 
coloured yellow; the lipoyl domain, coloured green; and the α-hairpin domain, 
coloured blue. BesA lacks the α-hairpin, while EmrA lacks a MPD, and CusB 
has an additional N-terminal domain. Figure adapted from Symmons et al. 
(2015)107 
 
These proteins form tripartite efflux pumps alongside inner membrane 
transporters (such as AaeB) and outer membrane channels (such as TolC) 
helping to bridge the gap between the membranes in Gram-negative bacteria 
such as E. coli108, although MFP proteins have been identified in Gram-positive 
bacteria, which do not have an outer membrane, suggesting that these proteins 
have a wider role109. Interestingly, although previous studies had shown that 
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both AaeA and AaeB were required to provide physiological protection against 
aromatic acid toxicity in E. coli, knockouts of TolC had only a minimal effect, 
suggesting that AaeA and AaeB do not form a complex with TolC in the manner 
of tripartite systems such as AcrA-AcrB-TolC110. This could also be because the 
substrate for transport in this case is a normal metabolic product that is a useful 
carbon source for the cell, and so export via the AaeB inner membrane 
transporter into the periplasm may leave the pHBA available for re-uptake and 
later use, rendering any export entirely out of the cell past the outer membrane 
unnecessary. Alternatively, a complex may be formed with another outer 
membrane protein such as the one found in the sdsQRP operon.  
1.5 MdtO/SdsQ - the Sulfa-drug Exporter  
The second bacterial ArAE family member identified in E. coli that has been 
studied to a degree is MdtO/SdsQ (sulfa drug sensitivity determinant), which 
was identified as a target of the LeuO transcription factor42. Expression of LeuO 
was shown to increase expression of the sdsRQP operon and as such increase 
resistance to sulfa drugs, while knockouts of the sdsRQP operon were more 
sensitive to sulfa drugs even in the presence of LeuO expression, suggesting 
that SdsRQP is a sulfa drug efflux pump42. Sulfa drugs have similar structural 
characteristics – such as a polar functional group attached to an aromatic ring – 
to pHBA, the substrate of AaeAB, which again shows that members of the 
bacterial PET family (or AeAE family) have similar aromatic substrates. 
Although the proteins of this operon have been shown to be involved in 
protection against sulfa drugs no further characterisation or isolation of the 
individual proteins has taken place, meaning that, like for AaeAB, there is room 
for much more exploration of these proteins and the wider family. Interestingly, 
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the operon contains proteins that are predicted to be an inner membrane 
transporter (SdsQ), a membrane fusion protein (SdsR), and an outer membrane 
channel (SdsP), analogous to bacterial tripartite efflux systems108.  
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1.6  Challenges in membrane protein expression and structural 
studies 
Membrane proteins represent around 30% of genes in organisms 111, and over 
50% of drug targets 112. Thus, they form a class of high-priority targets for 
structural studies. Yet, despite this importance, less than 2% of published 
structures in the PDB are membrane proteins, although this number is growing 
as seen in Figure 1.10. This disparity is due to difficulties in expression and 
solubilisation of these proteins. Indeed, a minor but not inconsequential 
exemplar of the problems encountered in studies of membrane proteins is that 
they often run as a much more mobile band on SDS-PAGE than would be 
expected from their molecular weight, sometimes at a size as little as 65% of 
the expected113–115. This complicates the analysis and identification of 
membrane proteins but is not a fatal flaw. However, there are many more 
significant challenges to overcome, which will be discussed in this section.  
Membrane proteins are very challenging targets as a large proportion of their 
surface area is hydrophobic, and they are covered with membrane lipids in the 
native state; conversely, most biochemical and structural assays are carried out 
in aqueous solution, and consequently detergents, or other solubilisation 
methods, are required to solubilise and maintain the function of membrane 
proteins in solution. However, these detergents can present problems of their 
own. A brief survey of the major challenges in any studies of membrane 
proteins, expression, solubilisation, purification, and of the challenges specific to 
structural biology is described in the following section.  
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Figure 1.10 – Cumulative number of membrane protein structures solved, 
showing an exponential increase over time. 
 List maintained by the White lab at UC Irvine. Figure taken from 
http://blanco.biomol.uci.edu/mpstruc/. 620 unique proteins, from ~2000 
coordinate files as of 05/06/2016 
 
1.6.1  Expression 
A primary problem when working with many membrane proteins is obtaining 
sufficient quantity of the protein of interest116. Membrane proteins are often 
found only at low levels in their native host, as they are localised within 
membranes, which comprise only a small total proportion of the cell, less than 
0.1% (whether the cell membrane, or particular endomembranes)117. Although 
some systems can be obtained from the native host without overexpression, for 
example, the mitochondrial ATPase and bc1 complex118 these systems are not 
the norm. As a result, heterologous overexpression can be used to generate a 
sufficient amount of material for biochemical and structural studies, which often 
require several milligrams of the protein of interest119. However, heterologous 
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expression can lead to aggregation of the protein and formation of inclusion 
bodies in the cytoplasm, and, depending on the target and expression system 
chosen, the expression host may lack important machinery for folding and post-
translational modification required to produce fully-functional membrane 
protein120,121. Thus, optimisation of expression is crucial in order to obtain 
sufficient material in an active state, and this is aided by the development high-
throughput methodologies for heterologous expression which allow for 
screening of a large number of conditions on a small scale, rapidly122. However, 
at present, it is not possible to predict what conditions will prove successful at 
the outset of an investigation. In a study of three closely related proteins, 
OCTN1, 2, and 3, protein expression was optimised in order to produce the 
three proteins for structural studies but the best conditions were not the same 
for each of the three proteins despite their close evolutionary relationship and 
structure, including expression vector, fusion tag, codon optimisation, 
expression strain, growth medium, and duration of expression115. Similarly, 
when expressing several inositol polyphosphate sensing SPX-domains (which 
are soluble in isolation, but often part of membrane proteins) from a variety of 
eukaryotic proteins, the study authors screened 45 combinations of protein 
source organism, truncation, mutation, type and location of tag, and found that 
less than half of the conditions expressed well in E. coli and crystals were 
obtained from only three of the constructs 123. There are no straightforward 
criteria for improving the yield proteins when expressing them in bacteria, even 
for closely related proteins.  
Choice of expression host is certainly a key factor for the success of protein 
expression124. While bacterial expression is attractive due to its low cost, high 
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scalability, and ease of use, eukaryotic membrane protein targets are rarely 
possible to express in the many common E. coli expression strains125. Bacterial 
expression hosts often have difficulty with several elements of expression. For 
example, codon bias, caused by factors such as E. coli  rarely using certain 
codons, such as AUA for Ile, resulting in a shortage of the corresponding tRNA, 
stalling expression126; or, problems with folding long complex sections of 
protein, which is difficult for bacterial machinery to process, followed by 
insertion into the membrane, which can overload the bacterial Sec translocon, 
with toxic effects127. There are a variety of different tools available, such as 
modified strains of E. coli, to help overcome these problems, many of which are 
commercially available and several of which are surveyed by Indiveri et al. 115.  
If an investigator plans to use a eukaryotic expression system instead, several 
options exist. Established eukaryotic expression hosts available include, in 
order of increasing expense and similarity to human systems, the yeasts128 S. 
cerevisiae and P. pastoris, the insect cell line Sf9129, and various mammalian 
immortalised cell lines130. There have even been recent developments in plant-
based expression systems which have seen success in creating vaccines, 
enzymes and antibodies131,132, and cell-free systems are available that can 
produce protein in vitro133,134. Often, choosing a system for expression requires 
trade-offs to be made: although human-derived immortalised cells may be the 
closest option for producing a human membrane protein in a near-native 
environment, the cost may be prohibitively high, especially when considering 
the large cultures required to produce sufficient purified protein for X-ray 
crystallography as eukaryotic systems have, with few exceptions, much lower 
expression yields when compared to E. coli115. In fact, data from the PDB 
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shows that the second most common expression host (after E. coli) to 
successfully produce a protein structure is the insect cell line, Spodoptera 
frugiperda, which perhaps strikes a balance between cost, ease of use, and 
complexity of internal machinery135.  
A significant challenge for many proteins is the problem of toxicity. 
Overexpression of a protein of interest may cause significant negative effects in 
the host cell, inhibiting protein synthesis of endogenous proteins through 
competition and potentially causing the cell to die as a result. This has the 
obvious side effect of reducing yields of heterologously expressed protein. 
Alternatively, a protein could be toxic due to unregulated biological activity. For 
example, overexpression of an ion channel, which rests in the “open state” 
could result in the host cell becoming ‘leaky’ as ions flow through the channels 
and destroy vital electrochemical gradients. As such, expression systems are 
often designed to prevent expression until it is desired. For example, 
biotechnological bacterial expression systems are frequently based on the lac 
operon. The LacI repressor gene is expressed, which prevents any expression 
of the target protein until the addition of IPTG. This allows for careful control of 
induction of expression136. A related system is the method of autoinduction137. 
This again takes advantage of the Lac repressor, by growing the cells in media 
containing three sugars. Glucose in the media provides a carbon source and 
allows the bacteria to grow to high density, while also ensuring that the lac-
operon based repression is held on; then as glucose is used up (at the point 
that the cells have reach high density) the lactose within the media induces 
expression of the target gene; and during this expression period the glycerol 
within the media provides a carbon source as an alternative to lactose to ensure 
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it is not used up137. By this method expression is prevented while the cells are 
grown to high density, then expression is induced and even if the target protein 
is toxic to the cells and they cannot express the protein to a high amount per 
cell, they are at such a high density that the yield per litre of culture is still 
significant116.  
Sometimes when expression in E. coli produces a high yield the protein is 
expressed in inclusion bodies, which sequester the target protein in insoluble 
aggregates. One approach to solve this problem is refolding the inclusion 
bodies using a denaturant such as urea, before removing the denaturant and 
allowing the protein to re-fold into its correct conformation138,139. Several helical 
membrane proteins have been refolded from inclusion bodies140 including Light 
Harvesting Complex II141 and Diacylglycerol Kinase142. This can also be 
achieved with β-barrel proteins, the outer membrane protein precursor 
proOmpA, for example, can be produced from inclusion bodies solubilised in 6M 
urea before using in downstream experiments143.  
The use of protein chimeras has also been developed to enhance expression. 
Often the study of protein complexes can be enhanced by the production of 
chimeric constructs to increase complex stability. The Kv1.2 K+ channel was 
solved with a chimeric paddle domain transferred from Kv2.1144. Similarly, when 
studying the structure of the tripartite AcrA-AcrB-TolC pump that spans from the 
inner to the outer membrane of E. coli, the proteins were expressed and fused 
with poly-glycine linkers in order to produce the first structure of the full complex 
and its quaternary organization110. Fusion of proteins that are stable but not 
directly related to the target protein such as a Maltose Binding Protein 
(MBP)145,146, glutathione S-transferase (GST)147, and thioredoxin (Trx)148 can 
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also be used. MBP is particularly appropriate as it is from a membrane protein 
system, and forms part of the maltose/maltodextrin uptake system from E. 
coli149. This will often generate a chimeric protein product in a greater yield that 
is more stable and soluble, and more amenable to study150,151, and can often 
create a larger area of crystal contacts. Over 100 structures in the PDB have 
been produced using MBP-fusion proteins alone, with the number growing 
every year.  
There are many other possible techniques, including expression of heat shock 
proteins and chaperones152,153, use of engineered E. coli strains154,155, and 
lowering the temperature of expression156 among many more, and these 
techniques are used in combinations too numerous to review in totality, and 
indeed no approach is a guarantee of success157. 
  
1.6.2  Structural Studies of Bacterial Proteins to Understand 
Eukaryotic Targets 
While prokaryotic proteins are important and deserving of study in their own 
right, they can also prove useful for the study of eukaryotic protein targets, 
especially given the intractability of many eukaryotic membrane proteins. 
Ideally, all studies of eukaryotic proteins would be done on the protein in 
question, but as discussed above, this is not always possible. As such, it is 
often easier to identify a homologue of the protein of interest from a bacterial 
species and then use that for structural experiments as they are usually more 
experimentally amenable and can be more frequently expressed to the high 
levels required for structural studies158, taking advantage of the ability to grow 
E. coli on a large scale (for example in a 30-100 L fermentation vessel). 
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Although bacterial membrane proteins can differ significantly in primary 
sequence to their eukaryotic homologues, structural motifs are generally much 
more strongly conserved159 and so there are often functional properties in 
common between the two proteins and the three dimensional structural 
information obtained from such experiments can inform modelling of the 
structure of the eukaryotic protein. This has been done, for example with human 
eukaryotic initiation factor 5A, based on two crystal structures of bacterial 
proteins 32-34% identical to the human protein160, and understanding of 
bacteriorhodopsin has informed the study of rhodopsin-like proteins161. A recent 
study detailed a method for generating high-resolution structural models of 
alpha-helical membrane proteins from distant homologues162. Such models can 
help generate hypotheses, and guide the design and interpretation of 
experiments. For example, information about residues involved in transport in 
one protein can guide mutagenesis studies to investigate the same in another 
protein, and these experiments will drive an iterative cycle of testing and re-
modelling. 
An example of such an approach is seen the study of NupG from E. coli, a 
bacterial homologue of nucleotide transporters found in humans which are 
important for cancer chemotherapy, neurotransmission, cardiac activity, and 
viral infection163,164. The study of the bacterial protein opened the way to 
elucidating the molecular mechanisms involved in transport for this family of 
membrane transporters30. Molecular modelling has since been applied to 
nucleoside transporter proteins165 based on a related crystal structure from 
Vibrio cholorae166 alongside the previously acquired data for the NupG 
secondary structure. More recently, a protocol for protein production, 
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solubilisation, and purification was developed further to enable greater variety in 
affinity tagging and applied to a range of bacterial proteins with homology to 
human proteins167.  
Often a strategy used is to find a homologous protein within a thermophilic 
species such as Thermus thermophilus168. Proteins from thermophiles are 
prime targets mainly because the enzymes and macromolecular complexes of 
thermophiles are more easily purified, manipulated, and more stable during the 
long time periods needed for crystallization and this has proved to be a 
successful route to the study of protein structures and 21% of the T. 
thermophilus proteome is now represented by a solved crystal structure 168. Of 
course, this approach is only appropriate if a closely-related protein can be 
found within the T. thermophilus genome. 
 
1.6.3  Solubilisation 
Once a sufficient level of expression has been achieved, then scaled up169, and 
the cellular membranes have been isolated either by centrifugation113 or 
tangential flow filtration170, a method must be found to extract the membrane 
protein from the lipidic environment, while maintaining the intact folded state 
and solubility 171. This is made more complicated by the fact that in many 
instances the membrane lipids that naturally interact with the protein are vital for 
stability, and may play a role in protein activity such as is seen in the case of 
TRPV1, which has bound lipids that are vital for its mechanism172. There are 
several potential strategies and many possible reagents including the use of 
detergents173, nanodiscs174, SMALPs 175, and amphipols 176, so finding the 
optimal approach often can be an expensive process of trial and error – often 
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using significant amount of precious overexpressed protein. This process has 
been aided by the development of high-throughput screens to allow faster 
identification of conditions, using less material177–179. One such method uses the 
dye 7-diethylamino-3-(4’maleimidylphenyl)-4-methylcoumarin (CPM), which 
binds to cysteines that become exposed as the protein is heated to measure 
thermal unfolding alongside light scattering180.  
The most established method for solubilisation is the use of detergents. These 
amphipathic molecules can solubilise the lipid bilayer and coat the hydrophobic 
surfaces of membrane proteins, rendering them stable in aqueous solution173. 
Each detergent has a Critical Micellar Concentration (CMC), dependant on the 
structure of the molecule, such as alkyl chain length and the nature of the polar 
head group and the CMC varies with pH, temperature, and other factors. Below 
the CMC the detergent exists as monomers in solution, but when the 
concentration of detergent is raised above the CMC, spherical micelles 
spontaneously form, driven by the hydrophobic effect. Figure 1.11A shows the 
process of adding detergent at above the CMC to a sample of protein held in a 
membrane. The protein is spontaneously extracted from the membrane and 
coated in a shell of detergent, which is of a size approximately equal in mass to 
the mass of the protein181. Also shown in Figure 1.11B are structures of several 
non-ionic or zwitterionic detergents routinely used for membrane protein 
solubilisation. Also shown for comparison is SDS, an anionic detergent used for 
much harsher solubilisation of proteins for experiments such as SDS-PAGE 
which require denatured proteins.  
An interesting and novel approach to solving the problems of solubilisation is to 
radically redesign the protein to render it soluble by substituting the exterior lipid 
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facing hydrophobic residues of the protein for hydrophilic ones182,183. If 
successful, the resulting soluble protein can be studied without the need for 
maintaining the solubility and stability of the protein with detergents. This 
technique, however, is yet to be deployed on a wide scale.  
 
 
Figure 1.11 Detergent solubilisation of membrane proteins.  
A) Detergent solubilisation of membrane proteins involves adding a detergent at 
a concentration above its CMC. Membrane proteins are then spontaneously 
extracted from heir lipid membrane environment and coated in detergent. B) A 
range of detergent structures commonly used for membrane protein 
solubilisation. The maltosides DDM and DMNG, the glucoside β-OG, the 
zwitterionic LDAO, and the non-ionic C12E8 are shown along with SDS, an 
ionic detergent used regularly to denature protein, for comparison.  
 
1.6.4  Purification  
Once sufficient protein has been produced and solubilised, the purification of 
the protein is the next hurdle to overcome. The low expression levels discussed 
above prove a problem for purification, as the target protein represents only a 
small proportion of the total protein extracted from cells and thus preparations 
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already intrinsically contain a higher proportion of contaminants that must be 
removed. Several proteins are known to contaminate IMAC purifications184, in 
particular, contamination by the E. coli membrane protein AcrB is of concern as 
it has been shown to crystallise readily185, at pg-quantities (thus making it 
undetectable on coomassie-stained SDS-PAGE gels that are routinely used to 
examine purified protein samples for purity) and especially in glucoside 
detergents that are commonly used for solubilisation of the target protein186.  
1.6.5  Crystallisation 
Even when protein can be purified in a soluble form at an appropriate 
concentration structural determination can be problematic. Membrane protein 
crystallisation is the “gold standard” structural technique, but it is limited in 
several ways, starting from the fact that there are a relatively small number of 
commercially available screens as compared to soluble proteins. Perhaps more 
pertinently, the low number of solved structures means that there is a lower 
amount of data available on conditions that have proved to work in the past. 
Thus a typical experiment will explore a smaller amount of the potential 
crystallisation conditions space, lowering the chances of finding a condition that 
is a hit187. This point can often be moot, though, if sufficient protein cannot be 
produced, as the number of trials that it is possible to set up is limited instead by 
the low amount of protein. This is exacerbated by the fact that there is often a 
need to screen the same protein in several detergents, thus spreading the 
sample even more thinly.  
A number of new strategies have emerged to aid in the production of crystals 
that are of particular use for those studying membrane proteins. Robots that 
enable screening of crystallisation conditions in drops that use 100 nL of protein 
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per drop enable a precious protein sample to be screened in a larger number of 
conditions than, for example, use of 2 μL drops in hanging drop trays187. 
Crystallisation by lipidic cubic phase (LCP, or lipidic mesophases)188 enables 
crystallisation in a native-like membrane environment and can produce higher-
quality crystals as compared to traditional crystallization from detergent 
solutions and has shown promise in the crystallisation of a membrane kinase133, 
several rhodopsins189,190, human β2 adrenoceptor10, and the outer membrane 
transporter, BtuB191.  A sparse screen for lipidic conditions has been developed 
to aid screening of ideal conditions192. This can help overcome the disruption of 
crystal contacts by detergent micelles, as shown by Figure 1.12 – the larger 
micelles cover the entire protein surface leaving no part able to make the 
protein-protein interactions needed for crystal formation.  Finally, once crystals 
have been obtained, they are often fragile, difficult to handle, and poorly-
diffracting187, which can require extensive optimisation, or co-crystallisation with 
a stabilising antibody, which can help create more crystal contacts10. However, 
despite these difficulties, the number of solved membrane protein crystal 
structures is increasing year by year, in a large part due to the ever growing 
knowledge within the field and development of new technology, which is 
comprehensively reviewed in: Moraes et al. (2014)15. Notwithstanding these 
recent advances, however, many membrane proteins have proved intractable to 
structural study.  
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Figure 1.12 - Effect of differing micelle sizes on membrane protein 
visibility and crystal contacts.  
A membrane protein (MP) surrounded by detergent micelles of steadily 
increasing size (diminishing intensity of blue). As the micelle size increases, 
progressively less and less of the protein surface is accessible to the solvent, 
and in the largest micelles the protein is completely embedded.  
 
1.6.6  Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR has limited applicability to membrane protein structural determination, with 
success being possible for only relatively small proteins193, and there is 
generally a need to produce isotopically-labelled proteins at a high purity and 
high concentration – as much as 1 mM, equivalent to 50 mg/mL for a protein of 
50 kDa. Solution-state NMR is made more difficult as the bound detergent gives 
particles of approximately double the molecular weight181 and so decreases the 
tumbling rate, impeding measurements. Solid-state NMR is an emerging 
technique to aid the study of membrane protein structures and can be applied to 
microcrystals formed in crystallography experiments that do not diffract 
sufficiently well194. The addition of constraints derived from NMR data can be 
applied to data from crystallography to improve resolution, particularly useful in 
combination with weakly-diffracting crystals, and in one example researchers 
were able to improve a 3.7 Å map derived from crystallography to a precision of 
0.92 Å in the membrane region195.   
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1.6.7  Electron Microscopy 
Although X-ray crystallography has so far been the dominant structural 
technique, recent developments in electron microscopy (EM), and especially 
cryo-EM, have driven a growth in solved structures year-on-year 186,196 
alongside developments such as the use of nanodiscs 108 or SMALPs175 for 
protein solubilisation rather than detergents, leading to samples that are better 
suited to analysis by EM. While crystallography has proved a powerful tool thus 
far for the study of membrane proteins, EM allows the use of radically smaller 
amounts of protein and can enable the study of proteins within the native 
environment, in a variety of conformational states. Targets considered 
intractable for crystallographic studies can now be re-evaluated by EM with 
improved chance of success and with new investments in EM technology 
researchers can re-visit previous projects that may have failed to produce 
crystals. A good example of this is the AcrA-AcrB-TolC tripartite pump: the 
organisation of the whole complex had proved intractable by crystallography 
and significant discussion has taken place in the literature over the exact nature 
of the interactions between the subunits and their stoichiometry, but the recent 
structure provided by EM of the intact complex enabled visualisation of the 3:6:3 
stoichiometry, and the mode of and location of interaction between AcrA and 
TolC110.  
The development of direct electron detectors (DED) is a significant 
improvement on traditional CCD cameras due to and improved signal-to-noise 
and has been key to obtaining high-resolution information. Moreover, DED’s are 
able to collect images as a series of frames, allowing the user to correct for 
sample movement from the electron beam and improve the quality of collected 
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images197. The resolution of more recent EM maps is sufficient even to locate 
bound ligands. For example, γ-secretase had proved intractable to 
crystallographic studies, until 2014 when a 4.5 Å resolution EM structure was 
published198. This was followed up by an improved study with larger dataset, 
increased magnification, and computationally accounting for heterogeneity in 
the sample that increased the resolution to 3.4 Å199 and then a third study 
allowed visualisation of the bound inhibitor200. Another example of recent 
successful application of improvements in EM technology is the rotary ATPase 
family. In single particle cryo-EM studies between 2011 and 2016, the F-
ATPase has improved in resolution from 32 Å to 6.2 Å3,201–203, the V-ATPase 
from 17 Å to 6.9 Å204–208, and A-ATPase from 16 Å to 6.4 Å29,201,209, leading to 
steadily more insights in structural features and mechanism, and the 
determination of distinct catalytic states. An example of the improvement in the 
V-ATPase structure is shown in Figure 1.13, which shows two cross sections 
through the protein structure and the significant improvement in resolution seen 
over the course of seven years.  
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Figure 1.13 - Cross section of V-ATPase showing improvements in 
resolution between 2009-2016.  
A) The 26 Å structure in 2009 is able to provide information on the general 
shape of the protein and some understanding of the symmetry and position of 
stators (labelled s1-s3)210. B) The 8.2 Å structure in 2016 is able to show the 
position of individual helices in the structure. Improvements in hardware, and 
novel data processing techniques to account for flexibility and movement in the 
sample account for the improvement in resolution 211. 
 
EM, of course, is not a panacea. EM datasets often have to be very large, with 
potentially over 1,000,000 particles required for analysis, necessitating 
thousands of micrographs to be collected over several days. The raw data 
requirements of these datasets are intense, as a single exposure can be 1-2 GB 
in size, and so an experimental dataset may represent over 7 TB of data and 
thus storage and processing of such data requires specialised IT 
infrastructure186. In addition, the problems discussed above in production of 
sufficient protein, solubilisation and stabilisation, and purification still apply, but 
are somewhat lessened as smaller amounts of protein are required for EM 
studies, and to a certain extent protein can be “purified” during data processing 
as particles that are not the target protein can be discarded. Indeed, “on grid” 
55 
 
purification is in development with the use of Ni2+-doped lipids to extract 
polyhistidine-tagged proteins directly212. Overall, EM stands as an attractive 
structural technique for examination of membrane proteins, and will become 
only more attractive as developments are continuing in microscopes, detectors, 
and data processing213. 
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1.7  Aims of this project 
Proteins from the ArAE Family from both plants and bacteria have many vital 
roles, and many homologues remain uncharacterised, suggesting that further 
roles are yet to be elucidated. However, despite this importance no high quality 
structural or mechanistic data exists for any family member and much of the 
limited understanding of key residues and overall organisation of the proteins 
remain ambiguous at best. In the present study, the overall aim was to derive 
structural information about ALMT family members, by means of studying both 
the CTD and full length ALMT proteins, and bacterial family members including 
AaeB. This would require the acquisition of the relevant DNA, construction of 
expression vectors suitable for the expression systems chosen, and then 
optimisation of production of protein by overexpression. The targets were as 
follows: 
1. The CTD of TaALMT1, expressed in E. coli. 
2. Full length TaALMT1, AtALMT5, AtALMT9 transiently expressed in 
tobacco plants. 
3. An E. coli protein, AaeB, expressed in E. coli, along with its proposed 
partner AaeA. 
Once produced these protein targets would be used in structural and 
biochemical experiments. High priority studies are X-ray crystallography and 
electron microscopy in order to determine the 3-dimensional structure of these 
proteins, but other studies include investigation of complex formation and 
stoichiometry by crosslinking and SEC-MALLS, alongside homology modelling 
were also of interest, especially with the ultimate aim to resolve the open 
questions and matters of contention discussed above in this introduction.  
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Chapter 2 
Materials and Methods 
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Analytical grade reagents were prepared using Milli-QTM water (resistivity 18.2 
MΩ•cm using either a Sartorius arium® mini plus (Sartorius AG), or a Milli-Q® 
Advantage A10 Water Purification System (Merck Millipore). Unless certified 
sterile by the manufacturer, solutions were sterilised by filtration through a 0.22 
µm filter or autoclaving at 121°C for 20 min.  
 
2.1  Chemicals and Reagents 
Unless otherwise stated all chemicals and reagents used were obtained from 
Sigma-Aldrich or Fisher Scientific. Restriction enzymes were purchased from 
NEB.  
2.2  Bacterial Growth and Expression Media 
2.2.1  Media for growth 
The following solutions were prepared for the growth of bacteria and expression 
of protein in E. coli, recipes were taken from Postis et al. (2013)116.  
Table 2.1 - Lysogeny broth (LB) medium 
Component Quantity (for 1L)   Concentration 
Tryptone 10 g  1% (w/v) 
Yeast Extract  5 g  0.5%  (w/v) 
NaCl 10 g  1% (w/v) 
Autoclaved 
Table 2.2 - Super broth (SB) medium 
Component Quantity (for 1L)  Concentration 
Tryptone 32 g 3.2% (w/v) 
Yeast Extract  20 g 2%  (w/v) 
NaCl 10 g 1% (w/v) 
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Autoclaved 
 
Table 2.3 - LB medium without salt for use in Autoinduction 
Component Quantity (for 1L)  Concentration 
Tryptone 10 g 1% (w/v) 
Yeast Extract  5 g 0.5%  (w/v) 
Autoclaved 
Table 2.4 - SB medium without salt for use in Autoinduction 
Component Quantity (for 1L)  Concentration 
Tryptone 32 g 3.2% (w/v) 
Yeast Extract  20 g 2%  (w/v) 
Autoclaved 
Table 2.5 - 5X M9 Salts for use in Autoinduction 
Component  Quantity (for 1L)   Concentration 
Na2HPO4 30 g 3% (w/v) 
KH2PO4 15 g 1.5% (w/v) 
NH4Cl 5 g 0.5% (w/v) 
NaCl 2.5 g 0.25% (w/v) 
CaCl2 15 mg - 
Autoclaved 
Table 2.6 - 20X NSPC for use in Autoinduction  
Component  Quantity (for 1L)   Concentration 
Na2HPO4  71 g 0.5 M 
KH2PO4 68 g 0.5 M 
NH4Cl 53.5 g 1 M 
Na2SO4 14.2 g 0.1 M 
pH adjusted to 6.7 with NaOH. Autoclaved 
 
 
0.5 M MgSO4 
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24.65 g MgSO4.7H2O, dissolved in water to give a final volume of 100 mL and 
autoclaved. 
 
Table 2.7 - 50X 5052 for use in Autoinduction 
Component  Quantity (for 1L)   Concentration (at 1X) 
Glycerol 250 g 0.5% (w/v) 
Glucose 25 g 0.05% (w/v) 
α-lactose 100 g 0.2% (w/v) 
Dissolved in 730 mL water, gently heated to dissolve the lactose, and sterilised 
by filtration.  
 
Table 2.8 - LB for autoinduction 
Component  Quantity (for 1L)   Concentration  
LB without salt  930 ml - 
0.5 M MgSO4 2 ml 1 mM 
50X 5052 20 ml 1X 
20X NSPC 50 ml 1X 
Antibiotics As required  
 
Table 2.9 - SB for autoinduction 
Component  Quantity (for 1L)   Concentration  
SB without salt  930 ml - 
0.5 M MgSO4 2 ml 1 mM 
50X 5052  20 ml 1X 
20X NSPC 50 ml 1X 
Antibiotics As required  
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Table 2.10 - M9 for autoinduction 
Component  Quantity (for 1L)   Concentration  
5X M9 Salts 200 ml 1X 
0.5 M MgSO4 2 ml 1 mM 
50X 5052  20 ml 1X 
20X NSPC 50 ml 1X 
Casamino acids 5% 
(w/v) 
40 ml 0.2% 
Antibiotics As required  
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2.3  Bacterial Strains 
Several E. coli strains were used during this project for DNA plasmid 
manipulation and expression of protein. Their genotypes are as follows: 
OmniMAX™ 2214: F´ {proAB+ lacIq lacZΔM15 Tn10(TetR) Δ(ccdAB)} mcrA 
Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ(lacZYA-argF) U169 endA1 recA1 
supE44 thi-1 gyrA96 relA1 tonA panD  
BL21 Star™(DE3)215: F- ompT hsdSB(rB- mB-) gal dcm rne131(DE3) 
BL21 Gold™(DE3)215: F- dcm+ Hte ompT hsdS(rB- mB-) gal λ (DE3) endA Tetr 
C41(DE3)216: F– ompT gal dcm hsdSB(rB- mB-) (DE3) 
C43(DE3)216: F– ompT gal dcm hsdSB(rB- mB-) (DE3) 
Agrobacterium tumefaciens217 strain LBA4404  rifampicin (chromosomal) and 
streptomycin (on the Ti plasmid) 
 
2.3.1  Preparation of Chemically-Competent Escherichia coli Cells 
Competent cells were prepared based upon the method of Hanahan218 with the 
following modifications. The required strain was aseptically streaked from a 
glycerol stock onto an agar plate containing appropriate antibiotics and grown 
overnight at 37°C. A 5 mL LB medium starter culture was inoculated with a 
single colony and grown for 16 hours at 37°C with shaking (200 rpm).  
Subsequently, 200 µL of the starter culture was used to inoculate 200 mL of LB 
medium, and cultured at 37°C with shaking (200 rpm) until an OD600 of 0.5 to 
0.8 was reached (typically 4-8 hours). Cells were chilled on ice for 15 minutes 
before centrifugation at 3,500 g for 10 minutes at 4oC and the pellets 
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resuspended into 20 mL ice-cold Tbf1 (3 mM CH3CO2K, 100 mM RbCl2 (Fluka 
Biochemicals), 10 mM CaCl2.2H2O, 50 mM MnCl2.4H2O, 15% (v/v) glycerol, pH 
5.8 (adjusted with acetic acid)).  After centrifugation (as above), the washed 
pellet was resuspended into 2 mL ice-cold Tbf2 (10 mM MOPS, 75 mM 
CaCl2.2H2O, 10 mM RbCl2, 15% glycerol, pH 6.5 (adjusted with KOH)).  
Competent cells were divided into 50 μL aliquots snap frozen in liquid N2 and 
stored at -80°C until use.  
 
2.3.2  Heat Shock Transformation of Escherichia coli Cells 
DNA (2 μL of a ligation reaction or 100-200 ng of plasmid DNA) was added to a 
freshly thawed 50 µL aliquot of chemically-competent E. coli cells, mixed and 
held at 4°C for 30 minutes. The cells were then heat shocked at 42°C for 30 
seconds and returned to 4°C for 2 minutes.  100 µL LB medium was added to 
the transformation and incubated at 37°C for 1 hour.  Transformed cells were 
plated out onto selective agar plates prior to overnight incubation at 37°C. 
 
2.3.3  Plasmid Maintenance in Bacteria 
Plasmids used were transformed into and maintained in One Shot OmniMAX 
Chemically Competent E. coli (Invitrogen). Colonies were grown either on solid 
media (Lysogeny Broth (LB) medium with 2% (w/v) agar containing appropriate 
antibiotic) at 37oC for 16-20 hours or liquid cultures in LB medium containing 
appropriate antibiotic at 37°C with shaking (200 rpm).  Permanent stocks were 
maintained in LB medium containing 20% (v/v) sterile glycerol at -80°C in 2 mL 
cryo-vials snap frozen in liq. N2. The cultures were revived by streaking onto 
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agar plates containing appropriate antibiotic and grown overnight until colonies 
appeared, which were then grown in LB medium.  
 
2.3.4  ALMT cDNA  
cDNA for AtALMT5 (AT1G68600, Clone: U14043) and AtALMT9 (AT3G18440, 
Clone: U24675) were obtained from the Arabidopsis Biological Resource Centre 
(ABRC, Ohio State University, USA). cDNA for TaALMT1 (Uniprot: Q76LB1) 
was synthesised by Genscript with XmaI and XhoI restriction sites flanking the 
gene. The primers in Table 8.12 were used for production of vectors.  
The pEAQ-HT vector and pEAQ-GFP were provided by Prof. George 
Lomonossoff, John Innes Centre. 
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2.4  Molecular Biology 
2.4.1  PCR 
PCR amplifications were performed using KOD Hot Start DNA Polymerase 
purchased from Novagen®. Typically, reactions of final volume 50 μL were set 
up as follows: 
5 μL 10 × KOD buffer (final concentration 1×) 
3 μL 25 mM MgSO4 (final concentration 1.5 mM) 
5 μL 2 mM dNTPs (mixture) (final concentration 0.2 mM) 
1.5 μL 10 μM Forward primer (final concentration 0.3 μM) 
1.5 μL 10 μM Reverse primer (final concentration 0.3 μM) 
5 μL 10 ng/μL genomic DNA or plasmid (total amount 50 ng) 
28 μL MilliQ H2O 
1 µL KOD Polymerase 
 
PCR Protocols followed the two methods as follows:  
 
TouchDown PCR 
95°C - 1 min 
95°C - 30 s 
70°C - 30 s decreasing each cycle by 1°C                    10 cycles 
70°C - 30 s per kb of desired product 
95°C - 30 s 
60°C - 30 s                                                                    30 cycles 
70°C - 30 s per kb of desired product 
70°C - 5 min 
4°C - continuous 
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Gradient PCR 
95 ºC - 4 min 
94 ºC - 30 s 
Gradient from 50 → 70 ºC - 30 s                             30 cycles 
72 ºC - 2 min 
4 ºC – continuous 
 
 
The primers used for construction of vectors and mutagenesis are listed in the 
tables below.  
 
Table 2.11 - List of primers used for the truncation of pTP1 and pTP2.  
F and R refer to the forward and reverse primer, respectively.  
Name Sequence 5’ -> 3’ 
pTP1_T-F GAAAACTCTGTTGCTAACACCATGGGTGGTAAAGACTCTCCGC  
pTP1_T-R GCGGAGAGTCTTTACCACCCATGGTGTTAGCAACAGAGTTTTC  
pTP2_T-F GTAAAGACTCTCCGCATATGCACAAATCTGTTC  
pTP2_T-R GAACAGATTTGTGCATATGCGGAGAGTCTTTAC  
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Table 2.12 - List of primers used for construction of plant expression 
constructs.  
Suffix C-F and C-R refer to the forward primer and reverse primer 
respectively to construct a protein with a C-terminal His-tag. Similarly, N-F 
and N-R refer to the N-terminal versions. No primers were needed for 
ALMT1N as the gene was synthesised with appropriate flanking restriction 
sites.  
Name Sequence 5’ -> 3’ 
ALMT1C-F TAAGCAACCGGTATGGATATAGATCATCGTAGGGAATC 
ALMT1C-R TAAGCACCCGGGAGTATCACAACATCAGGCAATGG 
ALMT1N-F N/A 
ALMT1N-R N/A 
ALMT5C-F ACCGGTATGGGAGGTAAAATGGGATCAG 
ALMT5C-R CCCGGGAACCTTAGGAATCTGATCAACAGC           
ALMT5N-F CCCGGGATGGGAGGTAAAATGGGATCAG 
ALMT5N-R GCTCGAGGTTATCAAACCTTAGGAATCTGATCAACAGC 
ALMT9C-F ACCGGTATGGCGGCGAAGCAAGG 
ALMT9C-R CCCGGGTTACATCCCAAAACACCTACGAATCTTC 
ALMT9N-F CCCGGGATGGCGGCGAAGCAAGG 
ALMT9N-R GCTCGAGGTTACATCCCAAAACACCTACGAATCTTC 
 
Table 2.13 - List of primers used for the amplification of bacterial genes.  
F and R refer to the forward and reverse primer, respectively. 
Name Sequence 5’ -> 3’ 
SoF CCTAGGATGTCCGTCTTTGCCCCTGC 
SoR CTGCAGAATTCGTCCCAATCGCTAAAATACATTGAAC 
DvF CCTAGGATGGACGGACGGGCATTGTGC 
DvR CTGCAGAGTACGGTACCTTGTGCGACTGC 
EcF CCTAGGATGGGTATTTTCTCCATTGCTAACC 
EcR CTGCAGAATTGATAGCCAGTTGCGTACAACTATG 
AaeAAaeB-F CAGGCTAGCGTGAAAACACTAATAAGAAAATTCTCC 
AaeAAaeB-R TGCTGCAGCACTATCGGTCAACGCATGTTG 
AaeA-F CTCTCCATGGGCAAAACACTAATAAGAAAATTCTCCCGTACG 
AaeA-R CTCTGTCGACACCAAACTCACGCAGGCG  
AaeAdTM-F CTCTCCATGGGC TCCCCCTGGACGCG    
AaeAdTM-R CTCTGTCGACACCAAACTCACGCAGGCG  
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2.4.2  Quikchange™ Site-Directed Mutagenesis 
For mutagenesis of DNA sequences, primers were designed to introduce the 
desired base change, ensuring that the ends of the primers terminated with a 
pair of G or C bases in order to ensure efficient anchorage to the DNA template. 
The conditions were set up as for PCR, as above. After thermocycling was 
complete, original template DNA was digested by addition of 1 μL DpnI 
restriction enzyme and CutSmart Buffer to 1X concentration. This mixture was 
incubated at 37°C for 1 h and then heat inactivated at 80°C for 20 min. A 4 μL 
sample was electrophoresed on a 1% agarose gel to check for the correct 
product remaining after digestion, and then 1 μL was transformed into OmniMax 
2 cells, as described above in Section 2.3.2.  
 
2.4.3  Cleaning of PCR Products 
PCR products were cleaned using the Wizard SV Gel and PCR Clean-Up 
System (Promega) following the manufacture’s protocol. 
 
2.4.4 Colony PCR 
To assay the presence of the ORF of interest within transformed bacteria colony 
PCR was performed. A pipette tip was touched to a colony (used for plasmid 
purification, above) and dipped into 10 μL of MilliQ H2O and heated to 95°C 
briefly. This was then used as the “Template” in a PCR, as described above.  
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2.4.5  Restriction Endonuclease Digestion of DNA 
DNA was digested with the appropriate restriction enzyme (New England 
Biolabs) using the optimal buffers and conditions recommended by the 
manufacturer – routinely, CutSmart Buffer at a concentration of 1X.  Generally, 
1 µg of plasmid DNA was digested per reaction using 5-10 units of restriction 
enzyme. The final volume added to any reaction was always less than 10% of 
the total volume. Digestions were routinely performed at 37°C for 2 hours and 
fragments separated by electrophoresis on an agarose gel. 
2.4.6  Agarose Gel Separation of DNA 
 
Agarose gel electrophoresis was performed to separate DNA fragments on the 
basis of their size. DNA gel loading dye (6x) (NEB) was added to samples at a 
1:5 volume ratio prior to electrophoresis.  DNA fragments were then separated 
on a 0.5% (w/v) SeaKem LE agarose (Lonza) TAE buffer gel containing 
SYBRSafe 10,000X concentrate (Life Technologies) at a 1:10,000 dilution by 
electrophoresis for 30 minutes at 100 V in TAE buffer. 
10X TAE Buffer  
Tris  48.4 g 400 mM 
EDTA  2.92 g 1 mM 
Acetic acid  11.4 ml to pH 8.3 
Make to 1 L with water  
(This buffer was diluted to 1X before use.) 
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2.4.7  Agarose Gel Extraction of DNA 
Bands of agarose containing DNA fragments were excised from gels using a 
clean scalpel blade after electrophoresis. They were subsequently purified from 
the agarose using the Wizard SV Gel and PCR Clean-Up System (Promega) 
following the manufacturer’s protocol. 
 
2.4.8  Dephosphorylation of DNA Fragments 
Dephosphorylation of linearised fragments of DNA was undertaken to prevent 
re-circularisation. This was performed using 1 µL Antarctic Phosphatase (NEB) 
in 1X Antarctic Phosphatase Buffer incubated for 15 minutes at 37°C for 5´ 
extensions or blunt-ends and 60 minutes for 3´ extensions, before inactivating 
at 95°C for 5 min.  
 
2.4.9  Ligation of DNA 
Previously digested linear vector DNA (25 ng) was mixed with either a threefold 
or tenfold molar excess of the purified DNA fragment to be inserted. Ligations 
were performed by two protocols: either in 1X Quick Ligation Reaction Buffer 
(66mM Tris-HCl, 10mM MgCl2, 1mM DTT, 1mM ATP, 7.5% Polyethylene glycol 
(PEG6000), pH 7.6), with 1μL of Quick T4 DNA Ligase (NEB) in a total volume 
of 10 µL and incubated at room temperature 5 minutes; or in T4 Ligase buffer 
(50mM Tris-HCl, 10mM MgCl2, 1mM ATP, 10mM DTT, pH 7.5) with 1 µL of T4 
Ligase (NEB) in a total volume of 10 µL incubated at 16°C for 16 h.  
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2.4.10  Plasmid Purification and Preparation: Mini-preparation 
A single bacterial colony was used to inoculate 10 mL LB medium containing 
appropriate antibiotics and incubated for 16 hours at 37°C with shaking (200 
rpm).  Cells were harvested by centrifugation in an Eppendorf swing-bucket 
centrifuge at 3,500 g for 10 minutes. Purification of plasmid DNA was carried 
out using the PureYield™ Plasmid Miniprep Kit (Promega) following the 
manufacturer’s protocol. 
 
2.4.11  DNA Sequencing 
DNA sequence analysis was performed by Source Bioscience 
(www.sourcebioscience.com). Plasmids were sent at 100 ng/µl, primers at 3.2 
pmol/µL, and PCR products at 10 ng/µL per 1000 basepairs. The sequence of 
the primers is given in Table 2.14 - Primers for sequencing 
 
Table 2.14 - Primers for sequencing 
Primer Sequence 5’ -> 3’  
T7F TAATACGACTCACTATAGGG 
T7R GCTAGTTATTGCTCAGCGG 
M13F TGTAAAACGACGGCCAGT 
M13R CAGGAAACAGCTATGACC 
pTACF TTGACAATTAATCATCGGC 
pTACR CGCCAGCTGGCGAAAGGGG 
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2.5 Protein Expression 
2.5.1  Expression Screening in Small Scale Cultures 
2 mL of LB with appropriate antibiotic was inoculated with a single colony and 
incubated overnight at 37ºC with shaking in a shaking incubator (200 rpm). 200 
uL of the resulting pre-culture was inoculated into 3mL samples of appropriate 
auto-induction media to be tested in a sterile 24-well deep-well plate. The plate 
was sealed with a breathable seal and grown in a humidified shaking incubator 
at 37ºC for 24h after which 400 uL samples were taken to test protein 
expression levels.  
 
2.5.2  Large Scale Expression 
10 mL of LB with appropriate antibiotic was inoculated with a single colony and 
grown overnight at 37ºC with shaking (200 rpm).  500 mL of medium (LBauto or 
SBauto) was added to each of eight 2.5 L flasks and each was inoculated with 
the pre-culture to give a final O.D. of 0.05 and grown at 37ºC with shaking (200 
rpm) for 24 or 28h. 1 mL samples were taken to test expression levels, and the 
remainder was centrifuged at 14,000 g for 15 minutes and cell pellets were 
stored at -80ºC for later use.  
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2.5.3  Membrane Preparation 
Cell pellets stored at -80°C were thawed on ice, and re-suspended with 
Resuspension Buffer (20 mM Tris pH 8.0, 1 mM DTT, 1x Complete Protease 
Inhibitors (Roche)) at a ratio of 6 mL buffer per g of cell pellet. The suspension 
was homogenised with an Ultra-Turrax (IKA) before lysis by passage through a 
cell disrupter (Constant Systems) at 30 kpsi. The lysate was centrifuged at 
14,000 g for 45 minutes in an Optima Ultracentrifuge (Beckman) to clear cell 
debris before the supernatant was centrifuged at 100,000 g to collect 
membranes. These were re-suspended in 20 mM Tris pH 8.0 before 
membranes were again collected at 100,000 g. The final membrane pellet was 
resuspended in a minimal volume of 20 mM Tris pH 8.0 and frozen as beads in 
liquid nitrogen before storage at -80°C. All steps were performed on ice.  
 
2.5.4  Detergent Screening for Membrane Protein Solubilisation 
Parallel samples of 1 µg of membrane protein was combined with appropriate 
test concentrations of detergents (e.g. 0.5%, 1.0%, 1.5%, 2.0% (w/v) for each of 
DM, DDM, and so on) in a buffer containing 20mM Tris, 10% glycerol, 150mM 
NaCl and made up to 200 µL. Samples were incubated with mixing at 4°C for 2 
hours and 50 µL samples were taken to show a “Total” fraction. The remaining 
150 µL was then centrifuged at 100,000 g for 1 hour in a TLA100 rotor 
(Beckman). 50 µL of the supernatant was then taken as the “Soluble” fraction, 
taking care to not disturb the pellet. Samples were then analysed by SDS-
PAGE and Western blotting.   
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2.5.5 Purification of Proteins by Immobilised Metal Affinity 
Chromatography 
Solubilised protein was incubated with HisPur™ Cobalt Resin (Thermo) at a 
ratio of 1 mL of resin per 10 mg of solubilised target protein overnight at 4°C in 
a buffer containing 10 mM of imidazole. The resin was collected using a 
disposable Gravity Flow Column (Pierce) with sufficient capacity to collect the 
resin volume, allowing the buffer solution to run through the column and be 
collected. The resin was then washed with 10x volumes of buffer containing 10 
mM imidazole as an initial wash, followed by identical washes containing 
increasing concentrations of imidazole until contaminants had been removed. 
Finally, target protein was eluted with buffer containing 300 mM imidazole in 
steps of 0.5-1 mL. Effectiveness of purification was examined by SDS-PAGE, 
Coomassie staining, and Western blotting.  
 
2.5.6  Protein Estimation by the BCA Method 
Protein concentration was determined using the Pierce BCA Assay Kit (Life 
Technologies), combining BCA Reagent A with 4% CuSO4 in a 50:1 ratio.  
Bovine serum albumin (BSA; Sigma) was used to generate a standard curve (0-
10 µg) and all samples were analysed in duplicate. All samples were analysed 
at 550 nm using a plate reader (ICN Biomedical Titerktek). 
 
2.5.7  Protein Estimation by Absorbance at A280 
Protein concentrations were also determined by measurement of absorbance at 
280 nm. 1 µL samples were analysed using the “A280” mode of a Denovix 
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DS11+ Spectrophotometer (Generon) using molar extinction coefficients 
calculated by the ExPASy ProtParam website219.  
 
2.5.8  Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis 
Proteins were separated on the basis of their molecular weight by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 
1970) using the Bio-Rad Mini Protean apparatus (Bio-Rad Laboratories, Ltd).  
Protein samples (routinely 10 µg of cell lysate or membrane fraction) were 
solubilised in a 5:1 ratio protein:buffer in SDS-PAGE Sample Buffer (0.15 M 
Tris, 2.5% (w/v) SDS, 20% (v/v) glycerol, 1 mM DTT, 0.1% (w/v) Pyronin Y) by 
incubation at 37oC for 30 minutes.  Samples were then loaded onto SDS-
polyacrylamide gels, either precast (4–15% Mini-PROTEAN® TGX™ Precast 
Gel (BioRad)) or handmade, prepared as shown in Table 2.15 below. Proteins 
were separated electrophoretically at 100V for between 60 and 90 minutes in 
SDS-PAGE Running Buffer (25 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS). 
 
Table 2.15 - Composition of 12% SDS-PAGE gels 
Component 12% Separating gel 4% Stacking gel 
MilliQ water 3.3 ml 3.025 ml 
Acrylamide-Bis acrylamide 
ratio 37.5:1 30% (w/v) solution 
4 ml 0.625 ml 
Separating buffer (1.5 M Tris-
HCl, pH 8.8) 
2.5 ml - 
Stacking Buffer (0.5 M Tris-
HCl, pH 6.8) 
- 1.25 ml 
10% (w/v) SDS 100 µl 100 µl 
10% (w/v) ammonium 
persulfate (APS) 
100 µl 100 µl 
Tetramethylethylaminediamine 
(TEMED) 
5 µl 5 µl 
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2.5.9  SDS-Polyacrylamide Gel Coomassie Staining 
Gels were routinely stained with a colloidal Coomassie protein stain.  After 
electrophoresis the gel was removed from the apparatus and fixed for 2 hours in 
Fixing Solution (25% (v/v) propan-2-ol, 10% (v/v) acetic acid).  The gel was then 
covered in Stain 1 (0.025% (w/v) G250 Coomassie Brilliant Blue, 10% propan-
2-ol, 10% acetic acid) for 2 hours before replacement with Stain 2 (0.0025% 
(w/v) G250 Coomassie Brilliant Blue, 10% propan2-ol, 10% acetic acid) for 2 
hours. The gel was then de-stained with several changes of De-stain (10% 
acetic acid) until background colour had diminished fully, typically between 2 
hours and overnight.  
 
2.5.10  SDS-Polyacrylamide Gel Silver Staining 
As a more sensitive alternative to Coomassie staining, gels were stained using 
the Pierce™ Silver Stain Kit (ThermoFisher Scientific) following the 
manufacturer’s recommendations. The silver stain has sensitivity down to 0.25 
ng per band, while the typical lower limit for Coomassie Brilliant Blue G250 is 
around 30 ng per band. 
  
2.5.11  Dot Blotting and Western Blotting of Proteins 
For dot blotting, protein samples were mixed with SDS-PAGE Sample Buffer 
(see above in Section 2.5.8) and 2 µL samples were dotted onto a 
nitrocellulose membrane. To serve as a positive control, samples of known 
amounts of His-tagged tobacco etch virus (TEV) protease were also dotted onto 
the membrane. When samples were dry, proteins were detected using specific 
antibodies.  Non-specific binding of antibodies was blocked by incubating the 
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membrane in 10 mL of 3 % (w/v) BSA powder in Tris-buffered saline with 
Tween 20 (TBST; 25 mM Tris, 0.15 M NaCl, pH 7.6, 0.2% (v/v) Tween 20) for 1 
hour at room temperature or overnight at 4oC with gentle mixing. The blot was 
then incubated with 2 µl of anti-His antibody, for 1 hour at room temperature 
with gentle mixing (Horseradish peroxidase-conjugated monoclonal anti-His6 
(R&D Systems, MAB050H) at 1:5,000 dilution). After washing 3 times for 5 
minutes in TBST detection of antigen/antibody interaction performed using 
SuperSignal® West Pico Chemiluminescent Substrate Kit (Pierce), following 
manufacturer’s instructions. The membrane was then photographed in a G:Box 
Chemi (Syngene). 
For western blotting the following protocol was observed. After separation by 
electrophoresis proteins were transferred from the polyacrylamide gel onto 
nitrocellulose membrane using a Trans-Blot Turbo™ Transfer System (Bio-
Rad). Transfer was achieved by two separate methods. The first used hand-
assembled stacks: before transfer, the nitrocellulose membrane was 
equilibrated by soaking in Transfer Buffer (25 mM Tris, 192 mM glycine, 20 % 
(v/v) methanol). For transfer, the membrane and gel were placed between 
sheets of pre-soaked WhatmanTM 3mm filter paper, orienting the membrane 
beneath the gel, at the anode. After compressing with a roller to remove any air 
bubbles, the electrotransfer of proteins was performed at 1 A for 30 min. The 
second method used Trans-Blot Turbo™ Nitrocellulose Transfer Packs (Bio-
Rad), used as per manufacturer’s instructions. Electrotransfer was performed at 
1.3 A for 7 minutes per gel. After transfer was complete, the membrane was 
incubated in 3% BSA in TBST, and treated as described above, using the same 
washing and antibody.  
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2.5.12  Densitometry Protein Estimation of Coomassie-stained 
SDS-PAGE gels, or Western blots  
Samples were run on an SDS-PAGE and either Coomassie stained or 
visualised by Western blotting. Image were captured using a G:Box (SynGene) 
and the picture analysed by comparing the relative density of the eluted protein 
band density against that of known protein standards using ImageJ software. 
 
2.6  Blue Native Polyacrylamide Gel Electrophoresis 
Purified samples of protein were separated by blue native PAGE using 10X 
NativePAGE™ Sample Buffer (BioRad) added at a ratio of 1:10 prior to 
electrophoresis. The gel tank was filled with 10X NativePAGE™ Running Buffer 
(BioRad) diluted 1:10 with MilliQ water. Proteins were analyzed by blue native 
(BN) electrophoresis on 4-20% Mini-PROTEAN® TGX™ Precast Gels 
(BioRad). Proteins were then transferred onto nitrocellulose membrane as in 
Section 2.5.11 or silver stained as in Section 2.5.10.  
 
2.7  Glutaraldehyde Cross Linking  
Purified protein (~0.1 mg/mL) was mixed with glutaraldehyde at a range of 
concentrations (0 mM – 100mM) and incubated for up to 1 hour at 4oC and the 
reaction stopped by adding SDS-PAGE sample buffer.  Samples were run on a 
4-20% (w/v) acrylamide SDS-PAGE gel and analysed by immunoblotting and 
Coomassie staining.  
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2.8  Expression of ALMTs in Plants 
Expression of ALMTs in plants was based on the method of Sparkes et al.220 
with modifications as follows. 
2.8.1  Plant Growth Conditions 
Tobacco (Nicotiana benthamiana) seeds were sown directly onto freshly 
watered compost (J Arthur Bower’s Topsoil) and grown in greenhouses 
maintained at 20°C with a 16h day length for 5 weeks. After infiltration, plants 
were maintained under the same conditions for the required number of days. A 
portion of plants were grown to maturity and seeds were collected and stored at 
15°C and 12% relative humidity in the dark.  
2.8.2  Transformation of agrobacteria 
1 µg of plasmid DNA was added to 50 µL of agrobacteria (strain LBA4404) and 
gently mixed by flicking. The tube was incubated on ice for 5 minutes and then 
flash frozen in liq. N2 before thawing at 37°C. 1 mL of YEP media was added, 
and then the cells were shaken at 28°C for 2 hours before plating onto YEP-
agar plates containing 100 µg/mL kanamycin, 50 µg/mL streptomycin, and 100 
µg/mL rifampicin. Rifampicin is light sensitive so stocks were stored in the dark 
at -20 and plates were freshly made. Plates were incubated at 28°C for 28 
hours before storage at 4°C in the dark before later use.  
2.8.3 Agrobacteria tumefaciens cultures 
A single well isolated colony was picked from a plate and incubated with 50 mL 
YEP medium containing 100 µg/mL kanamycin, 50 µg/mL streptomycin, and 
100 µg/mL rifampicin and grown with shaking at 28°C for 24 hours.  
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2.8.4  Agrobacteria tumefaciens infiltration 
The agrobacteria were collected by centrifugation at 4000 g for 10 minutes, 
pellets were then resuspended in 50 mL Infiltration Medium (50 mM MES pH 
5.6, 2 mM Na3PO4, 0.5% glucose 100 µM acetosyringone (4'-hydroxy-3',5'-
dimethoxyacetophenone)) to wash the cells. Then centrifugation was repeated 
and re-suspended to the required O.D.600. Agrobacteria suspensions were then 
infiltrated into the underside (abaxial) of tobacco leaves by nicking the leaf 
surface lightly and pressing a 5 mL syringe (without needle) onto the resultant 
small hole, with a finger on the other side of the leaf to provide support.  
 
2.8.5  Protein extraction from tobacco leaves 
Leaves were harvested, main ribs were removed and leaf material was ground 
in a pestle and mortar under liq. N2 followed by protein extraction in Plant 
Extraction Buffer (20mM Tris pH 8.0, 10% (v/v) glycerol, 100 mM NaCl, 25% 
(w/v) sucrose, and 1x cOmplete protease inhibitors (Roche)) at a 1:1 g:mL ratio 
of leaf mass to buffer volume. Lysates were incubated on ice for 20 minutes and 
vortexed before centrifugation at 600 g for 5 minutes to pellet cell debris. The 
supernatant was then spun down at 100,000 g for 1 hour at 4°C to collect 
membranes. Membranes were then re-suspended in 20 mM Tris pH 8.0 and 
frozen as beads in liq. N2. Protein expression was assessed by SDS-PAGE and 
Western blotting as in Sections 2.5.9 and 2.5.11. 
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2.8.6  Imaging of GFP in leaf 
Whole infiltrated leaves were excised from plants and imaged in a G:BOX 
Chemi XX6 (Syngene) directly on the black using blue LED illumination and a 
filter for GFP fluorescence using the “Fluorescent Gel” present mode. Images 
were saves as .tif files.  
 
2.9  Measurement of Protein Stability in Varying Buffer 
Conditions 
Screening buffer conditions to optimise protein stability was undertaken using 
the Optim (Avacta) (now called the UNit from Unchained Labs). 5 μL of purified 
protein was mixed with 5 μL of each buffer condition to be screened and loaded 
into the supplied capillaries, which were then sealed into the machine. 
Temperature runs were performed in 1°C steps from 15-95°C measuring both 
static light scattering at 266 nm and fluorescence at 250–720 nm, from which 
the barycentric mean was computed and reported. The data were plotted 
against temperature, along with the derivative of the fluorescence data to aid 
location of the midpoint of the unfolding curve. Data were exported to produce 
further plots in Microsoft Excel.  
 
2.10  Protein Structural Homology Modelling with Phyre2 
The sequence of AaeA was submitted to the Phyre2 server 
(www.sbg.bio.ic.ac.uk/~phyre/) using Intensive Mode159. This produced a model 
based on the published structured for EmrA, AcrA, MacA, ZneB, MexA, and 
HlyD, with areas not covered by these structures modelled ab inito. The model 
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produced placed the predicted TM helix directly adjacent to the main body of 
the protein. Therefore, this was manually adjusted in Chimera to lie parallel to 
the main axis of the protein, as expected. This model was exported for the 
production of figures and analysis. The conservation scores were computed by 
the Consurf webserver (http://consurf.tau.ac.il/2016/), and these were applied to 
the modelled structure in Pymol replacing the crystallography B-factors with a 
conservation score. This conservation score was displayed in Pymol as a 
surface. The surface charge was calculated using the PDB2PQR server221 
(http://nbcr-222.ucsd.edu/pdb2pqr_2.1.1/). The resulting electrostatic surface 
was displayed in Pymol using the APBS plugin tool. RLS motifs from other MFP 
proteins were located manually from their sequence, and aligned using 
clustalW. Molecular Phylogenetic analysis was performed using MEGA7222. The 
evolutionary history was investigated using the Maximum Likelihood method 
based on the JTT matrix-based model223. Initial tree(s) for the heuristic search 
were obtained automatically by applying Neighbor-Join and BioNJ algorithms to 
a matrix of pairwise distances estimated using a JTT model, and then selecting 
the topology with superior log likelihood value. The tree is drawn to scale, with 
branch lengths measured in the number of substitutions per site. The analysis 
involved 19 amino acid sequences, including four SMR-type, two ABC-type, 
three MFS-type, three RND-type, alongside four identified by Saier et al. as 
PET-type36 and two of unknown family. 
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2.11  Circular Dichroism Spectroscopy  
Purified protein was loaded into 1 mm cuvettes at a concentration of ~0.2-0.4 
mg/mL and measured in a Jasco J715 (Jasco Analytical Instruments). Two 
repeat spectra were captured between 180-260 nm at 20°C in addition to a 
buffer blank that was subtracted from the experimental spectra. For the 
temperature ramp the temperature was raised in 1°C steps then held for 60 
seconds before acquisition of a spectrum. Data was exported to Microsoft Excel 
for calculations before analysis using the algorithms available at the Dichroweb 
server (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml) using SELCON3, 
CONTIN and K2D with the SMP180 reference set in order to calculate the 
proportions of secondary structure present.  
2.12  Size Exclusion Chromatography-Multi Angle Laser Light 
Scattering (SEC-MALLS) analysis of the oligomeric states 
of membrane proteins 
SEC-MALLS analysis 224,225 was performed using a DAWN HELEOS II (Wyatt 
Technology) after separation on either a Superdex 200 10/300 column (GE 
Healthcare) or a WTC-MP030S5 column (Wyatt Technology), driven by a 
Prominence HPLC system (Shimadzu). Data analysis was undertaken using the 
Astra software using the Conjugate Method analysis to compute protein MW.  
2.13  Electron Microscopy and Single Particle Analysis 
Negative stain grids were prepared by applying 3 μL of purified protein solution 
(10-100 μg/mL) onto a carbon-coated copper grid that had previously been 
charged using a PELCO easiGlow glow-discharge unit for 30 seconds. Excess 
solution was blotted with Whatman paper and the grid was then stained with 3 
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μL 1% w/v uranyl acetate for 1 minute, before blotting the excess. The staining 
step was repeated and the final drying step was done under a desk lamp. Grids 
were then stored until imaging. Grids were imaged using a Technai T12 
microscope fitted with a LaB6 source operating at 120 kV. Micrographs were 
recorded on a 2000 ×2000 Gatan CCD camera with 30,000X magnification or 
50,000 magnification with between 0.5 and 2 μm defocus. Particles were picked 
by a combination of semi-automated swarm picking and hand-picking using the 
Boxer program in EMAN2226. Particles were centred, masked, and classified in 
IMAGIC-5227, resulting in a crude set of reference images, which were used for 
multireference alignment. The classes produced were significantly improved, 
and representative ones were used for a further stage of multireference 
alignment. Once a stable alignment had been achieved, poorly aligning particles 
and those that produced poor classes were removed to generate a new data 
set. Further classification was then carried out on the “best” particle stack 
2.14  Screening for Crystallography 
One MRC Plate 96 well 2 Drop UV Crystallization Plate (Molecular Dimensions) 
was used for each crystallisation screening experiment. Each well was filled 
with 60 μL of crystallisation buffer using a multi channel pipette. Sitting drop 
crystallisation trials were then set up using a NT8 robot via the RockMaker 
software (Forulatrix). Purified samples of AaeA were concentrated to ~10 
mg/mL and 100 nL protein was mixed with either 100 nL or 200 nL of well 
reservoir solution before being placed into the top well and the plate was sealed 
with a ClearVue Sheet (Molecular Dimensions). The plates were stored at 20°C 
in a RockImager 1000 (Formulatrix), which performed automated imaging of the 
drops over several weeks.  
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Chapter 3 
Production of the C-terminal 
Domain of TaLMT1 
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3  
3.1  Introduction 
The C-terminal domain (CTD) of ALMTs has been shown to be critical for 
regulation of channel activity and has been a subject of investigation83. 
However, no high-quality structural data exists and this makes biochemical 
characterisation and mutagenesis experiments both difficult to design and their 
results challenging to interpret. Thus, there is a pressing need for such 
structural characterisation, both of the CTD and also of the full length channels. 
To this end, constructs were designed to express the CTD in isolation, in the 
anticipation that the isolated soluble regulatory domain would prove 
experimentally amenable. The aim was to produce sufficiently high quantities of 
soluble, folded, monodisperse protein and then utilise this in structural and 
biochemical investigations including X-ray crystallography, binding studies, and 
mutagenesis then use these experiments to derive an understanding of the 
structure and mechanism of the regulatory CTD of ALMTs.   
 
Figure 3.1 - Overall model of the domain organisation of ALMT proteins. 
Prepared by Steve Baldwin.  
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3.2 Production of the CTD of TaALMT1 
3.2.1  Vector construction - pTP1 and pTP2 
The first aim of this investigation was to express the CTD of TaALMT1 in 
sufficient amounts for biochemical and biophysical investigations. To this end, a 
codon-optimised sequence for the CTD of TaALMT1 (residues 219-433, shown 
in orange in  
Figure 3.2B) beginning after the last predicted transmembrane segment and 
excluding the final 26 residues, which were predicted to be unstructured, was 
synthesised by Genscript and provided in the vector pL51. This was then 
subcloned from this vector and ligated into a pET28(b) expression vector as 
described in the following section. As it has been shown that the placement of 
affinity tags onto proteins can affect expression levels151, it was decided to 
produce two variants, with each having the affinity tag placed at opposing ends. 
pET28(b) also allows for a thrombin cleavage site between the N-terminal tag 
and the target protein, enabling later cleavage to return an untagged protein. 
The construct containing a C-terminal tag was designated pTP1, and the 
construct with N-terminal tag and thrombin cleavage site was designated pTP2. 
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Figure 3.2 – TP1 and TP2 vectors 
A) Schematic to show overall domain architecture of TaALMT1, consisting of N-
terminal helix, six transmembrane helices, and a large C-terminal domain. B) 
Schematic of constructs TP1 and TP2, with C-terminal and N-terminal 
hexahistidie tags (His-6), respectively. TP2 also incorporated a thrombin 
cleavage site (T) between the tag and the coding region. It can be seen that the 
constructs encode a sequence that begins just after the final TM helix. C) 
Hydrophobicity across residues in TaALMT1. Graphs created from ProtParam 
(http://web.expasy.org/protparam)  
 
 
By selection of restriction sites used for subcloning into the expression vector 
pET28(b) the two constructs were generated. Use of the restriction sites NcoI 
and XhoI yielded pTP1, an example of the digests is shown in Figure 3.3. By 
contrast, in the construction of pTP2, pET28(b) was digested at the sites NheI 
and SalI, while NheI is present within the coding sequence for the CTD and so 
could not be used to digest the insert. Thus the enzyme AvrII was used as it 
produces a compatible end with NheI. Restriction enzymes were initially tested 
on a small scale (~500 ng plasmid) for activity, and then digestions were scaled 
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up (~3 μg plasmid) and bands were excised from a 0.5% agarose gel and 
purified. 
 
 
Figure 3.3 – Digests to show pTP1 construction.  
 A) pL51-ALMT, undigested (P), digested with XhoI (X), digested with NcoI (N), 
double digested with XhoI and NcoI (X+N), and DNA size marker. Insert 
containing ORF at approximately 700 bp indicated by arrow on the left. B) 
pET28(b), undigested (P), digested with XhoI (X), and digested with NcoI (N). 
Linearised vector band indicated by arrow on the right.  
 
Purified fragments were combined and ligated with T4 DNA Ligase overnight. 
After ligation of the CDS into the expression vector and isolation of the plasmid 
from OmniMax2 cells, the produced constructs were digested with restriction 
enzymes to assess whether cloning had been successful. Digestion of pTP1 
plasmid singly with NcoI and XhoI yielded a band of approximately 6 kbp, 
consistent with that expected for the recombinant product, while double 
digestion yielded a fragment corresponding to the expected insert size of 700 
bp (Figure 3.4A). Similarly, double-digestion of pTP2 with NheI and SalI 
produced two bands, including one at the expected size of the insert, 700 bp 
(Figure 3.4B). The sequence of the insert plus flanking regions was then 
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confirmed by DNA sequencing for both constructs in both directions using the 
T7F and T7R sequencing sites provided by pET28(b). 
 
 
 
Figure 3.4 - Restriction Digests of pTP1 and pTP2 to conform correct 
cloning.  
A) DNA size maker (L), and TP1 digested with XhoI (X), NcoI (N), or double-
digested with XhoI and NcoI (X+N). Bands are seen at approximately 6000 bp 
for the single digests- the correct size for the full plasmid, and approximately 
700 bp for the double digest – the size of the inserted ORF (indicated with an 
arrow). B) undigested TP2 (P), and TP2 digested with NheI and SalI (N+S), 
which reveals a band at approximately 700 bp as expected for excision of the 
inserted ORF.  
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3.2.2  Expression trials from pTP1 and pTP2 
3.2.2.1 Initial expression trial  
 
Figure 3.5 – Dot blot and Western blot of His-tagged protein expressed 
from pTP1 
 A) Dot blot of initial expression test of pTP1 in 12 conditions, 24h after 
autoinduction. 3 µL of each sample was applied to nitrocellulose membrane and 
the blot was stained for the presence of the His6-tag. B) Western blot of the six 
best conditions for TP2. 
 
Once the expression constructs were confirmed by sequencing, an examination 
of the optimal expression conditions was conducted, starting on a 3 ml scale on 
a range of four E. coli expression strains (C41(DE3), C43(DE3), BL21-Gold 
(DE3), and BL21 Star (DE3)) and three media (M9, LB, and SB). Initial testing 
of protein expression following autoinduction for 24 h at 37°C by dot blotting 
cellular lysate (Figure 3.5A) showed that the most successful three conditions 
for expressing both TP1 and TP2 were BL21 Gold in LB medium and BL21 Star 
in either LB or SB medium. These conditions were taken forward for tests on a 
50 ml scale to further optimise conditions and ensure that expression levels 
were maintained upon scale-up. Blots such as Figure 3.5B showed good 
expression levels, and the bands seen on the Western blot ran at the expected 
size of approximately 25 kDa, with a second His-reactive band at around 50 
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kDa, perhaps giving early evidence of multimerisation. Quantification of the 
bands seen in the Western blot, by densitometry, show approximately 10-30 mg 
protein expressed per L of culture. 
 
3.2.2.2 Solubility Screen 
In addition to assessing the conditions for their levels of total protein produced, 
the material was checked for solubility. This was done by two methods, firstly, 
centrifugation at 14,000 g and secondly, filtration through a 0.2 μm membrane 
in order to remove any particulate matter from the sample. As seen in Figure 
3.6A, the material produced was largely insoluble, despite the initial levels of 
protein expression seeming promising.  
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Figure 3.6 - Selection of Western blots comparing total and soluble 
fractions from TP1 expressed over a range of time-points in either BL21 
Gold or BL21 Star in LB media. 
 A) Std = 125ng. While there is a significant signal in the total (T) fraction, 
almost no signal is seen from the soluble (S) fraction.  B) Std = 125ng. IPTG 
expression does not result in an improvement in solubility. C) and D) expression 
at a lower temperature (20°C) may result in a slight improvement in solubility 
from protein expressed in both BL21 Gold and BL21 Star.  
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 At this stage, the screening of conditions was widened to encompass a range 
of variables. Table 3.1 summarises the conditions assessed for both TP1 and 
TP2 but, briefly, these included media, induction type, and cell type, as 
previously, but also a wider range of time-points were taken. As seen in a 
representative example given in Figure 3.6B, this was largely unproductive, 
with almost all conditions failing to show any signal in their soluble or filtered 
fractions.  
An additional variable that was changed was a reduction in temperature of the 
expression cultures, to 20°C and 25°C; this reduction in temperature was hoped 
to be effective by slowing the rate of translation and thus allowing the cells to 
have more time to correctly fold the protein, producing natively-folded protein, 
albeit with a lower yield. Figure 3.6C and Figure 3.6D show that this reduction 
in temperature seemed somewhat effective, with a larger proportion of the 
produced material falling in the soluble fraction for some conditions.  
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Table 3.1 – Table listing expression conditions attempted for TP1 and TP2 
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3.2.2.3 Lysis screen 
Alongside this screening, an assessment was also made as to the most 
effective way to extract protein from the cells, either by chemical lysis with 
detergents to disrupt the membrane, or by use of the cell disruptor using 
mechanical force to lyse cells. Equivalent samples were lysed using each 
method and protein signals were compared via a dot blot. The signal seen from 
the sample lysed by the cell disruptor was greater as seen in Figure 3.7 and 
thus this was chosen as the method of choice for future protein extraction.  
 
 
 
Figure 3.7 - Dot blot assessing the effectiveness of chemical lysis with 
Triton against lysis in a cell disruptor. 
 
 
The solubility of the two protein fragments expressed from pTP1 and pTP2 was 
low, thus far. This was despite the screening of a large range of expression 
conditions. It was suspected that the constructs themselves were the source of 
the insolubility, and as such a redesign of the constructs was considered.  
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3.3  Production of a Truncated Construct for the CTD 
3.3.1  Mutagenesis to Truncate pTP1 and pTP2 
 
Figure 3.8 Overview of mutagenesis strategy with pTP1 as an example.  
Mutagenesis is used to insert an additional NcoI site within the coding sequence 
(B). This product was then digested with NcoI, purified, and re-ligated to form 
an expression vector with a truncated coding region (C). 
 
The constructs encoded by pTP1 and pTP2 both begin very soon after the final 
predicted TM helix of ALMT1, and so it was suspected the N-terminal part of the 
constructs could be part of a membrane embedded region, causing the 
aggregation seen in Section 3.2.2.2. Thus, PCR-based QuikChange 
mutagenesis was employed to add a restriction site to the coding region (NcoI 
for pTP1 and NheI for pTP2) at sites identified near the 5’ end of the coding 
sequence, as shown in Figure 3.8. This enabled the plasmid to be cut by 
restriction digestion to remove a short segment of the coding sequence, before 
re-ligation of the compatible sites completed the truncation of the construct and 
production of two new plasmids, designated pTP1_T and pTP2_T. This 
removed 36 or 45 residues, respectively and ensured that expression started in 
a hydrophilic part of the CTD, shown in Figure 3.9.  
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Figure 3.9 -Truncated vectors overview.  
 A) Schematic to show overall domain architecture of TaALMT1, consisting of 
N-terminal helix, six transmembrane helices, and a large C-terminal domain. B) 
Schematic of constructs, including the truncated versions TP1_T and TP2_T, 
with C-terminal and N-terminal His-tags, respectively.  
 
A gradient PCR was performed between 55°C and 65°C for each mutagenesis 
(see Figure 3.10). A product of size ~7000bp was seen as expected in the gel. 
After digestion with DpnI to remove the original template DNA (which would be 
methylated as it was prepared from E. coli, and thus is a substrate for the 
enzyme, unlike the newly produced DNA), the DNA was purified transformed 
into OmniMax2 to allow isolation of sufficient plasmid via miniprep.  
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Figure 3.10 - Characterisation of products produced by QuikChange 
mutagenesis.  
Samples were separated by electrophoresis on a 1% agarose gel of products 
after gradient QuikChange PCR to add an NcoI restriction site to the coding 
region of pTP1. All temperatures produced equivalent results. Approximate size 
markers are indicated on the left.  
 
These mutagenised plasmids were then digested at the inserted restriction site, 
purified, and re-ligated together with T4 ligase, and isolated from OmniMax2 
cells. After isolation, the final products were sequenced and this confirmed that 
the truncation was successful for both pTP1_T and pTP2_T. 
 
3.3.2  Expression of Truncated Constructs 
Similarly to TP1 and TP2, a range of culture conditions were tested to optimise 
expression of the truncated constructs. BL21(DE3) Gold and BL21(DE3) Star 
were approximately equivalent in expression with LB being the best medium, as 
shown in Figure 3.11A. The six samples from BL21 Gold and BL21 Star were 
run on an SDS-PAGE gel and assessed by western blotting. The size was 
approximately 20 kDa for TP1_T, as expected, with TP2_T being slightly 
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smaller (data not shown) confirming that truncation had been successful. Again, 
LB media appeared to give the best expression for each cell type. Expression 
tests on TP1_T show that the protein expresses well, to similar levels seen for 
TP1 and TP2. Expression levels seen in Figure 3.11B are at approximately 10 
mg protein per L of culture, as quantified by densitometry. 
 
Figure 3.11 –Blots to assess truncated TP1_T 
 A) dot blot of 2 μL samples of small scale expression trial of four strains and 
three media for TP1_T expressed by 24h of autoinduction n a 3 ml scale. BL21 
Gold and BL21 Star show the best levels of expression. B) Western blot to 
assess expression of TP1_T in BL21 Gold and BL21 Star using 24h 
autoinduction 10 µL of each sample was loaded and samples were resolved by 
SDS-PAGE, transferred to nitrocellulose and then stained for the presence of 
the His6 tag. Std = TeV-His6 standard, 125 ng. 
 
The next step was to assess the solubility of the expressed protein, as before. 
BL21Gold and BL21 Star cells were used to express the constructs using 
autoinduction and IPTG induction over a range of time points between 5 h and 
48 h and at both 37°C and 25°C detailed in Table 3.2. Cells were lysed in the 
cell disruptor and split into three fractions: firstly, a total fraction; secondly, a 
soluble fraction which was centrifuged at 14,000 g before taking the 
supernatant; and thirdly, a sample that was filtered through a 0.2 μm 
membrane. It is clear from Figure 3.12 (results representative for all conditions) 
that the truncated constructs were not markedly more soluble than the originals.  
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Figure 3.12 - Western blot to assess expression of TP1_T in BL21 Star 
using autoinduction for three time points.  
10 µL of each sample was loaded and samples were resolved by SDS-PAGE, 
transferred to nitrocellulose and then stained for the presence of the His6 tag. 
T=total, S=centrifuged at 14,000 g, F=filtered through 0.2 μm filter. A large 
amount of expression is seen, but a low proportion is seen to be soluble after 
centrifugation or filtration. Approximate position of MW markers is indicated on 
the left.  
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Table 3.2  - Table listing expression conditions attempted for TP1_T and 
TP2_T 
 
 
 
 
  
Strain Media Auto/IPTG Time (hr) Temperature (C)
M9 
LB
SB
M9 
LB
SB
M9 
LB
SB
M9 
LB
SB
5
9
20
30
5
9
20
30
24
36
48
C41
C43
BL21 Gold
BL21 Star
BL21 Star
BL21 Gold
BL21 Star
BL21 Gold
C43
BL21 Gold
2524autoLB
LB
LB
auto 37LB
37
37
IPTG
IPTG
auto
auto
24
24
C41 auto 24 37
37
37
37
auto 24
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3.3.3  Testing additives to aid solubility 
A concurrent project in the lab that was also attempting to resolve a solubility 
problem while expressing an isolated protein domain found that adding 
Triton X-100, EDTA, and DTT after cell lysis helped to stabilise the protein 
produced. Thus, this was attempted for TP1_T, and as seen in Figure 3.13A 
this was able to solubilise some of the protein (by densitometry, approximately 
20%). This presented a problem though as DTT and EDTA are incompatible 
with the standard IMAC resins used for purification of His-tagged proteins. Thus 
a follow-up solubility test was attempted to assess whether all of these additives 
were strictly required. If the EDTA and DTT were removed, or the Triton 
concentration was decreased, the solubility of TP1_T was sharply decreased, 
as seen in Figure 3.13B.  So, it was concluded that these components are 
strictly required in order to aid solubility.   
 
 
 
Figure 3.13 – Assessment of the effects of additives to the solubility of 
TP1_T.  
A) Western blot of Total (T) and Soluble (S) fraction of TP1_T when assessing 
additives to aid solubilisation. Addition of 1% Triton X-100, 1 mM DTT and 5 
mM EDTA enables partial solubilisation of TP1_T. B) Western blot to assess 
whether any of the additives can be omitted from the solubilisation buffer. 
Solubilisation is unsuccessful if either EDTA and DTT are omitted from the 
solubilisation buffer, or the level of Triton X-100 is decreased.  
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3.3.3.1 Attempted purification of the solubilised truncated CTD 
Conditions had been found to somewhat enhance the solubility of the produced 
protein. The next step was to perform a purification to assess how viable it 
would be to produce purified soluble protein, whether this would be possible 
and whether it would be viable on a large enough scale. As it was necessary to 
include DTT and EDTA in the protein solution, cOmplete His-Tag Purification 
Resin (Roche) was used, as this is resistant to reducing agents and chelators.  
Each of TP1, TP2, TP1_T, and TP2_T were purified using IMAC, binding 
protein to the resin for 1-2 hours and then washing with concentrations of 
imidazole (generally between 10 mM and 50 mM) before eluting the protein 
using 500 mM imidazole. In general, purifications showed some promise, an 
example is shown in Figure 3.14 for TP1_T. The target protein generally bound 
to the resin and eluted in the appropriate fractions, and although the purity 
needed improvement there was some potential shown if enough soluble protein 
could be produced, as there is scope for significantly more washing with 
imidazole before elution.  
Unfortunately, after purification and upon dialysis to remove the imidazole from 
the eluted fractions, the protein began to precipitate. This indicated that the 
protein was still not stable, and though the buffer conditions had seemingly 
improved solubility, the protein was still not in a suitable state for further studies.   
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Figure 3.14 - A purification of a sample of TP1_T containing triton, EDTA, 
DTT.  
A) Western blot for the His-tag, StA = 50 ng of His-tagged protein standard, StB 
= 100 ng of His-tagged protein standard. Other lanes are as marked on the gel 
below.  B) Coomassie stained SDS-PAGE gel of purification fractions (20 μL). 
Molecular weight maker (L), 36 ng protein standard (St1), 52 ng protein 
standard (St2), 112 ng protein standard (St3), washes of increasing imidazole 
concentration (5-30), and elutions at 300mM imidazole(E1-E5).  Position of  
TP1_T indicated by arrows. Although TP1_T correctly binds to and is eluted 
from the Ni-NTA resin, a lot of contamination remains and more purification is 
required.  
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3.3.4  Denaturation and Refolding  
As a final attempt to produce the CTD in a stable, soluble form refolding of the 
inclusion bodies was attempted following previously published methods138,139. 
Briefly, inclusion bodies were prepared by pelleting in a centrifuge and washing 
with detergent and 1M NaCl, before the pellet was incubated at room 
temperature for 1h with 6M guanidinium chloride (GdnCl), to solubilise and 
denature the protein. Any insoluble material was removed by centrifugation at 
100,000 g and then the supernatant was incubated with cOmplete Ni IMAC 
resin overnight. The protein was then refolded on the column by washing with 
buffer not containing GdnCl. However, upon buffer exchange a sandy 
precipitate formed in the column, indicating that refolding was unsuccessful. 
Protein could not be eluted from the column with 300 mM imidazole, as seen in 
Figure 3.15A. The column was re-washed with buffer containing 6M GdnCl plus 
300mM imidazole to clean the column, and this material was dialysed to remove 
the GdnCl and imidazole. This dialysis again resulted in the crashing out of a 
sandy precipitate (Figure 3.16) and both the soluble and a sample of the re-
dissolved precipitate were assessed by a dot blot. In Figure 3.15B it can be 
seen that all the TP1 is in the insoluble precipitated material washed out of the 
column by the denaturing elution buffer and thus TP1 is insoluble and cannot be 
refolded.  
At this point the prospect of producing the material required did not seem 
promising so this line of enquiry was abandoned.  
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Figure 3.15 – Assessment of refolding TP1. 
A) Western blot of fractions of a purification of TP1 refolded on the column. No 
target protein is seen in the washes or the elution fractions.  B) Dot blot 
assessing the presence of His-tagged TP1 in the supernatant (S) and 
precipitate (P) from re-folded TP1. It can be seen that TP1 has not correctly 
refolded.  
 
 
 
Figure 3.16 - Photograph of re-folded TP1 after dialysis. All material 
precipitates.   
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3.4  Discussion and Conclusions 
Production of constructs to express the CTD of TaALMT1 (residues 219-433) 
with a C-terminal or N-terminal hexahistidine tag for TP1 and TP2, respectively, 
was successful and protein could be expressed in significant amounts: above 
10 mg protein per L of culture. Similarly, expression from constructs encoding a 
truncated CTD (residues 255-433 for TP1_T and 262-433 for TP2_T) lacking a 
region predicted to be disordered was successful. Unfortunately, the CTD had 
consistently proved to be impossible to isolate in a soluble form despite 
attempting a large variety of conditions. An explanation as to why is presented 
in analysis by Dreyer et al.45 published after the conception of these 
experiments, summarised in Figure 3.17. Their bioinformatics study suggested 
that along with the 6 TM helices in the N-terminal half of the protein, there are 
potentially two further TM helices within the CTD. The position of these helices 
is indicated in red between Figure 3.17B and Figure 3.17C and matches well 
with more-hydrophobic stretches of the TaALMT1 sequence. If there really are 
two TM helices within the constructs expressed within this chapter then that 
would explain the extreme difficulty in obtaining soluble protein, and the 
observation that the detergent Triton X-100 was able to help solubility 
somewhat.  
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Figure 3.17 – Putative TM helices in the CTD of TaALMT1. 
A) Overall schematic of TaALMT1 at the outset of this investigation. B) 
Schematic to show position of constructs expressed in this chapter. The 
location of two putative TM helices is shown below in red. All constructs contain 
these regions. C) Hydrophobicity analysis of TaALMT1 with position of two 
putative extra TM helices above in red. The location of these regions matches 
with regions identified as more-hydrophobic.  D) Hydrophobicity analysis by 
Dreyer et al. 45 over 300 ALMT/QUAC family members identifying two extra 
putative TM regions within the CTD.  E) Revised topology model as presented 
by Dryer et al. containing two putative transmembrane helices in the previously-
though soluble CTD45. 
 
The sequences identified as putative TM7 and TM8 are given in Figure 3.18. It 
can be seen that these sequences contain a high proportion of hydrophobic 
residues, as expected. Although there are charged residues within these 
sequences it is possible for these to have a role within a TM helix. For example, 
they could be involved in formation of a salt bridge, as seen between TM1 and 
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TM2 of AtALMT993. Indeed, for a channel protein there must be a hydrophilic 
cavity though the membrane that is solvent-accessible and thus such 
hydrophilic residues are entirely plausible.  
 
Figure 3.18 - Sequences of two putative TM helices identified by Dreyer et 
al.45  
Hydrophobic residues highlighted in blue, charged residues are highlighted in 
gold and polar residues in white.  
 
It remains to be proved whether or not the two additional TM helices predicted 
by Dreyer et al. truly are embedded within the membrane, but the 
hydrophobicity of the regions – which is consistent across all clades – and the 
strong conservation of the sequence in this region also reported by Dreyer et al. 
supports the hypothesis. The data presented here showing that the isolated 
CTD is not a soluble domain, even with truncation, are also consistent with this. 
Indeed, the findings explain the lack of success in producing soluble protein 
reported here and had the analysis been available before the conception of this 
project the above strategy of expressing the isolated CTD would not have been 
undertaken.  
As production of the CTD in a stable, soluble form had proved unsuccessful and 
bioinformatics analyses by other groups had indicated that the CTD was 
probably not a soluble domain as we had initially expected it was decided that 
this approach would not produce fruitful results and as such it was decided to 
move on and attempt to express full-length ALMTs.   
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 Chapter 4 
Expression of ALMTs in Tobacco  
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4  
4.1  Introduction 
Given that production of correctly folded soluble protein from the constructs 
created in the previous chapter to express the C-Terminal Domain of TaALMT1 
had proved impossible, an approach to express the full-length ALMTs was 
devised. Successful expression of these proteins and production in quantities 
suitable for structural studies would enable the study of ALMTs towards a 
detailed understanding of their structure and mechanism. Membrane proteins 
represent a set of high-value targets for structural studies. However, relatively 
few membrane protein crystal structures have been solved at present: only 604 
membrane proteins are found from a total of 37,855 distinct protein structures 
recorded in the Protein Data Bank228 on 21 March 2016 
(http://www.rcsb.org/pdb/home/home.do), and of these only 7 plant membrane 
proteins are represented. Thus, membrane proteins – and especially plant 
membrane proteins – represent an under-explored set of targets. ALMTs play a 
large variety of roles in plants, are ubiquitously expressed in all plants, and have 
no detailed structural data available for any family member nor for any 
homologue that could be used for in silico modelling of the rest of the family 
members. Thus, they present an ideal target for expression with the aim of 
structural studies.  
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4.1.1  Choice of plant expression and the pEAQ-HT vector 
Expression of eukaryotic proteins for structural studies is often challenging, 
especially in E. coli, a favoured system due to its relatively low cost and its well 
established experimental protocols. Prokaryotic expression hosts lack the more 
sophisticated machinery for post-translational modification that is necessary for 
successful expression of functional eukaryotic membrane proteins – especially 
their long hydrophobic segments229. To overcome these challenges, a variety of 
eukaryotic expression systems exist, including yeast (both Saccharomyces 
cerevisiae230 and Pichia pastoris231), insect (via the baculovirus system232), and 
mammalian233. More recently, a system for expression of proteins in plants has 
been developed utilising a viral-based cassette for high translational efficiency – 
the pEAQ-HT vector for transient expression via agro-infiltration132,234.   
Of the varying options available, expression in planta is an attractive route for 
successful production of plant proteins for structural studies. A plant-based 
expression system should be able to undertake all necessary steps including: 
expression, folding, posttranslational modification, trafficking to the correct 
intracellular compartment and insertion into the membrane, as these will be 
occurring in an environment very similar to the native host. Recently, 
differences have also been shown in the results obtained from plant-based and 
animal-based expression, with animal cells not producing functional protein75. 
Transient expression allows for the production of high amounts of recombinant 
proteins in a matter of days without the need to produce transgenic plants, and 
for several constructs and conditions to be screened relatively rapidly. Transient 
expression is also useful when expressing proteins that can have deleterious 
effects that would otherwise affect growth of the plants, as expression does not 
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occur until the plants are sufficiently grown. This can be achieved by using 
Agrobacterium tumefaciens carrying an expression plasmid, such as pEAQ-
HT132 with an ORF of interest inserted. For this method, the intercellular space 
within the plant leaves is flooded with a suspension of bacteria in a process 
known as agro-infiltration, using a syringe (for small scale experiments) or by 
vacuum infiltration (if larger amounts of material are required)220.  
As shown in Figure 4.1, the pEAQ-HT viral-based vector contains a modified 5′-
untranslated region (UTR) and 3′-UTR from Cowpea mosaic virus (CPMV) 
RNA-2 to flank the target sequence and drive expression. These flank the 
polylinker region that is used for insertion of the target gene in frame with either 
an N- or C-terminal His-tag, which permits identification of the target protein by 
Western blotting and allows for purification via IMAC. A key feature is the P19 
suppressor of gene silencing from Tomato bushy stunt virus, which stabilises 
the mRNA to enable high levels of expression. This system has been used to 
produce viral proteins and viral-like particles235, as well as active human and 
plant enzymes236,237 and a similar CMPV-based system has been used to 
produce human antibodies with properties indistinguishable from those 
produced by mammalian expression systems with milligram-level yields238.  
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Figure 4.1 - Schematic view of pEAQ-HT sequence, highlighting key 
elements.  
The pEAQ-HT vector contains the CPMV-HT expression cassette, the P19 
suppressor of gene silencing, and the NPTII kanamycin resistance gene, and 
allows for the addition of an N- or C-terminal hexahistidine tag. Adapted from 
Peyret and Lomonossoff (2013)132. 
 
 
4.1.2  Proteins chosen from ALMT family for expression  
Protein targets for the present study were selected firstly from those available 
from the Arabidopsis Biological Resource Centre (ABRC, https://abrc.osu.edu/). 
Two cDNA clones were available from A. thaliana: ALMT5 and ALMT9. In 
addition, wheat ALMT1, the founding member of the ALMT family, was 
synthesised by Genscript (http://genscript.com) and inserted into the pUC57 
cloning vector. This gave a total of three genes (as shown boxed in Figure 4.2): 
TaALMT1, plasma membrane localised and Al-responsive; AtALMT9, vacuolar-
localised and Al-insensitive; and AtALMT5 of unknown function. Structural 
studies on these three proteins is of interest to find differences that explain their 
different functions, and perhaps the structural knowledge can help to suggest a 
functional role for AtALMT5 which can be tested in future studies, as well as 
other uncharacterised family members in future.    
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Figure 4.2 Phylogenetic tree of ALMTs with known functions plus family 
members from Arabidopsis with unknown function. Proteins studied 
herein are boxed. 
Numbers on nodes denote likelihood of correctness. Tree made using MEGA6 
software, sequences were aligned by the inbuilt MUSCLE functionality, and 
constructed with the Maximum Likelihood method and 500 iterations of 
bootstrapping. Figure adapted from Palmer et al.37  
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4.2  Cloning  
In order to produce plasmid vectors for the transient expression of ALMTs in 
tobacco leaves the coding sequences for three genes of interest were obtained. 
Firstly, AtALMT5 and AtALMT9 obtained from Arabidopsis Biological Resource 
Center (ABRC), were transformed into chemically competent OmniMax2 E. coli 
by the heat shock method, and then the plasmids were isolated for use in the 
present study. Secondly, TaALMT1 was synthesised by Genscript with the 
addition of flanking restriction sites to allow insertion into pEAQ-HT at the sites 
which enable construction of N-terminally tagged protein (i.e. XmaI/XhoI) and 
inserted into the standard pUC57 cloning vector. The pEAQ-HT expression 
vector was obtained from Prof. George Lomonossoff, John Innes Centre. 
4.2.1  Primer design  
The pEAQ-HT vector is designed to enable production of proteins with either an 
N- or C-terminal His tag. By use of the XmaI and XhoI restriction sites a protein 
fusion is produced with an N-terminal His tag; conversely, use of the AgeI and 
XmaI restriction sites generates a C-terminally tagged protein. It was decided to 
make both versions for each gene, as the placement of tags on proteins has 
been shown to affect their expression and function167 and thus production of 
both options maximises the chance of a well-expressing functional protein. 
However, the sequence for XhoI (CTCGAG) can be found within the coding 
sequence for both ALMT5 and ALMT9, necessitating that another restriction site 
be chosen for digestion of the ORF-containing insert fragments. PspXI was 
chosen; this enzyme recognises the sequence VCTCGAGB (where V = A, C, or 
G; and B = C, G, or T), which is not found within the coding sequence of either 
AtALMT5 or AtALMT9 and when cut forms and overhang compatible with XhoI.  
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4.2.2  Vector construction 
The open reading frames (ORFs) encoding the three target proteins were 
amplified from the corresponding purchased plasmids using primers detailed 
Chapter 2 by means of Gradient PCR to assess a range of annealing 
temperatures between 60-70°C for each pair of primers. An example is shown 
in Figure 4.3. Small differences were seen in contaminant bands, but the major 
band in each case was of the expected size. As no strong effect was seen, 
annealing temperatures were set at 65°C. The resultant PCR products were 
then electrophoresed on a 1% agarose gel, and each amplification was shown 
to correspond approximately to the predicted size for the desired fragments 
from the ORFs (exact sizes 1329 bp for TaALMT1, 1623 bp for AtALMT5, 1809 
bp for AtALMT9) as shown in Figure 4.4.  
The products were then purified and ligated into StuI-digested pCR-Blunt vector 
(Invitrogen) before transformation into OmniMax2 competent E. coli grown on 
LB-agar plates containing both kanamycin and IPTG which selects for growth of 
only colonies that contain the pCR-Blunt vector that contains an insert. 
Plasmids were isolated from bacterial cultures grown from these colonies. 
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Figure 4.3 - Gradient PCR with a range of annealing temperatures to 
amplify AtALMT9N.  
Size expected is approximately 1809 bp and this is the major band seen in each 
case.  
 
 
Figure 4.4 PCRs of TaALMT1C (1C), AtALMT5N (5C), AtALMT9C (9C), 
AtALMT5N (5N), AtALMT9N (9N). 
A 1% agarose gel for PCR products. Bands are seen at approximately correct 
sizes (1329, 1623, 1809, 1623, 1809 bp respectively), position of known DNA 
MW markers are shown on left (L). 
 
The ORFs were then digested out of their pCR-Blunt cloning vectors using 
appropriate restriction sites (AgeI and XmaI for C-terminally tagged constructs, 
XmaI and PspXI for N-terminally tagged constructs); an example is shown in 
Figure 4.5. In parallel, samples of pEAQ-HT were digested with the 
corresponding enzymes. Fragments were purified from a 0.5% agarose gel, and 
ligated together overnight at 16°C with T4 Ligase before transformation into 
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Omnimax2 competent E. coli and grown on LB-agar plates with kanamycin 
selection.  
 
Figure 4.5 -Digests of Blunt Vectors 
 1% Agarose gels of pCR-Blunt-AtALMT5C digested with AgeI and XmaI (5C) 
and pCR-Blunt-AtALMT5N digested with XmaI and XhoI (5N) and pCR-Blunt-
AtALMT9C digested with AgeI and XmaI (9C) and pCR-Blunt-AtALMT9N 
digested with XmaI and XhoI (9N). Samples show bands corresponding to 
vector (expected approximately 3519 bp) and insert indicated by an arrow 
(ALMT5 1623 bp and ALMT9 1809 bp).  
 
Colonies were picked and grown in LB medium with kanamycin selection 
overnight then plasmids were isolated and the final constructs were assessed 
for the presence of an insert by double restriction digestion. Constructs 
encoding C-terminally tagged proteins were digested with AgeI and XmaI, while 
constructs encoding N-terminally tagged proteins were digested with XmaI and 
XhoI. Digests of final constructs are shown in Figure 4.6 and Figure 4.7. An 
additional test for the presence of insert was by the use of Colony PCR, using 
the primers initially used for PCR an exemplar of the results for a successful 
Colony PCR is shown in Figure 4.8. 
The final plasmids were confirmed by sequencing.  
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Figure 4.6 – 1% Agarose gel of digested final constructs for plant 
expression.  
AtALMT5 with C terminal His tag (5C) doubly digested with AgeI and XmaI, 
AtALML5 and AtALMT9 with N-terminal His tag (5N, 9N) doubly digested with 
XmaI and XhoI. Bands for the insert were found in six lanes at approximately 
the expected size (ALMT5:1623 bp, ALMT9: 1809 bp) Also shown is the empty 
vector, pEAQ-HT digested singly with AgeI (V1) and with XhoI (V2) to confirm 
enzyme activity. The gap between lanes 9N and V1 shows where empty lanes 
were cropped from the picture.  
 
 
Figure 4.7 - 1% Agarose gel showing doubly digested ALMT1C and 
ALMT1N.  
Six samples of each plasmid were prepared and samples of each were digested 
with either AgeI and XmaI or XmaI and XhoI respectively. Bands are seen at the 
expected sizes in all lanes (~10,000 and ~1400 bp) 
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Figure 4.8 - 1% Agarose gel of 5 μL samples of colony PCR to confirm the 
presence of inserts in quadruplicate. 
Bands were seen at approximately the expected size for each construct 
(ALMT5 ~1623, ALMT9 ~1809) suggestive of correct incorporation of insert into 
the expression plasmid.  
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4.3  GFP expression in tobacco as a proof of principle 
Before proceeding with expression of the plant ALMTs, a proof of principle trial 
was performed with a pEAQ-HT expression vector containing a sequence 
encoding GFP (also obtained from Prof. George Lomonossoff) in order to 
confirm that protein expression could be obtained using the system in the 
experimental conditions available. The following experiment was designed with 
reference to the method of Sparkes et al.220. The GFP construct was 
transformed into Agrobacterium tumefaciens LBA4404 by freeze-thaw, and 
cultures were grown and infiltrated into the leaves of tobacco (Nicotiana 
benthamiana) five weeks after sowing, at O.D.600 = 0.01, 0.05, or 0.1 and left to 
express protein for 5 or 10 days. Control leaves were infiltrated with the 
Infiltration Medium only, or left to grow undisturbed.  
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Figure 4.9 - Fluorescence image of a set of leaves infiltrated with 
Agrobacterium tumefaciens LBA4404 transformed with pEAQ-GFP.  
Control leaves that were un-infiltrated (A) and infiltrated with Infiltration Medium 
only (B) were imaged alongside leaves infiltrated with transformed Agrobacteria 
at a range of optical densities (O.D.600) from 0.01 (C), to 0.05 (D) to 0.1 (E) after 
5 days of expression. It can clearly be seen that strong GFP expression occurs 
in leaves infiltrated with O.D.600 >0.05.  
 
Imaging of whole leaves using the fluorescence gel imaging mode of a G:Box 
Chemi XX6 (Syngene) was used to visually confirm the presence of expressed 
GFP in the leaves. No signal was seen from leaves that were not infiltrated; 
leaves infiltrated with Infiltration Medium only showed some autofluorescence at 
the site of infiltration (the small dark circle in the centre of the “Buffer only” leaf 
in Figure 4.9). By contrast, the leaves infiltrated with agrobacteria transformed 
with pEAQ-GFP showed fluorescence under illumination with the blue LED 
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module (470 nm), with an increase in signal intensity as the O.D.600 of the 
infiltrated solution was increased from 0.01 to 0.05, but the signal was saturated 
above 0.05. Thus, an O.D. of 0.05 was chosen to be ideal for expression of 
GFP in tobacco leaves. The same relative level of expression was seen in 
leaves left to express for 5 days and for 10 days.   
Having visually confirmed expression of GFP within the leaves, the next step 
was to develop a protocol for extraction of the protein from the leaves. Briefly, 
leaves were ground under liquid nitrogen in a chilled pestle and mortar and the 
resulting powder was incubated with Extraction Buffer (20 mM Tris pH 
8.0,100 mM NaCl, 10% glycerol, 5 mM EDTA, 1x protease inhibitors) before 
centrifugation at 100,000 g to pellet cell debris and insoluble material. The 
supernatant was decanted and visualised under blue light illumination, as done 
for the whole leaves. Fluorescence was compared against a protein sample 
extracted in the same manner from control leaves that were not infiltrated with 
Agrobacteria. As seen in Figure 4.10, the tube containing protein extracted 
from GFP-expressing leaves fluoresced strongly, in contrast to the control tube 
that contained extracted protein from un-inoculated leaves.  
 
Figure 4.10 - Fluorescence image of two tubes containing protein 
extracted from a set of leaves infiltrated with Infiltration Medium (Blank), 
or Agrobacterium tumefaciens LBA4404 transformed with pEAQ-GFP 
(GFP). 
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To further assess the extracted GFP, the material was analysed by SDS-PAGE. 
20 μL samples of protein extracted from un-infiltrated leaves, Infiltration 
Medium-only leaves, and the leaves expressing GFP were loaded and run on 
14-20% gradient gels and then imaged via the fluorescent gel imaging function 
of the G:Box Chemi XX6. As seen in Figure 4.11, below, a single band was 
found in the GFP-containing lane at approximately 30 kDa, confirming the 
presence of GFP.  
 
Figure 4.11 - Fluorescence image of SDS-PAGE gel of extracted samples 
from leaves.  
Un-infiltrated control, X; buffer-only control, B; pEAQ-GFP-infiltrated sample, G. 
Markers on the left indicate approximate positions of molecular weight 
standards. A clear single band is shown in the lane containing the extracted 
protein from leaves infiltrated with GFP, at approximately 30 kDa as expected. 
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4.4  Transient expression of His-tagged ALMTs via 
agrobacteria-mediated agroinfiltration in tobacco 
Having successfully expressed GFP in tobacco by agrobacterium-mediated 
transient expression and extracted the protein from the leaves, the focus moved 
onto using the system to express ALMTs with the vectors prepared in Section 
4.2. Agrobacteria were transformed with the pEAQ-ALMT constructs as above 
for GFP. Simultaneously, agrobacteria were also transformed with pEAQ-GFP 
to provide a positive control to ensure expression was occurring consistently. 
Experimental conditions were maintained from Section 4.3 as they had been 
shown to work for GFP. The objectives for this were three-fold. Firstly, to assess 
whether full length ALMTs could be expressed using the pEAQ-HT expression 
system in tobacco; secondly, to assess whether it was possible to produce 
protein in sufficient amounts to be suitable for structural studies and on what 
scale plants would need to be grown to do so; and thirdly, to extract, solubilise, 
and purify the proteins that could be produced with the intention of use in 
structural studies.  
During the expression of full length ALMTs, a positive control was always run 
with the pEAQ-GFP construct as before. Expression was seen in these leaves, 
whether the GFP-expressing leaves were in separate plants, in separate leaves 
in the same plant as the ALMT, or whether co-infiltrated into different sides of 
the same leaf, as seen below in Figure 4.12. Leaves were visualised to confirm 
expression of GFP as in Section 4.3, before proceeding with protein extraction. 
Through each experiment the positive control leaves always showed 
expression.  
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Figure 4.12 – Fluorescence image of a tobacco leaf infiltrated with two 
pEAQ constructs.  
GFP in left hand half, indicated by the oval, imaged in G:Box XX6 with 
blue LEDs. Right hand side infiltrated with N-terminally His tagged TaALMT5 
indicated by the rectangular box. This confirms transient expression in the 
leaves for GFP, suggesting the experimental conditions were conducive to 
transient protein expression. The dashed circle shows the approximate outline 
of the leaf surface. 
 
4.4.1  An initial expression trial of AtALMT5C 
pEAQ-AtALMT5C was the first construct confirmed by sequencing, so this was 
used for an initial test of the system. Duplicate transformations were performed 
into Agrobacteria, and a fresh transformation of pEAQ-GFP was also 
undertaken to provide a positive control. As previously for GFP, suspensions of 
transformed Agrobacteria were infiltrated into the leaves at O.D.600 = 0.01, 0.05, 
and 0.1. After 5 and 10 days of expression, leaves were removed from the 
plants and protein was extracted in a similar manner as for the extraction of 
GFP previously, with the following modifications in light of ALMTs being 
membrane proteins. Membrane proteins are often separated from cellular 
debris and soluble proteins by a two-part centrifugation protocol116. After 
extraction protein samples were centrifuged first at 14,000 g to pellet cellular 
debris and then the supernatant was centrifuged at 100,000 g to collect the 
membrane fraction that should contain the protein of interest. In this initial test, 
three separate samples of leaves infiltrated at different O.D.600 values were 
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extracted in duplicate, for a total of six samples. Each of these was extracted 
and the fractions were assessed for the presence of His-tagged ALMT5C by dot 
blotting, while the membrane pellets were loaded onto a SDS-PAGE gel and 
assessed by Western blotting. As seen in Figure 4.13, expression was seen in 
each sample, although the protein of interest was mostly contained in the initial 
cell debris pellet rather than the cell membranes fraction as expected. One 
explanation for the target protein being found in the cell debris pellet is that it 
has been expressed in insoluble inclusion bodies, or otherwise this can be a 
sign that the fractionation buffer is not optimal, or cell lysis is not complete. This 
will be explored in the following section. 
 
 
Figure 4.13 - Dot blot of two pairs of pellet/supernatant fractions extracted 
from each of six samples of leaves infiltrated with ALMT5C after 5 days of 
expression.  
Samples infiltrated with Agrobacteria in duplicate at three O.D.600 1,2 = 0.01, 3,4 
= 0.05, 5,6 = 0.1. Most of the protein of interest is seen in the first pellet 
containing the cell debris, and only a small amount of signal is seen in the 
membrane fraction (the pellet collected after centrifugation at 100,000 g). 50 ng 
of His-tagged protein standard was included as a positive control (50 ng). 
 
50 ng  
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The membrane pellets, which were expected to contain the protein of interest, 
showed only a small amount of signal in the western blot as the protein was 
mostly contained in the first pellets (Figure 4.14); however, some signal was 
seen in two lanes, corresponding to an infiltration at O.D.600 0.05 and at 0.1. 
Interestingly, the bands were seen at a lower MW than expected – although the 
molecular weight markers washed off the membrane so these could not be 
used for determination of the MW of the visible bands. However, the protein 
standard used (TEV-His) has a MW of ~27 kDa so the MW of the bands in 
lanes 4 and 6 can be estimated at MW 30-40 kDa. This is significantly smaller 
than the expected MW of AtALMT5C, which is 61 kDa. One explanation for this 
could be that as a membrane protein ALMT5C runs at a lower MW than 
expected, as is seen for many membrane proteins116, alternatively this could be 
evidence either of a contaminant protein from tobacco that cross reacts with the 
anti-His antibody, or evidence that ALMT5C is degrading. Given that the bands 
are only present in two samples it seems unlikely to be a cross-reacting native 
protein and so is most likely ALMT5C running anomalously low, or a cleaved 
product of ALMT5C.  
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Figure 4.14 – Western blot of membranes prepared from six leaf samples 
inoculated with varying O.D. of Agrobacteria and expressing AtALMT5C. 
Two biological replicates were taken for each O.D.600 tested.  
Lanes are S, 50 ng TEV-His standard. (1, 2) O.D. = 0.01, (3, 4) O.D. = 0.05, (5, 
6) O.D. = 0.1. Signal is seen in lanes 4 and 6 but at a lower height than 
expected (~30 kDa rather than ~61 kDa).  
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4.4.2  Improving fractionation with a high-density sucrose buffer 
In order to move forward with protein extraction, as the protein was seen in the 
cell debris pellet rather than the final membrane pellet, a modification was made 
to the extraction buffer as it was suspected that cellular lysis was not complete 
and the buffer used for extraction could be optimised. Following the 
methodology of Abas and Luschnig239 for improved fractionation of plant 
membrane proteins, sucrose was added to a final concentration of 25% in order 
to increase the density of the buffer and prevent the membrane proteins from 
sedimenting in the initial spin to clear the cell debris. Furthermore, a change 
was made to the protocol: the plant material was passed through a cell disruptor 
at 30 kpsi in order to homogenise the material and fully lyse the cells, enabling 
all the protein to be extracted from the cell. This should also ensure the 
membrane protein can be separated from the pelleted material (such as the cell 
wall) in the initial 14,000 g spin.  
After the first trial of ALMT expression, a second attempt was set up with 
ALMT1N as the protein of choice. This time, three time-points were chosen, 4, 
8, and 12 days, again with the same three values for O.D.600 of inoculation. The 
results from the 8-day time-point are shown in Figure 4.15. The Coomassie 
stained gel shows an improved extraction of total protein, and more of the target 
protein is visible in the Western blot. However, despite this improvement, 
expression levels as determined from the Western blot are low, measured by 
densitometry to be on the order of 5 μg per leaf. Promisingly, all three 
conditions at this time point show some level of expression, and that material is 
specifically detected by the anti-His antibody and of approximately the right size 
(~60 kDa), and visible in the membrane fraction.  
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Figure 4.15 - Samples of protein extracted from leaves infiltrated with 
three O.D.600 of Agrobacteria harbouring pEAQ-TaALMT1N harvested after 
8 days of expression  
A) Coomassie and B), Western blot of the three samples, loaded in duplicate 
with either 5 μL or 25 μL per lane. C) shows a zoomed view of the section of the 
blot outlined in B for a clearer view of the intensities of the bands.  
  
- 134 - 
4.4.3  Improving expression conditions  
As the levels of expression seen so far were relatively low (μg levels per leaf) a 
review of the literature was conducted to assess the conditions used to 
generate high yields of protein in previous experiments. A total of eleven studies 
were reviewed and these are summarised in Table 4.1.  
Table 4.1 - Summary of conditions used for expressing high yields of 
protein from CPMV- and pEAQ-based expression vectors from recent 
papers 
 
Age of 
plants 
/weeks 
Days of 
expression 
O.D. of 
agrobacteria at 
infiltration 
Reference 
 3-5 4-6 0.3 240 
 4-6 1-6 1.0 241 
 8 4-10 1.0 242 
 3 6 1.0 243 
 4-8 14 2.0 
244 
 3 6 0.13-1.2 
234 
 4 6-8 1.2 236 
 3-4 3-10 0.4 245 
 6 6 0.5 
238 
 3 6 1.2 237 
 - 5-6 1.2 246 
Range 3-8 1-14 0.1-2.0  
 
Based on this set of papers, the conditions used in previous studies match up 
well with the initial experiments in this study for both the age of the plants and 
for the length of expression following infiltration, but the O.D.600 of infiltrated 
Agrobacteria used thus far in this study was around an order of magnitude 
below the average used for previous studies. Based on this summary, the 
following conditions were chosen for a larger screen of constructs and 
conditions, shown in Table 4.2.  
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Table 4.2 - Revised conditions for screening ALMT expression in tobacco 
Plant age 5 weeks after sowing (approx. 4 weeks after 
germination) 
Days of 
expression 
5 days, 10 days 
O.D.600 0.1, 0.5, and 1.0 
 
This set of three O.D.s and two time-points gave a set of six conditions per 
expression trial, allowing a pair of plants to be infiltrated per condition, which 
gives sufficient leaf material to extract protein from while still permitting one set 
of plants (i.e. 12 tobacco plants) to grow together in a single tray in the 
greenhouses. Several further trials with all six constructs were attempted in 
order to attempt to find the best combination of conditions to produce the 
maximum yield of protein. A full list of conditions for all trials assessed in this 
chapter is found in Table 4.3. Additionally, when simply testing for expression, 
samples were lysed and spun to pellet cell debris, then whole protein extracts 
were run on SDS-PAGE gels in order to assess relative expression, and 
standard amounts of His-tagged protein was loaded to calculate absolute 
values of protein per band.  
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Table 4.3 –Full list of conditions tested for ALMT 
expression trials. 
  Plant age 
/weeks 
O.D.600  Days of 
expression 
Construct 
 
 
Initial 
screen 
5 0.01 5  
AtALMT5C 5 0.05 5 
5 0.1 5 
5 0.01 10  
AtALMT5C 5 0.05 10 
5 0.1 10 
 
 
 
 
 
 
 
 
 
 
 
Further 
testing 
4 0.1 5  
AtALMT5C 4 0.5 5 
4 1.0 5 
5 0.1 4  
AtALMT1N 5 0.5 4 
5 1.0 4 
5 0.1 8  
AtALMT1N 5 0.5 8 
5 1.0 8 
5 0.1 12  
AtALMT1N 5 0.5 12 
5 1.0 12 
5 0.1 5  
AtALMT5C 5 0.5 5 
5 1.0 5 
5 0.1 5  
AtALMT5N 5 0.5 5 
5 1.0 5 
5 0.1 5  
AtALMT9C 5 0.5 5 
5 1.0 5 
  
 Plant age 
/weeks 
O.D.600  Days of 
expression 
Construct 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further 
testing 
5 0.1 5  
AtALMT9N 5 0.5 5 
5 1.0 5 
5 0.1 5  
TaALMT1C 5 0.5 5 
5 1.0 5 
5 0.1 5  
TaALMT1N 5 0.5 5 
5 1.0 5 
5 0.1 10  
AtALMT5C 5 0.5 10 
5 1.0 10 
5 0.1 10  
AtALMT5N 5 0.5 10 
5 1.0 10 
5 0.1 10  
AtALMT9C 5 0.5 10 
5 1.0 10 
5 0.1 10  
AtALMT9N 5 0.5 10 
5 1.0 10 
5 0.1 10  
TaALMT1C 5 0.5 10 
5 1.0 10 
5 0.1 10  
TaALMT1N 5 0.5 10 
5 1.0 10 
5 1.0 10 AtALMT5N 
Final 
purifica
tion 
5 1.0 5 AtALMT5N 
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An example of an expression trial is shown in Figure 4.16. Samples tend to 
smear, likely due to the samples containing whole leaf extract, and therefore 
being a heavily loaded lane, due to the low expression levels requiring more 
total protein to be loaded than is optimal (the protein may also be glycosylated, 
which would also cause smearing).  Nonetheless, it is possible to determine that 
there is at least some expression of each protein tested and generally a longer 
expression produces a greater amount of protein. Quantification of expression 
levels is impossible as the bands are too smeared to compare accurately to the 
standards, but it is clear that the best-expressing samples have approximately 
the same order of magnitude of protein as the bands of standards. Working on 
a basis of 20 ng of target protein in 20 μL of sample per well this extrapolates to 
~1 μg of target protein per g of leaf. This level of expression would be at the 
lower limit of feasibility for later studies, as 1 kg of leaf material would be 
needed for 1 mg of target protein, which would require a rational number of 
plants.  
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Figure 4.16 - Western blot of total protein extracted from tobacco leaves 
expressing TaALMT1C, TaALMT1N, AtALMT5C, AtALMT9C, AtALMT9N.  
Leaves innoculated with agrobacteria at O.D.600 = 0.01, 0.05, and 0.1 containing 
plasmids expressing TaALMT1C (1C), TaALMT1N (1N), AtALMT5C (5C), 
AtALMT9C (9C), AtALMT9N (9N).  Leaves were collected after 5 days, or 10 
days of expression. Some expression seen in a variety of conditions, with 10 
days of expression producing better results than 5 days. Standards of 10, 20, 
and 50 ng of His-tagged TEV protease were loaded to aid quantification and act 
as a positive control. Lane containing MW marker indicated with L, and 
approximate MW markers identified to left.  
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4.4.4  Improving ALMT extraction 
Detergents are required to solubilise membrane proteins once they are 
extracted from the cells, but they may also prove useful for extracting 
membrane proteins from the rest of the cell in the first place. It was suspected 
that a single extraction with buffer alone was not sufficient to extract all the 
target protein and so to assess the extent that detergents can aid extraction of 
ALMTs and ensure that the maximum amount of protein is extracted a re-
extraction of the 14,000 g pellet was attempted. This second extraction 
contained the detergent Triton X-100 at 1% (w/v). Samples of ALMT-expressing 
leaf were extracted with PBS after grinding under liq. N2 and passage through 
the cell disruptor as before and then centrifuged to pellet debris; the pellets 
were then re-extracted with detergent-containing buffer and samples of 
extracted protein were assessed by Western blotting.  
 
Figure 4.17 - Western blot of 20 μL of samples extracted from tobacco 
leaves expressing expressing TaALMT1C (1C), TaALMT1N (1N), 
AtALMT5C (5C), AtALMT9C (9C), AtALMT9N (9N) Extraction first with 
buffer and secondly with buffer containing 1% Triton X-100.   
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Figure 4.17 shows the effect of a second extraction containing Triton X-100. 
The second set of samples re-extracted with Triton X-100 contain a significant 
proportion of the target protein. Therefore, extraction can be optimised and the 
presence of detergent will permit more target protein to be extracted from the 
leaves and was used from this point forward.  
A second assessment of the extraction was undertaken to assess whether 
detergent-containing buffer can extract all the target protein in one extraction, or 
whether multiple extractions will be required even with detergent added to the 
buffer. Three samples of ALMT5N were extracted with PBS containing 1% 
Triton X-100 and then re-extracted with the same buffer (in each case 1 ml 
buffer per g of ground leaf material). The results are shown in Figure 4.18 and 
show that the first extraction is able to extract almost all the target protein. 
Additionally, now that the protein is extracted reliably in a single extraction, it 
can be seen that an infiltration of O.D.600 = 1.0 appears to be best condition for 
expression of ALMT5N, confirming that a higher O.D.600 of infiltration is 
beneficial to expression levels.  
 
Figure 4.18 - Western blot of 20 μL of three samples of leaf containing 
ALMT5N, inoculated with Agrobacteria at O.D.600 = 0.1, 0.5, or 1.0, each 
extracted twice with buffer containing Triton X-100.  
Almost all protein is extracted in the first samples and O.D.600 = 1.0 appears to 
be the best condition.  
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Thus, the best strategy appears to be using an infiltration of Agrobacteria at 
O.D.600 = 1.0 and as higher densities of bacteria have not been tested as they 
were outside the scope of the initial screen, increasing this may prove fruitful. 
Moreover, it is helpful to extract protein from leaf samples with buffer containing 
detergent. As the target protein will require solubilisation with detergents as part 
of the purification in any case, this provides a useful modification to the protocol.  
The next question was to quantify the amount of extracted protein from the best 
condition, namely, ALMT5N from leaves inoculated with Agrobacteria at an 
O.D.600 = 1.0. Samples of ALMT5N from above (stored overnight at -20°C) were 
re-rerun on an SDS-PAGE gel and compared with His-tagged protein standards 
from 5-20 ng. As seen in Figure 4.19, no signal was seen from the lanes 
containing extracted ALMT5N. This could be a sign that the protein was being 
degraded by the action of proteases released upon homogenisation of leaf 
tissue. Alternatively, it could be that the protein samples were significantly more 
dilute than the lowest His-standard. The smallest amount of standard loaded 
was 5 ng and the largest volume of extracted protein loaded was 20 μL; this 
gives a maximum concentration of ALMT5N of 0.25 ng/μL, equivalent to 0.25 
μg/ml. As ~6-8 g of leaves were extracted for these experiments this produced 
approximately 6-8 ml of extracted protein i.e. 1.5-2 μg of ALMT5N. So, either 
the ALMT5N is being rapidly degraded, despite the presence of protease 
inhibitors, or it is being expressed in levels at the limit of detectability, unsuitable 
for structural studies. Neither of these possibilities is favourable for this study. 
However, as previous gels that also contained His-tagged standards showed 
visible protein it seems likely that the target protein is being expressed at an 
appreciable level, but it is being degraded during storage.  
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Figure 4.19 - Western blot of ALMT5N with His-standards to assess 
expression levels.  
No signal is seen from the target protein (expected position indicated by arrow) 
indicating that either protein levels are below 0.25 ng/μL or that the protein has 
degraded.   
- 143 - 
4.4.5  Test of rapid purification of ALMT5N 
Before further optimisation of conditions was attempted, given the initial 
relatively-low expression levels combined with the seeming instability of the 
extracted protein (despite the presence of protease inhibitors), an attempt was 
made to solubilise and purify the extracted protein immediately after extraction 
in order to assess firstly, whether purification was feasible, and secondly, 
whether purifying ALMTs would stop the apparent degradation seen in samples.  
 
Figure 4.20 - Dot blot of protein extracted from tobacco leaves expressing 
AtALMT5N.  
10ng of His-tagged standard and a dot of 5 μL extracted protein. Expression of 
N-terminally His-tagged AtALMT5 is confirmed.  
 
ALMT5N has shown the highest expression overall, so it was chosen for the 
purification test. A sample of ALMT5N-expressing leaves was ground and lysed 
before extraction with buffer containing 1% DDM at 4°C and centrifugation at 
100,000 g in order to discover whether the material being produced was able to 
be solubilised. A sample of the supernatant was taken for a dot blot to confirm 
the presence of ALMT5N, as shown in Figure 4.20, then the supernatant 
containing solubilised proteins was bound to HisPur Cobalt resin for 2h at 4°C 
before washing with increasing concentrations of imidazole (10 mM, 20 mM, 
40 mM) and elution with buffer containing 300 mM imidazole. 20 μL samples of 
each fraction were run on SDS-PAGE gels and analysed by Western blotting 
and coomassie staining. This data, shown in Figure 4.21, did not clearly show 
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any of the protein of interest. More promisingly, there were very minimal 
contaminants in the elution fractions and 10 mM of imidazole was sufficient to 
wash off major contaminant bands, indicating that if target protein yields were 
sufficiently high then it would be possible to purify the proteins to high levels of 
purity in one step. However, the lack of protein present in the Western blot was 
the major problem. 
 
Figure 4.21 - ALMT5N purification.   
Western blot (A), and coomassie stained (B) SDS-PAGE gel for a purification of 
ALMT5N with 20 μL from each fraction. Washes of 10-40 mM imidazole (10, 20, 
40) and three elutions (E1-E3) No signal is seen in the expected lanes for 
Solubilised (S) and Eluted (E) protein. 20 ng of His-tagged standard is seen in 
the western blot, however, indicating successful transfer and antibody binding. 
Arrows indicate the expected size of ALMT5N. 
 
However, re-imaging of the Western blot was able to provide further 
information. Setting the camera to exclude the protein standard so that the 
relative brightness of that band did not obscure signal from the samples it was 
possible to see some signal from the purification lanes, as seen in Figure 4.22. 
Here it is possible to see that the protein has been correctly solubilised by the 
DDM, and although some signal is seen in the flowthrough, there is signal from 
the His-tagged protein in the fractions eluted from the IMAC resin. A gel was 
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also silver stained with the Pierce Silver Stain Kit, as this kit has a greater 
sensitivity than coomassie staining, but bands for ALMT5N were not seen 
above the background staining.  
 
Figure 4.22 - Western blot of 20 μL of fractions of a AtALMT5N 
purification, without standards. 
 The protein is solublilised (S), although some material does not bind to the 
resin and so is seen in the flow through (FT). Washing with increasing imidazole 
(10-40 mM) does not elute the protein until 300 mM is used, which washes the 
protein back off the resin (E1, E2). However, the protein is degraded – firstly 
during solubilisation the MW drops from 50 kDa to 40 kDa, and during the 
washing and elution of the resin, the MW decreases further to ~20 KDa.  
 
Figure 4.23 - Silver stained SDS-PAGE gel of ALMT5N purification.  
MW markwer (L), soluble fraction (S), flowthrough (FT), washes with 10-40 mM 
imidazole (10, 20, 40) and two elutions at 300 mM imidazole (E1-2). Amounts of 
protein in washes and elutions are at undetectable levels against the 
background signal.  
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The low levels of protein expression seen and especially the rapid cleavage of 
the expressed proteins suggests that transient agro-infiltration-mediated 
expression of ALMTs in tobacco is an unpromising route to production of high 
levels of target protein for structural studies.  
In hindsight, further evidence of protein degradation is visible in the previous 
data. The data shown in Figure 4.14 also indicate that there was cleavage of 
the protein at some point during extraction. That construct was C-terminally 
tagged and showed a size of ~30-35 kDa while the construct analysed in the 
purification trial shown in Figure 4.22 is an N-terminally tagged construct and 
thus represents the “other side” of the degraded material. The MW of this 
fragment is initially ~40 kDa before decreasing to ~20 kDa during purification. 
So both the N- and C-tagged constructs are degrading. There is also a small 
band in Figure 4.15C in the first lane around 30 kDa that is detected by the 
antibody for the His-tag, suggesting that this band is also from the target protein 
and a possible sign that it was degrading in that experiment too. Also supporting 
this was that it was never possible to return to samples extracted the previous 
day in order to, for example, re-run gels as it was not possible to detect any 
signal from the Western blot.  
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4.5  Discussion and Conclusion  
In this chapter, the expression of three ALMT proteins was investigated using a 
transient expression system in tobacco. This system was chosen to provide an 
environment that is as close to the native plant environment as possible and 
maximise the likelihood that protein would be produced in a correctly-folded and 
active form. Constructs were created by inserting the ORFs for each gene of 
interest into the pEAQ-HT vector in two positions in order to produce constructs 
that would be tagged at either their C- or N-terminus with an oligohistidine 
affinity tag. These six constructs were then transformed into Agrobacterium and 
infiltrated into leaves. Conditions for plant growth, protein expression, and 
protein extraction were screened, developed, and optimised. A purification 
showed that it was possible to produce solubilised and purified protein. 
However, despite testing a range of expression conditions, expression levels of 
all six constructs was consistently low, producing nanograms-to-micrograms of 
protein, insufficient for extensive biochemical or structural studies without 
significant scale up. Additionally, and more problematically, the protein 
produced appeared to be unstable, with signal on Western blots not being 
detectable if samples were stored overnight. When attempting an extraction 
followed directly by purification it was possible to observe the cleavage and 
breakdown of the protein products with ALMT5N reduced from 50 kDa to 40 
kDa followed by a second drop to 30 kDa.   
The use of transient expression in tobacco appears not to be a promising route 
to the production of these plant membrane proteins for structural studies. This 
may be because the protein targets in question are anion channels, and high 
levels of expression are impossible without causing cell death as their 
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expression leads to making the membrane of the cell leaky due to the presence 
of these channels. Indeed, necrosis of the infiltrated leaves was observed 
during the course of many experiments. However, this was not tracked 
comprehensively enough to draw firm conclusions, but generally there was 
more necrosis observed at higher infiltrations of agrobacteria. This may reflect a 
higher toxicity due to the infiltration itself, or the fact that higher infiltration 
caused expression of target protein, and thus toxicity from overexpression. 
While membrane proteins in general are known to be difficult targets for 
overexpression, anion channels perhaps represent an even more difficult target 
due to this fact. Channel activity would lead to loss of anions (in this case 
malate, an important compound in carbon metabolism and also chloride and 
nitrate, which have been shown to be substrates for ALMTs48) and this would 
lead to depolarisation. These factors would especially drive the plant cell to 
attempt to degrade the ALMTs rather than suffer the deleterious effects of 
overexpression, and if uncontrolled cell death was occurring then this could also 
lead to the release of proteases that would degrade the target protein. Indeed, 
black patches were observed on the leaves, especially those infiltrated with 
higher concentrations of Agrobacteria, or those left to express for a longer 
period of time, consistent with necrosis and degradation within the leaf. This is 
on top of the usual potential problems with overexpression such as the risk of 
saturating the host quality control, posttranslational-modification, and trafficking 
systems.  
There is some promise in these experiments, however. Each construct could be 
expressed, to some level and when solubilisation was attempted 1% DDM was 
sufficient to solubilise ALMT5N. Indeed, the final trial showed that it was 
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possible to purify the degraded ALMT5N by IMAC suggesting that if an 
approach was found that optimised the expression levels and prevented protein 
degradation then it would be possible to both solubilise and purify the resultant 
proteins.   
Given that this in planta expression approach has not been successful, future 
studies (which are out of the scope of this current study) could utilise one of 
several options. Eukaryotic expression systems are developed for yeast, insect, 
and mammalian cells. For example, it may be convenient to try to exploit the 
similarity of yeast to plants, and express ALMTs in either S. cerevisiae or P. 
pastoris these two model organisms have been widely used for protein 
production and can be considered a proxy system for plants. Additionally, a 
larger range of protocols, vectors, and tools have been developed for use with 
these systems making them a more convenient approach. The shorter time 
period and better controlled expression of these systems may also help with 
expression. Cells can be harvested before extensive cell death occurs, and 
protein can be extracted before the action of proteases can degrade the protein 
of interest. Alternatively, success has been seen with expression of plant 
proteins in insect cells using the baculovirus system247,248. Although this 
approach is more expensive and technically demanding, it may be suitable and 
the system has proved successful at generating crystal structures deposited in 
the PDB249. These may present future avenues of work, but have not been 
explored in the present study.  
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Chapter 5 
Expression and Purification of 
Bacterial ArAE Exporters 
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5  
5.1 Molecular biology 
5.1.1  Identification of candidate genes 
In an attempt to find more experimentally amenable targets for structure 
function investigations, three bacterial candidates from the ArAE family, with a 
close identify to the wheat channel, TaALMT1 were initially selected from the 
genomic DNA stocks available in the lab. These three genes were SO_0154 
(Uniprot:Q8EKE1) from Shewanella oneidensis (So), DVU_0077 
(Uniprot:Q72FY6) from Desulfovibrio vulgaris (Dv), and AaeB (Uniprot:P46481) 
from E. coli (Ec), listed in Table 5.1.  
These genes were selected based on their sequence identity to the 
transmembrane region of TaALMT1. When aligned using MUSCLE via the 
EMBL-EBI website250,251, So, Dv, Ec showed 20, 22, and 17% identity to 
TaALMT1, respectively (Table 5.1). However, when looking at the predicted 
transmembrane regions specifically (taken as the first 180 residues of the 
bacterial proteins and the first 225 residues of the plant protein) the sequence 
identity rises to 30, 24, and 25% respectively, for identity, and 62, 70, 62% for 
similarity. Likewise, the bacterial proteins are predicted to have similar topology: 
So and Dv are predicted to have a 6 TM topology by Transmembrane Hidden 
Markov Modelling13 similar to the transmembrane domain of ALMT family 
members, and Ec is predicted to have an internally-repeated 2x 6 TM topology 
(Error! Reference source not found.). The E. coli gene has been characterised 
in vivo already and so provides a good target for study, while the two other 
genes are 6-TM and thus closer in structure to the ALMTs. 
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As such, it was reasoned that these proteins may provide good models for 
understanding the transmembrane domain of ALMT proteins, while their study 
could prove easier because they are bacterial proteins.  
Table 5.1 – Information on genes identified as homologous to ALMT family 
members 
Designation Gene 
name 
Uniprot 
ID 
Predicted 
topology 
Length 
/bp 
% Sequence 
Identity 
(TaALMT1) 
Ec AaeB P46481 2x (6 TM) 1,965 17 
So SO_0154 Q8EKE1 6 TM 1,122 20 
Dv DVU_0077 Q72FY6 6 TM 1,080 22 
 
5.1.2 Design and Preparation of a Suitable Expression Vector 
5.1.2.1 Design of pTTQ18-TP 
The first step after identification of candidate genes was to prepare a suitable 
vector to insert the ORFs of interest into. The base vector chosen was pTTQ18, 
a vector that has proved successful for expression of bacterial membrane 
proteins due to its expression of the LacIq gene, which represses any ‘leaky’ 
expression that could otherwise retard bacterial growth, and strong tac promoter 
for high levels of expression after induction252. The expression vector, 
designated pTTQ18-TP, was constructed from two fragments of existing vectors 
used in the lab, a schematic is shown in Figure 5.1. The purpose of this was to 
introduce an improved cleavage site, swapping the thrombin cleavage site in 
the original vector for a more efficient HRV-3C site.  
The first vector used was “pUC-T4-Lysozyme+0294 frag-0476 frag”. Three 
sequences were extracted from this: a ribosome binding site, a start codon, and 
a pair of restriction sites (NheI and SbfI) to be used for subcloning the gene of 
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interest between. Also included was a copy of the CDS for lysozyme, which was 
used for a previous project, between the NheI and SbfI restriction sites. The 
construct was designed for insertion in frame with the Start codon and HRV3C 
cleavage site and His-tag using the PstI enzyme rather than SbfI. PstI 
recognises the sequence CGTACG, which is found within the recognition site 
for SbfI (CCGTACGG). However, SbfI could be used (if, for example, the PstI 
recognition sequence was found within the ORF of interest) by design of PCR 
primers with one fewer base or two additional bases in order to put the 
sequence back in frame.  
After insertion of the ORFs of interest, the lysozyme gene is removed, allowing 
for an easy check that digestion had proceeded as expected by looking for the 
excised band on the gel (as seen in Figure 5.4A).  In summary, this fragment 
provided a cassette into which any CDS of interest could be inserted into, 
ensuring that the sequence would be in frame and correctly positioned with 
respect to the RBS and start codon, as seen in the top half of Figure 5.1.  
Secondly, the existing expression vector “pBPT0294-CVH” provided the main 
pTTQ18 backbone as seen in the bottom half of Figure 5.1. This fragment 
added a HRV-3C cleavage site and His-tag followed by a stop codon onto the 
end of the CDS inserted between NheI and SbfI to enable purification of the 
target protein by IMAC, and later cleavage of the tag. It also contains the 
required sequences for effective replication of the vector, and for lactose-
inducible expression of the target gene.  
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Figure 5.1 - Schematic of the pTTQ18-TP expression vector.  
Fragment excised from “pUC-T4-Lysozyme+0294 frag-0476 frag” using XbaI 
and SbfI sites contributes the Ribosome Binding site (RBS), Start Codon 
(Start), and Lysozyme gene between NheI and SbfI sites as shown in the top 
half of the figure. Fragment excised form “pBPT0294-CVH” using XbaI and SbfI 
sites contributes a C-terminal HRV-3C cleavage site (HRV\cleavage\site) and 
His8-tag(RGSH8 tag), followed by the stop codon (Stop), along with the major 
vector backbone comprising the Origin of Replication to allow proliferation (Ori), 
Ampicillin resistance gene for selection (Ampr), LacI gene for repression of 
expression (LacIq), LacZ gene for metabolism of lactose (LacZ\alpha). Figure 
produced using Geneious 8.1.  
 
The resulting vector should result in very small levels of ‘leaky’ expression 
before induction due to expression of the LacIq repressor protein, high levels of 
expression after induction from the Tac promoter, and a final recombinant 
protein product containing a His-tag for the purposes of purification and 
identification by western blotting, which is cleavable to provide a further 
purification step, or in order to produce a protein in close-to-native state.  
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5.1.2.2 Construction of pTTQ18-TP 
To prepare the expression vector, each of the plasmids required for its 
construction was digested with both XbaI and SbfI in order to cut the fragments 
required; additionally, the vectors were cut with each of XbaI and SbfI 
individually to ensure that both of the enzymes were active and could cut at the 
recognition site. The desired bands, indicated with arrows on   
Figure 5.2, were then cut from the gel and purified, before ligation together to 
form the final expression vector. Sequencing confirmed that the sequence was 
as expected.  
  
Figure 5.2 –0.5% agarose gels of digested samples of the two vectors 
used to create the expression plasmid used in this study. 
“pBPT0294-CVH” and “pUC-T4-Lysozyme+0294 frag-0476 frag”, each digested 
with XbaI (X) and SbfI (S) singly, and then double-digested (X+S). The white 
arrow (approximately 5 kbp) and the black arrow (approximately 500 bp) 
indicate the bands excised and purified. 
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5.1.3  Production of expression vectors 
5.1.3.1 Amplification of target genes 
The next step required was to amplify the open reading frames (ORFs) 
encoding the three target proteins from the corresponding genomic DNA via the 
Touchdown PCR protocol and using the primers detailed in Chapter 2. 
Samples of each of the resultant PCR products were electrophoresed on a 
0.5% agarose gel, as seen in Figure 5.3, with the band for So running at 
approximately 1000 bp and the band for Ec (AaeB) running at approximately 
2000 bp, as expected.  However, the Dv reaction produced a smear instead of 
a band at the expected size of approximately 1000 bp. Although further PCR 
optimisation by adjustment of annealing temperature and time was attempted, 
no improvement was seen. Accordingly, investigation into the D. vulgaris gene 
was stopped in favour of the two genes that could be successfully amplified.  
 
Figure 5.3 - Touchdown PCR to amplify three ORFs from S. oneidensis 
(So), D. vulgaris (Dv), and E. coli (Ec) genomic DNA.  
The S. oneidensis and E. coli genes successfully amplify, with bands at the 
expected sizes of approximately 1000 and 2000 bp, respectively, but the 
reaction for the D. vulgaris DNA produced only a smear.  
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The two successful products, So and Ec (AaeB), were purified and then used to 
produce an ‘cloning vector’ by ligation into a linearised sample of the vector 
pCR-Blunt (Invitrogen), forming So-Blunt and Ec-Blunt. The ligation mixtures 
were then transformed into E. coli strain OminiMAX 2 cells and recombinants 
were then selected by plating onto LB agar containing 100 μg/mL kanamycin 
and 1 mM IPTG. Cloning vectors were isolated and used in the production of 
the expression vectors.  
 
5.1.3.2 Insertion of ORFs into the expression vector pTTQ18-TP 
In order to produce the linearised DNA fragments required for the expression 
vectors, pTTQ18-TP, So-Blunt, and Ec-Blunt were each digested with NheI and 
PstI, followed by electrophoresis on a 0.5% agarose gel, as seen in Figure 5.4. 
The digestion of pTTQ18-TP produced a band of almost 6000 bp with the 
removed Lysozyme gene seen at approximately 500 bp. Meanwhile, ORFs from 
So-Blunt and Ec-Blunt were seen at approximately 1000 bp and 2000 bp, 
respectively. These fragments were excised, purified, and ligated together to 
form the final expression vectors, designated So-TTQ and Ec-TTQ. These were 
confirmed to be correct by sequencing before proceeding with expression.  
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Figure 5.4 - Double digests to prepare fragments for construction of 
expression vectors.  
Approximate DNA size markers are indicated on the left hand side and are 
equivalent in A and B. A) pTTQ18-TP digested with NheI and PstI (TTQ) in 
duplicate. The expression vector backbone taken is indicated with a white arrow 
at approximately 5 kbp and the excised CDS for lysozyme originally present in 
the vector is visible at approximately 500 bp. The S. oneidensis gene previously 
amplified and captured in PCR-Blunt was digested with NheI and PstI (SoB) in 
duplicate. The digested insert is indicated with a black arrow at approximately 1 
kbp as expected.  B) The E. coli gene previously amplified and captured in 
PCR-Blunt was digested with NheI and PstI (EcB) in duplicate. The digested 
insert is indicated with a black arrow at approximately 2 kbp as expected.  
 
  
- 160 - 
5.1.4  Expression of bacterial genes in E. coli  
The two constructs containing genes from either S. oneidensis (SO_0154) or E. 
coli (AaeB) in the newly-produced vector pTTQ18-TP, designated So-TTQ and 
Ec-TTQ, were now transformed into expression strains of E. coli (C41, BL21 
Gold, BL21 Star) and expression was induced on a 3 mL culture scale using 
autoinduction in three media (M9, LB, SB). The results are shown in Figure 5.5, 
and showed that both constructs could be expressed, with BL21 Star producing 
reliable expression for both constructs in either LB or SM media. M9, by 
contrast, produced undetectable-low levels of expression. At this stage, the 
expression levels of Ec-TTQ were significantly higher than So-TTQ.   
 
 
Figure 5.5 - Dot blot of 3 μL samples from small scale expression tests of 
two bacterial constructs.  
LB and SB media appear to give the best expression for all combinations of cell 
lines and constructs. BL21 Star is the best expressing strain for Ec-TTQ, and is 
joint best for So-TTQ. By contrast, M9 media performs very poorly in all cases.  
 
As both constructs had expressed in a range of cell and media combinations, 
early progress was promising. Scaling up of expression and screening 
conditions to optimise expression levels would be needed.  
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5.1.4.1 Solubilisation and purification trials for So-TTQ 
So-TTQ solubilised readily in a range of detergents, such as DM, DDM, and 
C12E8 seen in Figure 5.6A. Following purification by IMAC, results looked 
somewhat promising as a band of expected MW was seen in the elution 
fractions, which were free from major contamination (Figure 5.5B). However, as 
only a small amount could be purified (resulting from low expression levels seen 
in the screening above) it was decided to move onto on further work with Ec-
TTQ and experiments were not taken any further with So-TTQ.  
 
Figure 5.6 - Solubilisation and purification of So-TTQ (20 μL).  
A) Solubilisation of So-TTQ in the detergent C12E8, which readily and 
quantitatively solubilises the protein in concentrations above 0.5%.  B) 
Coomassie stained SDS-PAGE gel of fractions taken from a purification of So-
TTQ by IMAC showing molecular weight marker (L), 100 ng standard (Std) 
Total (T), Soluble (S), Flowthrough (FT), 50mM imidazole wash, and elutions 
with 300 mM imidazole (E1-E3). Bands seen in elution are of the expected size 
for the construct, at approximately the 37 kDa marker.  
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5.1.4.2 Ec-TTQ expression and solubilisation  
Expression levels of EcTTQ were good and a Western blot showed a band at 
70 kDa as expected (Figure 5.7A) giving confidence that the correct protein 
was being overexpressed. While culture conditions were being optimised to 
ensure the maximum level of expression was achieved, an assessment of 
solubility was undertaken. However, when a range of detergents were screened 
(including DM, DDM, LDAO, C12E8, β-OG, DMNG, LMNG), only very limited 
solubilisation was seen, with less than 10% of the material solubilised, and most 
often no solubilisation occurring (Figure 5.7B). The protein was correctly 
inserted into the membrane, as evidenced by it separating into the (100,000 g) 
membrane fraction upon centrifugation rather than the 14,000 g fraction 
containing aggregates, but it was impossible to extract it from the membrane 
and solubilise it in detergent with high yields.  
  
- 163 - 
 
Figure 5.7 -  Solubilisation of Ec-TTQ (20 μL). 
 A) Western Blot of membranes prepared from BL21 Gold expressing Ec-TTQ 
(Ec). 125 ng of His-tagged standard (Std) and A band is seen at approximately 
70 kDa as expected.   B) Western blot showing the results of a detergent 
screen for Ec-TTQ with four detergents. Although the Total (T) fraction is 
consistent, relatively little is seen in the Soluble (S) fraction. The best results are 
seen with DDM, where some signal is seen in the soluble lanes for 
concentrations above 1%. However, only a small proportion is soluble.  
 
A literature search revealed that the gene expressed from Ec-TTQ (AaeB) is 
natively expressed from an operon containing a second, smaller protein (called 
AaeA). Both proteins had been shown to be required to confer physiological 
resistance to aromatic acids38, and it was hypothesised that they formed a 
complex. Therefore, it was suspected that both proteins were required in vitro, 
and AaeA was required to enable AaeB to be isolated in a stable, soluble form. 
Thus, it was decided to prepare a construct to express both AaeA and AaeB in 
tandem.  
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5.2  Construction of vectors for expression of AaeAB, AaeA, 
and AaeAΔTM 
In E. coli, both AaeB and AaeA are expressed from the same operon, and so 
co-expression was trialled to see if AaeA could act as a potential chaperone to 
improve stability. As such, PCR was performed on genomic DNA with primers 
designed to flank both coding sequences and amplify a fragment containing the 
sequences of AaeA followed by AaeB. This was then inserted into the pTTQ18-
TP expression vector using the restriction sites NheI and PstI, as seen for the 
constructs designed in the preceding section of this chapter (A schematic can 
be seen in Figure 5.8A).   
In addition to its potential role alongside AaeB, AaeA also presents an 
interesting target in itself. Although it has been shown to be vital, no studies 
have reported on its exact function, and from its sequence it has been identified 
to be a member of the Membrane Fusion Protein (MFP) family often found co-
expressed in operons containing inner membrane transporters. AaeA is, 
therefore, of interest to study in its own right. Thus, a construct was designed to 
insert the DNA for AaeA into pET28(b) with the intention of expressing it for 
biochemical studies in a C-terminally His-tagged form (Figure 5.8B).  
Analysis of the primary sequence of AaeA predicted that it was likely to contain 
a N-terminal transmembrane helix (as seen in Figure 1.8A) (approximately 
residues 10-30), and previous structural studies of MFPs had seen success by 
expressing soluble, truncated constructs106,253–255. Thus, in an effort to produce 
a constructs that would express as soluble protein, a forward primer was 
designed to amplify the cDNA excluding the first 96 bases (equivalent to 32 
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amino acids). Thus, AaeAΔTM represents a construct to express residues 33-
310 of AaeA with the addition of a C-terminal His-tag (Figure 5.8C).  
 
 
Figure 5.8 - Schematic to show constructs. 
 A) AaeAB. The DNA is taken from the operon and inserted into the vector 
between NheI and PstI restriction sites, resulting in transcription of both genes. 
AaeA is expressed before AaeB, which has a C-terminal His-tag. B) AaeA. The 
DNA for the full gene is inserted between XhoI and NcoI sites in pET28(b) to 
express a C-terminally His-tagged protein. C) The DNA coding for a construct 
with residues truncated from the N-terminus is inserted into pET28(b) as for 
AaeA.  
 
In order to produce the desired expression vectors, Touchdown PCR was 
performed, as described previously, to amplify the required CDSs. These PCR 
products were purified and then directly digested with the appropriate restriction 
enzymes (NheI and PstI in the case of AaeA-AaeB, and XhoI with NcoI in the 
case of AaeA and AaeAΔTM), purified, and then inserted into a purified 
linearised vector digested with the same enzymes. Figure 5.9 shows this, with 
the PCR product inserts shown in Figure 5.9A and the linearised vector in 
Figure 5.9B (which was pTP1 made in Chapter 3. The previously inserted CDS 
for the CTD of TaALMT1 was seen cut out of the vector in Figure 5.9B).  
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Figure 5.9 – Vector construction.   
A) PCR to amplify AaeA and AaeAΔTM, bands are seen at ~1000 bp and ~800 
bp as expected. B) Double digest in duplicate of TP1 constructed in Chapter 3. 
Vector backbone used for expression vector construction indicated by arrow on 
the right.  
 
These digested fragments were ligated together using T4 DNA ligase overnight, 
and transformed into Omnimax 2 cells. Once sufficient plasmid had been 
isolated a small sample was tested by re-digestion, as seen, for example in 
Figure 5.10 for AaeA, and then the vector was sequenced to confirm that they 
had been constructed correctly, before moving on to expression trials. 
 
Figure 5.10 - Digest to test the expression vector AaeA in pET28(b) on a 
1% agarose-TAE gel.  
Double digestion with XhoI and NcoI leads to a band at approximately 6000 bp, 
representing the vector backbone, and a band at approximately 500 bp, 
representing the coding sequence cleaved in half.   
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5.2.1  Production of AaeB co-expressed with AaeA 
Once the three plasmids for expression of AaeA-AaeB, AaeA, and AaeAΔTM 
had been constructed and verified by sequencing, conditions for their 
expression were screened. Although AaeB had been trialled already when 
expressed alone, it was decided to start the process again for the new construct 
as co-expression with AaeA could require significantly different conditions. 
Optimisation of production of AaeB was thusly the first priority. 
5.2.1.1 Optimisation of expression conditions for AaeA-AaeB. 
After producing the AaeA-AaeB construct the next stage was to screen for the 
optimal overexpression conditions. To achieve this AaeA and AaeB were co-
expressed by autoinduction in four E. coli strains (C41, C43, BL21 Gold, Bl21 
Star) with three media (M9, LB, SB) over four time-points (12, 24, 36, 72h) 
resulting in a total of 48 conditions. These cultures, grown on a 3 mL scale, had 
total protein extracted and AaeB-specific expression was assessed by dot-
blotting. Although this method is nor quantitative, it can be seen from Figure 
5.11, the best culture conditions were using LB media at the 48 h time-point, 
with any of the four cell types, and C41 over 72 h. These conditions were later 
further examined by Western blotting.  
 
Figure 5.11 - Dot blot assessing culture conditions for AaeA-AaeB.  
3 μL of lysate was loaded onto membrane before blocking, antibody binding and 
visualisation.  
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5.2.1.2 Assessment of IPTG- vs Auto-induction for optimised yield 
After this assessment, ITPG was also tested as an induction method to assess 
whether it could produce a greater yield than autoinduction. BL21 Gold cells in 
LB media were chosen for this experiment and IPTG induction was assessed at 
four time-points after induction (2, 3, 4, 6h), which occurred after the cultures 
reached an OD600 of 0.8. The growth curves measured for these cultures can be 
seen in Figure 5.12, with exponential growth as expected up to the point of 
induction, followed by a slower, linear growth while the cells were expressing 
protein.  
 
Figure 5.12 - Graph monitoring optical density of bacterial cultures 
expressing AaeB, co expressed with AaeA, after IPTG-induction.  
A) Each culture grew with an exponential curve until 1 mM IPTG was added at 
3h. B) Cultures continue growth during 2, 3, 4, or 6 h of induction. 
 
These conditions were compared by Western blotting extracted protein against 
parallel cultures expressing AaeB (co-expressed alongside AaeA) by 
autoinduction and collected after 24h and 48h. The cells were lysed in a cell 
disruptor and total membranes were collected by centrifugation at 100,000 g 
and then analysed by SDS-PAGE and Western blotting. The results, seen in 
Figure 5.13, show that there is not a large difference between each of the 
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conditions, with 2 to 3 h of IPTG-induced expression providing approximately 
double the expression level as compared with 24 h of autoinduction. Either 
approach is equally feasible for large-scale expression, with IPTG producing 
slightly higher yields in a shorter time, but autoinduction requiring less hands-on 
experimenter time, and cheaper reagents.  
 
Figure 5.13 - Western blot of 20 μL of protein extracted from six cultures 
of BL21 Gold expressing AaeB.  
IPTG expression for 2-3 hours produces the most intense signal and thus the 
highest expression, although the levels seen are not greatly above those seen 
in autoinduced cultures collected at 24 or 48 hours.  
 
5.2.1.3 Solubilisation of AaeB co-expressed with AaeA 
As sufficient quantities of AaeB has been expressed to perform initial 
experiments on, the next step was to determine whether it was possible to 
solubilise AaeB in detergent now that it was co-expressed alongside AaeA. A 
range of detergents were tested between 0.5% and 2.0% and results can be 
seen in Figure 5.14. All detergents tested, except for OMNG, were able to 
solubilise AaeB when added at approximately 1% or above. This is expected for 
a well-folded membrane protein and so it appeared that co-expression of AaeA 
with AaeB had resulted in an improvement in stability of AaeB. 
Interestingly, the blots showed higher-MW bands in addition to the bands at 
approximately 70 kDa (the expected size of AaeB). For example, Figure 5.14B 
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shows in the top DM-solubilised sample bands at approximately the markers for 
100 kDa (which corresponds roughly to the MW of AaeA + AaeB), and 130 kDa 
(which corresponds to the molecular weight of a dimer of AaeB). This is an 
initial sign of potential multimerisation occurring, although as membrane 
proteins often run anomalously so it is hard to say with precision.  
 
Figure 5.14 - Western blots showing that AaeB can only be solubilised in 
detergent when co-expressed with AaeA.  
When co-expressed with AaeA, AaeB is readily solubilised by the detergents 
DM, LDAO, DNPG. Unusually, ONPG is not effective at solubilisation of AaeB. 
There are some higher-MW bands seen on the blot, perhaps evidence of 
multimerisation.    
 
5.2.1.4 Purification of AaeB 
After optimising the overexpression conditions for the AaeA-AaeB co-
expression and ensuring it could be solubilised, the next stage was to purify the 
protein using its His-tag. The initial purification trial saw promising levels of 
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protein purified (visible by Coomassie staining without need for concentration), 
with only a small amount of lower-MW contaminants, and AaeA co-purifying 
along with AaeB, as seen in Figure 5.15 and Figure 5.17A-B. AaeA is clearly 
interacting with AaeB in order to be co-purified alongside it, and it can be seen 
that over the course of multiple elution steps the proportion of AaeA decreased. 
AaeA and AaeB were each identified by mass spectrometry. 
 
Figure 5.15 - 20 μL samples from each fraction of a purification of AaeB. 
A) Western blot, and B) Coomassie stained SDS-PAGE gel. Flowthrough (FT), 
10 mM and 40 mM imidazole washes, and four elution fractions (E1-4) were 
run. The position of AaeB is indicated by arrows on the right. The washes 
remove a significant amount of contaminating bands 
 
Analysis of the bands by Mass Spectrometry identified the smaller band as 
AaeA and the larger band as AaeB, as shown in Figure 5.16.  
- 172 - 
 
Figure 5.16 - Peptides identified in mass spectrometry analysis of bands 
in purified samples of AaeB co-expressed with AaeA.  
A) The peptides identified in the smaller band identify this protein as AaeA. 
Position of deamination identified with a red d, while oxidation is highlighted 
with an orange o. B) The peptides identified in the larger band identify this 
protein as AaeB. Position of oxidation identified with a red o.  
 
An observation that supports AaeA having a stabilising “chaperone” type role is 
that when later elution fractions (that had less, or no, AaeA present) were stored 
overnight at 4°C, the AaeB sample precipitated. Conversely, the first elution 
fractions, which likely have a more optimal ratio of AaeA:AaeB, were stable over 
the course of several days storage. 
In an attempt to enrich the purified protein samples with AaeA, membranes 
containing His-tagged AaeA (prepared in Section 5.5.2) were mixed with 
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membranes containing His-tagged AaeB and then purified. The elution lanes in 
Figure 5.17C show an increase in the amount of AaeA purified alongside AaeB, 
as expected because AaeA is also His-tagged.  
This purified samples of AaeB, and AaeB enriched with AaeA, were used for 
later experiments in the following chapter. It had been shown that AaeB could 
now be expressed, solubilised, and purified in amounts that, while still relatively 
low in the context of crystallographic studies, could be used for EM and other 
biochemical studies. In an attempt to produce a significant amount of AaeB, a 
30 L fermentation was undertaken by Mr David Sharples. Unfortunately, no 
expression of the target protein was detected, so expression in 500 ml flasks 
was continued.  
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Figure 5.17 - Coomassie stained samples of three purifications of AaeB, 
run on SDS-PAGE gels.  
A) AaeB co-expressed with AaeA purified by IMAC with 10 mM and 40 mM 
imidazole wash steps followed by elution at 300 mM imidazole (E1-4). B) A 
second purification of AaeB runs at approximately 70 kDa when eluted, with 
AaeA also present at approximately 35 kDa (both indicated by arrows). A 
second elution step continues to elute more AaeB, but there is no AaeA left on 
the resin. C) AaeB co-expressed with AaeA was mixed with membranes 
containing AaeA before purification in the same way as A). It can be seen that 
the ratio of AaeA:AaeB in the eluted protein is increased.  
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5.2.2  Expression of AaeA and AaeAΔTM 
5.2.2.1 Initial expression conditions screening for AaeA and AaeAΔTM 
An initial screen of expression conditions for both AaeA and AaeAΔTM was 
performed on a 3 ml scale with four strains (C41, C34, BL21 Gold, and BL21 
Star) and three media (M9, LB, SB). Figure 5.18 shows the results, with BL21 
Gold and BL21 Star consistently outperforming C41 and C43. AaeA expressed 
well independently of the media, but AaeAΔTM performed best in SB medium 
using BL21 Star cells. 
 
 
Figure 5.18 - Dot blot to assess initial expression trial for AaeA and 
AaeAΔTM.  
A) For AaeA, each medium performs equally well compared to each other, but 
best with BL21 Gold and BL21 Star cells. B) For AaeAΔTM, BL21 Gold and 
BL21 Star are again the best cell types, with LB and SB performing as the best 
media. BL21 Star in SB medium appears to be the best condition.  
 
Before further optimisation of expression was attempted, the localisation and 
solubility of the protein produced was assessed.  
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5.2.2.2 Assessing the membrane localisation and solubility of AaeA 
AaeA had proved to express well in a number of conditions. The next step was 
to assess whether the predicted N-terminal hydrophobic helix is a 
transmembrane helix (as shown in Figure 1.8A); the hydrophobic helix could 
also be a hydrophobic core, around which the rest of the protein folds. The first 
experiment was to assess into which fraction AaeA would fall when membranes 
were prepared from the E. coli expressing AaeA.  
Cells were lysed and the cell debris was removed by centrifugation at 14,000 g, 
after which the supernatant was spun at 100,000 g in order to collect the 
membrane fraction. If AaeA is a membrane protein it would be expected to be 
found in the final pellet of membrane proteins, whereas if it was a soluble 
protein it would be localised in the final supernatant, while misfolded and 
aggregated protein would be present in the initial pellet used to remove the cell 
debris. Each of these fractions was assessed by Western blotting (Figure 5.19) 
and signal was seen in the final pellet, indicating that AaeA was associated with 
the membrane fraction.  
  
Figure 5.19 - Western blot of a fractionation of cells to locate AaeA.  
20 μL of each sample was loaded. Signal is seen in the total protein extract (T). 
After centrifugation at 14,000 g, some signal is seen in the pellet containing 
aggregates (P1), but most signal is seen in the supernatant (S1). After 
centrifugation of the supernatant at 100,000 g the protein is all seen in the pellet 
(P2), indicating that AaeA is part of the membrane fraction.  
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AaeA was shown to associate with the membrane fraction, as expected. The 
next stage was to assess whether AaeA was an integral membrane protein, or 
merely associated with the membrane – for example, as part of a complex with 
AaeB. Samples of membrane containing AaeA were re-suspended in buffer 
containing increasing concentrations of NaCl up to 1 M, or 50 mM sodium 
carbonate pH 11.5, which are both treatments that should extract AaeA into the 
soluble fraction if it is merely a membrane-associated protein. As can be seen in 
Figure 5.20A, after washing with salts the majority of AaeA was still present in 
the pellet, and so AaeA was not washed off the membranes and solubilised by 
these treatments. This provides strong evidence that AaeA is an integral 
membrane protein, as predicted.  
 
Figure 5.20 - Western blot of attempted solubilisation of AaeA.  
20 μL of each sample was loaded. A) NaCl and sodium carbonate washes. 
Increasing salt concentrations, or washing with sodium carbonate leads to a 
slight increase in soluble AaeA, but the majority of the material remains in the 
pellet, indicating that AaeA is truly an integral membrane protein. B) Western 
blot showing AaeA solubilisation by detergents. A concentration of 1% DM, 
DDM, and DMNG all solubilise AaeA quantitatively.  
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After confirming that AaeA is an integral membrane protein, the next 
requirement was to solubilise it in detergent. A range of detergents was trialled 
and Figure 5.20B shows that AaeA was readily made soluble by use of a 2 h 
incubation with 1% of either DM and DDM, commonly used maltoside 
detergents, or DMNG, a favoured detergent for crystallographic studies256,257.   
 
5.2.2.3 Purification of AaeA 
After establishing that AaeA was an integral membrane protein that could be 
solubilised in detergent, a purification was performed. DDM-solubilised 
membranes containing AaeA were subjected to IMAC purification in order to 
isolate soluble, purified AaeA. As seen in Figure 5.21, AaeA could be isolated 
in high yield, with only minor contaminating bands. All bands were sent for 
identification by mass spectrometry and each was identified as AaeA. The 
higher-MW band at 70 kDa is likely a dimer of AaeA, while the lower-MW 
species are degradation products. The largest of these is also visible on the 
Western blot, indicating the His-tag is intact and thus cleavage is from the N-
terminus, while the lowest bands are not detected by Western blotting, and so 
they must have a C-terminal deletion, possibly in addition to the N-terminal 
deletion. AaeA had been successfully purified, and the final step was to produce 
a sufficient amount to enable biochemical and structural studies to be 
performed.   
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Figure 5.21 - Purification of AaeA.  
A) Western with 20 ng protein standard (Std) and B) coomassie stained SDS-
PAGE gel with 2 μg protein standard (Std). Molecular weight markers are 
indicated on the left (L), Total (T), Soluble (S), Flowthrough (FT), washes of 10 
mM (10) and 30 mM (30) imidazole, followed by elution in 300 mM imidazole 
(E1-6). Position of AaeA is indicated with arrows to the right. All bands were 
identified by mass spectrometry to be AaeA. 
 
5.2.2.4 Production of sufficient AaeA for structural and biochemical 
studies 
While AaeA has been shown to be membrane localised, it is readily solubilised 
by detergents, and successfully subject to purification by IMAC. Therefore, the 
next step was to ensure sufficient material could be made for biochemical 
investigations. Initial screening had proved promising and so to confirm the best 
expression conditions, the cultures were scaled up to 500 mL using BL21 Gold 
and LB medium, and eight conditions were assessed: autoinduction for 18, 24, 
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30, 48 h and IPTG induction for 2, 4, 6, 8 h. Total protein was extracted from 
these cultures and samples were assessed by Western blotting. Figure 5.22 
shows that yield increased over time for both IPTG induction up until 6 h, and 
autoinduction, with the largest increase between 18 h and 24h and smaller 
increases beyond. Autoinduction produced the highest yields, in the range of 
approximately 1-4 mg/mL, as determined by densitometry with reference to the 
protein standard run in the first lane. In addition, the protein runs as a clear 
band at approximately 35 kDa (the expected size).  
 
 
Figure 5.22 - Western blot of several samples of AaeA expressed in BL21 
Gold using LB medium.  
25 ng protein standard (Std), run alongside 20 μL samples of four time-points of 
IPTG-induced (2-8 h) cultures and four time-points of autoinduced (18-48 h) 
cultures. Longer expression times after IPTG induction leads to more protein 
produced, up to a limit of 6 h, while higher overall yields are seen across 
autoinduced cultures. Positions of approximate protein molecular weight 
standards are indicated to the left.  
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Expression at the levels seen here is sufficient to produce enough protein (in 
the mg-range) for the anticipated structural and biochemical studies. In order to 
produce a large batch of AaeA it was decided to undertake a fermentation on a 
30 L scale. For this the conditions chosen were the cell type BL21 Star in LB 
medium, using autoinduction for a period of 24h. This was carried out by Mr 
David Sharples in the fermentation facility. From the cell paste produced 
(approximately 500 g) membranes were prepared. These were then used for 
the studies that follow.   
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5.2.2.5 Assessing the membrane localisation and solubility of AaeAΔTM 
Having ensured that AaeA could be produced in a sufficient amount and 
solubilised reliably, the focus moved onto ensuring the same for AaeAΔTM. 
Having removed the putative TM helix that anchors AaeA in the membrane, it 
was expected that AaeAΔTM would be soluble without the need for detergents, 
and that it would be found in the soluble fraction after lysing cells.  
Total protein from cells expressing AaeAΔTM was spun first at 14,000 g and 
then at 100,000 g and the supernatant and pellet from each step was assessed 
for the presence of AaeAΔTM by dot blotting. As seen in Figure 5.23, the 
protein of interest was found in the cell debris fraction rather than the soluble 
fraction. This is indicative that the protein is likely to be in inclusion bodies, as 
seen in Chapter 3.  
 
 
Figure 5.23 - Dot blot of supernatant and pellets from centrifugation of 
AaeAΔTM.  
Signal is seen in the total protein extract (T). After centrifugation at 14,000 g, all 
signal is seen in the pellet (P1), indicating that the material was part of the cell 
debris and AaeAΔTM is not soluble.  
  
Refolding of the inclusion bodies was attempted, as this has previously been 
shown to be an effective approach to production of proteins in E. coli 258. The 
pelleted material was washed with 1 M NaCl and 2% Triton X-100, before 
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centrifugation and then the pellet was resuspended in 6 M GdnHCl to unfold the 
protein. After a 30-minute incubation the sample was spun to remove any 
aggregated material, and each fraction was assessed for the presence of the 
target protein by dot blot. As seen in Figure 5.24, salt and Triton X-100 do not 
solubilise AaeAΔTM, and the protein remains in the pellet, however 6 M 
GdnHCl leads to retention of the target protein in the supernatant. This 
supernatant was taken and bound to cobalt resin overnight.  
 
Figure 5.24 - Dot blot to monitor solubilisation of inclusion bodies of 
AaeAΔTM.  
Material seen in the total extracted protein (T) is found in the pellet after 
centrifugation at 14,000 g (P1) and after washing with 1M NaCl and 2% Triton 
X-100 (P2), but some material does seem to be solubilised by this washing, as 
a small fraction is seen in the discarded supernatant (S2). However, after 
incubation with 6 M GdnHCl, AaeAΔTM is then present entirely in the 
supernatant (S3) and none remains in the pellet (P3).  
 
When the protein was eluted from the resin using 300 mM imidazole buffer 
containing no GdnHCl, then dialysed to remove the imidazole, the protein once 
again precipitated out of solution, indicating refolding was not successful.  
An attempt was made to express AaeAΔTM at lower temperatures (both 30°C 
and 22°C) to ensure protein synthesis proceeded at a slower rate and give 
more time for the bacterial machinery to fold and chaperone the AaeAΔTM, but 
this did not produce an improvement in solubility.  
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The hydrophobic helix could by hypothesised to be a hydrophobic core of the 
protein, around which the rest of the protein folds. This would be supported by 
the catastrophic lack of solubility when expressing AaeAΔTM. However, the 
data presented Section 5.5.2.2 indicate that AaeA is an integral membrane 
protein, and similar MFP proteins have been shown to have a transmembrane 
helix at the N-terminus, and thus this helix is most likely to be a legitimate 
transmembrane helix. In this case the most rational explanation for the 
complete lack of solubility of AaeAΔTM as compared to AaeA (which expressed 
at similarly high levels but was readily solubilised by detergents and seems well 
behaved) is that the truncation leaves an unstable N-terminal end, perhaps with 
part of its structure unanchored or an incomplete fold. A better approach for 
attempting to produce a soluble truncated version of AaeA would have been to 
perform serial truncations, removing one residue at a time over a range of 10-20 
residues after the predicted transmembrane helix. Screening all of these would 
then have provided more opportunities to identify a high-expressing, soluble, 
stable construct.   
As the truncation of AaeA with the intention of forming a soluble protein had not 
proved successful, this line of investigation was abandoned in favour of 
experiments on full length AaeA and AaeB.  
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5.3  Summary and Conclusions 
This chapter presents the work done to establish a protocol for the production 
and purification of bacterial ArAE family members. The first stage was 
construction of an expression vector to be used for bacterial membrane proteins 
based on pTTQ18, which has previously been used to express bacterial 
membrane proteins as it allows tight control of expression, minimising potential 
toxicity. The newly-created vector, designated pTTQ18-TP, has an improved 
cleavage site to allow removal of the His-tag and a cloning site that allows 
simple use of the restriction sites NheI and PstI to insert any bacterial ORF in 
frame with the RBS, start codon, and C-terminal fusion tag.  
The ORFs for two bacterial genes, AaeB from E. coli and SO_0154 
(Uniprot:Q8EKE1) from S. oneidensis, were cloned into this vector and 
expression was tested. Although some promise was seen with So, expression 
levels were consistently low and as such AaeB was prioritised. However, 
although AaeB expressed well, it was not stable and could not be readily 
solubilised by detergents. As such, the genes for AaeA and AaeB were both 
inserted into the expression vector, as this is how they are expressed from the 
native operon. This resulted in the production of AaeB that could be solubilised 
in a range of detergents, confirming that co-expression had stabilised AaeB. 
In addition, a vector to express the partner to AaeB, AaeA, was produced, as 
this protein has also not been subject to study and although it has been shown 
to be vital, no studies have reported on its exact function. This protein was 
characterised as an integral membrane protein by assessing its localisation 
when fractionating E. coli cells and washing the membrane fraction with salt and 
Na2CO3 pH 11.5, and assessing the effect of detergents. The expression 
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conditions were optimised to produce mg-level quantities of AaeA and a 
protocol was devised for solubilisation and purification of AaeA. 
A final construct was created to express a truncated version of AaeA, 
designated AaeAΔTM, which was intended to express a version of AaeA 
lacking the putative transmembrane helix. This truncated construct, however, 
was not soluble when expressed in E. coli and could not be refolded from 
inclusion bodies.  
In summary, an expression vector was created from two pre-existing vectors in 
order to express bacterial membrane proteins. Two proteins were cloned into 
this vector and expressed from it, with strategies devised for their solubilisation 
and purification. The first in vitro evidence of an interaction between AaeA and 
AaeB has been shown, with AaeA vital for AaeB stability (which cannot be 
detergent-solubilised in the absence of AaeA), perhaps operating in a 
“chaperone”-type manner. In addition, a strategy to express, solubilise, and 
purify AaeA has been developed, and its status as an integral membrane 
protein has been confirmed. Sufficient AaeA and AaeB has been produced to 
proceed with biochemical, biophysical, and structural studies.   
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Chapter 6 
Biochemical and Structural 
Investigations of AaeA and AaeB 
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6  
In the previous chapter both AaeA and AaeB from E. coli were expressed and 
purified in sufficient amounts to undertake a range of biochemical and structural 
experiments, which are detailed below. 
6.1 In silico homology modelling of AaeA and bioinformatics 
analysis 
The Phyre2 webserver was used to create a model of AaeA using “Intensive 
Mode”, which constructs a model of the protein based on the folds of 
homologous proteins that have already had their structures solved, and then 
attempts to model any remaining sections of the protein using ab inito 
techniques159. The six proteins selected by the Phyre2 algorithm, due to 
significant sequence similarity, and used to produce the model were EmrA, 
AcrA, MacA, ZneB, MexA, and HlyD. These are all bacterial MFP proteins, as 
expected, and they were able to be used as a template for all but 67 residues. 
The initial 30 residues, which are predicted to be a membrane anchor region 
were not part of this template, as all MFP structures solved thus far have either 
been constructs that have been truncated to remove this section or this region 
has not been resolved in the crystal structure; the secondary structure 
prediction is modelled with high confidence in this region, however, as seen in 
Figure 6.1. In the model produced, this helix was modelled lying close to the 
rest of the protein and so it was manually adjusted using Chimera to be oriented 
along the plane of the molecule at an angle more appropriate for a 
transmembrane helix that needs to be embedded in the inner membrane (seen 
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in Figure 6.2A). The localisation of this helix in the membrane is supported by 
data in Chapter 5 that showed that AaeA was found in the membrane fraction 
of E. coli and could be solubilised by addition of detergents. 
  
 
Figure 6.1 - Secondary structure and disorder prediction by Phyre2 for 
AaeA.  
The algorithm predicts an N-terminal sequence containing a transmembrane 
helix, followed by alternating regions of β-sheet and α-helix, with high 
confidence for secondary structure for almost the entire protein.  
 
The model produced by Phyre2, visible in Figure 6.2A and also in four rotations 
in Figure 6.4B, has 3 domains after the hydrophobic N-terminal helix: a β-barrel 
domain, a lipoly domain, and an α-hairpin domain, each connected by flexible 
linkers. And as can be seen from the N-to-C rainbow colouring in the cartoon 
models, the β-barrel and lipoyl domains are constructed from β-sheets using 
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residues from both ends of the sequence. These domains are anchored to the 
periplasmic face of the inner membrane and project outwards into the 
periplasm. The model for AaeA lacks the membrane proximal domain (MPD) 
found in some other MFPs, notably RND- and ABC-type transporters that 
contain significant periplasmic loops107. The MPD is predicted to act as a 
‘spacer’ and also to interact with periplasmic loops of the inner membrane 
transporter by helping to load substrates from the periplasm. AaeA lacks this 
domain most likely because AaeB is predicted to extend only minimally into the 
periplasm, with the majority of the non-membrane-embedded regions of the 
protein being located in the cytoplasm and only small loops on the periplasmic 
face. Indeed, as the substrate for AaeAB is a metabolic product produced in the 
cytoplasm there is no need for the pump to load substrate in the periplasm, 
unlike in the case of multidrug transporters. Instead, the main site of interaction 
for AaeA and AaeB may be within the membrane, as suggested for MFS-type 
transporters which do not contain any significant soluble domains107, and for the 
complex AcrA-AcrB-AcrZ, which has an additional small protein, AcrZ, located 
in the inner membrane that modulates the activity of the pump259.  
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Figure 6.2 - Model of AaeA produced by Phyre2.  
The position of the inner membrane helix was adjusted manually in Chimera. A) 
AaeA forms an extended structure projecting into the periplasm, consisting of a 
hydrophobic helix to anchor it into the inner membrane, a β-barrel domain, a 
lipoyl domain, and an α-hairpin domain. B) The residues of the RLS motif found 
among all MFP proteins is present at the tip of the helical α-hairpin.  
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6.1.1 The RLS Motif 
In addition, an RLS motif (canonically, R-X3-L-X6-S) is present in AaeA and 
found at the tip of the α-hairpin, although with a single residue deletion between 
L114 and S120 as compared to the canonical sequence. This motif is found 
conserved throughout all MFPs and is proposed to be the key interaction 
between MFPs and TolC when forming tripartite complexes260–262. As the AaeA-
AaeB pump has not been shown to have a requirement for TolC38, perhaps this 
deletion causes a rearrangement in the location of the residues required to form 
an interaction and so disrupts binding. To investigate this, the sequences at this 
RLS-motif region for several MFPs that form complexes with inner membrane 
proteins were aligned, shown in Figure 6.3. Several MFPs expressed in 
operons with PET family transporters have this single deletion conserved, and 
two MFPs that are not expressed in operons with any inner membrane 
transporter (YiaV, YibH) also show this deletion. This may support the 
hypothesis that that PETs do not need to use TolC to export substrate out of the 
cell and instead pump into the periplasmic space. As the known substrates for 
AaeB are organic acids such as pHBA38 that are part of normal metabolism, it 
may be sufficient to merely remove them from the cytoplasm when they build up 
to toxic levels, after which it is possible for them to be taken up again and used 
productively.  
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Figure 6.3 - RLS motif alignment for several MFP proteins from several 
families.  
MFPs from operons containing PET transporters, except for SdsR, have a 
deletion between the Leu and Ser of the canonical motif. Two MFPs found in 
operons without any inner membrane transporter also contain the same 
deletion, along with a S→T mutation that is also seen in HlyD.  
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6.1.2  Conservation and Surface Charge 
The model produced by Phyre2 was analysed further by assessing the 
conservation of residues and also the surface charge. AaeA seems to have a 
well-conserved and a less-conserved face, as seen in Figure 6.4B, and there 
are a number of highly-conserved residues on the β-barrel domain which are 
perhaps important for interaction with AaeB. The outside face of the protein 
shows a number of poorly conserved residues; as these are facing the solvent 
rather than interacting with any other protein surface there is unlikely to be any 
evolutionary pressure to prevent modification of these residues. Conversely, the 
inner face of the β-barrel and lipoyl domains appear to have much more 
strongly conserved residues, reflecting their likely role in interaction with 
substrates and AaeB.  
The analysis of surface change showed that opposing sides of AaeA are 
positive and negative, as seen in Figure 6.4C. This may provide a mechanism 
for side-by-side multimerisation, with a negative “right-face” having electrostatic 
affinity for the positive “left-face”, allowing the AaeA monomers to assemble into 
a funnel shape as seen for other MFPs. The inside face of the α-hairpin, which 
may be expected to form a barrel for the substrate to travel along, has an 
overall neutral charge, with some regions of positive charge, which would 
interact favourably with a deprotonated acidic substrate such as pHBA. 
Interestingly, the tip of the membrane helix is positively charged and as this is 
located in the cytoplasm: this is in agreement with the “positive inside” rule for 
membrane proteins263.  
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Figure 6.4 – Examination of the AaeA model.  
A) Four 90 degree rotations (in order: left, outside, right, inside) of the AaeA 
model in cartoon representation coloured with a rainbow from N to C, and B) 
surface representation coloured as to the conservation score as calculated by 
Consurf264 in order from lowest to highest blue, green, yellow, orange, red. The 
protein displays a less strongly conserved left hand side than right hand side, 
and shows a number of highly conserved residues on the β-barrel, likely to be 
important to form interactions with the inner membrane transporter. C) surface 
charge coloured from blue (positive) to red (negative), showing a positively-
charged left hand side and a positively charged right hand side, and while the 
outer side is charged, the inner face is largely neutral.   
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6.2  Examination of buffer conditions for optimal stability of 
AaeA.  
Since the ultimate goal for the project was to undertake structural studies, 
especially crystallography, conditions for stability of AaeA were optimised. This 
was achieved using the Optim (Avacta) (now called the UNit from Unchained 
Laboratories)180. The capillary system allowed 48 samples to be assayed in 
parallel on a very small scale (5 μL per condition) and this allowed the following 
conditions to be examined: pH from 3.5 to 9.5, NaCl concentration from 0 to 
1500 mM, and glycerol from 0% to 35%.  
Two measurements were taken in parallel. Firstly, intrinsic fluorescence to 
assess protein unfolding, reported as the barycentric mean (BCM). As the 
protein unfolds, fluorescent side chains are exposed to a different local 
environment, for example by bringing residues from the core of the protein and 
exposing them to the solvent, and thus changing their fluorescent signal. In this 
case, protein unfolding leads to a decrease in BCM of fluorescence, and by 
taking the derivative of the fluorescence curve it is possible to identify the 
midpoint of the unfolding transition, and calculate the melting temperature (Tm). 
An example can be seen in Figure 6.5A, where the vertical orange line marks 
the midpoint of the unfolding transition. Secondly, static light scattering (SLS) 
was measured at 266 nm to assess aggregation. As the protein unfolds it 
aggregates, and this forms larger particles which scatter more light. By 
identifying the start of this aggregation transition as light scattering increases 
sharply an Aggregation Temperature (Tagg) can be identified. An example can 
be seen in Figure 6.5B, where the vertical orange line marks the beginning of 
aggregation. 
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Figure 6.5 - Example graphs produced from Optim data.  
A) Thermal unfolding curve. Solid line shows the BCM and a decrease as 
temperature is increased. Dashed line shows the derivative and the Tm can be 
identified at the inflection point (orange line). B) Graph of SLS, a sharp increase 
is seen at Tagg, indicated by the orange line.  
 
The values measured for Tm and Tagg over the conditions assayed were plotted 
against their respective condition, as shown in Figure 6.6. In summary, stability 
as measured by thermal melting and aggregation was not strongly affected by 
the pH, with perhaps evidence of increased stability at pH 5.5, but no obvious 
and consistent trend over the pH range assessed (Figure 6.6A and Figure 
6.6D). Increasing salt concentration promoted stability, but not significantly, with 
only a few degrees’ difference between 0 mM and 1 M NaCl (Figure 6.6B and 
Figure 6.6E). The strongest stabilising effect came from glycerol, with 
increasing concentrations strongly stabilising AaeA (Figure 6.6C and Figure 
6.6F). Thus, the buffer chosen for continued work with AaeA would now contain 
30% (w/v) glycerol, where feasible, in order to provide maximum stability.  
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Figure 6.6 - Summary graphs from Optim reporting Tm (A-C) and Tagg (D-F) 
over a range of pH (A, D), NaCl concentration (B, E), and Glycerol % (C, F) 
in the buffer.  
Protein stability is relatively insensitive to pH. NaCl has a small stabilising effect. 
A strong stabilising effect was seen when increasing glycerol.  
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6.3  Circular Dichroism measurement of AaeA 
With the in silico model, some validation was required. Circular dichroism (CD) 
in the far-UV region of the spectrum can be used to provide information on the 
secondary structure composition, as α-helices and β-sheets each have 
distinctive CD spectra based on the regular arrangement of their backbone 
peptide bonds. As such, CD was employed in order to generate an estimate of 
the relative proportions of secondary structural elements and see if it is in 
agreement with the model produced by Phyre2. CD would also confirm that the 
protein was folded, and provide evidence that the produced material was of 
good quality.   
Two repeat spectra were captured between 180-260 nm at 20°C in a buffer 
containing, 20 mM HEPES pH 8.0, 100 mM NaCl, 25% (w/v) glycerol, and 
0.05% DDM, plus a spectrum of the buffer alone to be used as a blank. These 
spectra are presented in Figure 6.7A. When the buffer blank was subtracted 
from the measured spectrum and repeats averaged, this produced a spectrum 
shown in Figure 6.7B. It was not possible to assign secondary structure from 
this data when using analysis by the SELCON3, CONTIN, or K2D methods as 
the errors between measured data and algorithm’s models were too large. 
There is evidence of the typical “double bump” trough centred around 215 nm, 
indicating α-helical content, but the signal below 190 nm seems to drop off 
sharply, indicating that the conditions were not optimal. The buffer contains 
chloride ions, glycerol, and detergent, all of which absorb in the UV region and 
thus worsen the signal-to-noise ratio for the measurement. An improved choice 
of buffer conditions may be able to enhance this, which is explored below. 
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Figure 6.7 – CD analysis of AaeA.  
(contd. overleaf) 
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 A) Raw CD spectra recorded for a sample of AaeA (in duplicate) and a buffer 
sample used as a blank. The repeats overlay almost exactly apart from below 
200 nm, where they diverge, indicating a less-reliable region with lower signal to 
noise. B) CD spectrum for AaeA, corrected using the buffer blank and averaged 
from two repeats. The sharply negative signal in the region between ~200-240 
nm is indicative of α-helical secondary structural elements, but CD signal is not 
seen in the region below 200 nm. C) CD spectra from a sample of AaeA 
measured over a temperature ramp from 20-90°C in 1°C steps. The curve 
indicating α-helical content seen in the 20°C sample steadily disappears as the 
temperature is raised. D) Data from previous graph in 10°C steps. The collapse 
in structured signal is clearly seen between the 40°C and 60°C measurements. 
E) CD signal measured at 220 nm over a temperature ramp from 20-90°C. A 
sharp transition is seen at approximately 48°C, indicative of cooperative 
unfolding as would be expected of a structure containing a coiled-coil, as 
predicted. F) CD spectrum for AaeA in an improved buffer with a lowered 
concentration of chloride and glycerol. The characteristic α-helical “double-
bump” is seen and signal below 200 nm is much better defined.  
 
 
6.3.1 Thermal Melt 
In addition to the static spectrum, a thermal melt was then taken in 1°C steps 
from 20-90°C. This showed that as temperature increased, the intensity of the 
circular dichroism in the spectrum dropped towards zero, indicating a loss of 
structure (Figure 6.7C). This is evidence that the apparent structure seen in the 
initial spectrum is real, as the thermal ramp would be expected to unfold the 
protein, losing structure, and therefore losing signal. A final measurement back 
at 20°C after the melting curve showed an almost identical spectrum to the 
90°C, indicating that the structure had been irreversibly lost, likely by 
aggregation as the protein unfolded, or potentially because a specific 
chaperone is required for re-folding. The spectra presented in Figure 6.7D, in 
10°C steps, shows more clearly the sharp transition occurring between the 40°C 
and 60°C measurements. An analysis of the CD intensity at 220 nm over the 
range of temperatures in Figure 6.7E shows a sharp transition centred at 
approximately 48°C, indicative of a defined α-helical structure that cooperatively 
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unfolds, as has been seen in previous studies265,266. This is likely to be the 
coiled-coil found in the predicted structure, which would be expected to show 
strong cooperative unfolding. Additionally, the melting temperature derived from 
this experiment agrees strongly with the melting temperatures measured in 
Section 6.2, particularly as Figure 6.6C estimated a Tm of approximately 50°C 
for these buffer conditions.  
6.3.2  Optimised buffer 
As glycerol, chloride, and detergent may absorb UV, creating too high a signal 
reducing the available information, the buffer was altered for a second 
measurement. Although the presence of detergent is non-negotiable for a 
membrane protein, the other components could be lowered or removed. The 
glycerol content was lowered to 10%, which was judged to still provide some 
stabilisation and 100 mM NaCl was replaced with 500 mM NaF, which removed 
the chloride entirely but increased the ionic strength of the buffer to help 
counteract the drop in glycerol.  
As can be seen in Figure 6.7F the CD signal at lower wavelengths is improved 
by the changed buffer conditions with a much more well defined shape. 
Analyses of this spectrum with three algorithms (SELCON3, CONTIN, and K2D) 
with the reference set SMP180, designed for use with membrane proteins 
showed that the measured proportion of α-helical, β-sheet, and coil were each 
roughly a third, as predicted by the Phyre2 model. The calculated predictions 
are summarised in Figure 6.8 and although the calculated values for both α-
helix and β-sheet are lower than the model predicts, this can be explained by 
the fact that the AaeA measured here is free in detergent solution, which may 
promote a more ‘loose’ structure, and is not in complex with AaeB which could 
- 203 - 
have the effect of promoting a particular secondary structure. Conversely, the 
structures that the model is based on are crystal structures which will 
necessarily be in a more rigid conformation. Previous studies on MFPs have 
measured a degree of conformational flexibility, also145. These data, therefore, 
provide support the Phyre2 model. While CD is able to determine the 
proportions of each secondary structure present in the solution as a whole, it 
cannot determine which specific residues are involved in forming those 
secondary structure elements; as such, it cannot be inferred that the model 
presented here, or any other model, is correct without further evidence, but 
these data support, rather than rule out the model’s prediction. 
 
- 204 - 
 
Figure 6.8 - Secondary structure prediction by CD as compared to Phyre2 
Model.  
A) Summary of the output of three algorithms used to process the spectrum 
shown in Figure 6.7F. B) stacked bar charts to show the relative proportions of 
α-helical and β-sheet found in the Phyre2 model presented in this chapter 
against the relative proportions measured by CD.   
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6.4  X-ray Crystallography of AaeA 
As large amounts of AaeA could be produced, solubilised and purified, the 
material was taken and used to set up trays of protein in crystallography 
screening buffers. Six commercial screens were selected, which are formulated 
to be suitable for both soluble and membrane protein crystallography. The six 
screen were MemGold, MemPlus/MemStart, Morpheus, ProPlex (all Molecular 
Dimensions), Crystal Screen, and Peg/Ion (both Hampton Research).  
Purified AaeA solubilised in DNPG with cholesterol hemisuccinate (CHS) 
(shown to help stabilise membrane proteins for crystallography267) was taken 
and concentrated to approximately 12 mg/mL and used to set up parallel drops 
for each of the 96 conditions in each screen, for a total of 1252 drops. Drop 1 in 
each well was made from a mixture of protein:well solution at a 1:1 ratio, while 
Drop 2 was made from a 2:1 ratio, meaning that it had a higher effective 
concentration of protein, but a lower concentration of precipitant. These trays 
were stored and imaged immediately and then again at 1, 2, 3, 5, 8, 13, 21 and 
34 days. Normal brightfield (visible light) images were taken alongside both 
Ultraviolet Two-Photon Excited Fluorescence (UV-TPEF) and Second Harmonic 
Generation (SHG) images. UV-TPEF excited any protein crystals present, as 
protein crystals will absorb UV light, meaning any protein crystals present in the 
drop can be more easily identified, and SHG identifies chiral crystals. Both of 
these help to differentiate between crystals that are formed of protein, and those 
that are formed from buffer components, or detergents. It should be noted, 
however, that not all protein crystal space groups are chiral and so a negative 
hit does not definitely rule out a crystal as being protein, and that some non-
protein molecules can crystallise in chiral space groups, especially, for example, 
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sulfate salts. These two imaging techniques, however, form another tool useful 
to help identify protein crystals.  
 
Figure 6.9 - A range of images of representative results from screening 
conditions for growth of crystals.  
Wells ranged from completely clean (A), through a range of levels of 
precipitation (B-D) up to a heavy, dense precipitate (E), and some wells 
contained a mix of levels of precipitation (F).  
 
A representative selection of results seen in the wells of the crystal screen is 
shown in Figure 6.9: broadly speaking observation of the images at 34 days, 
and on the intervening days, showed that some wells contained completely 
clear drops, while some had heavy precipitation, with a range of drops in 
between these extremes. This is indicative that the concentration of protein 
present in the drops is in the correct range, and the concentration used in 
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similar studies of other MFPs has indeed been at approximately this 
concentration145,254. 
A number of wells showed evidence of some “microcrystals”, perhaps as large 
as 10 μm across. A selection of these is shown in Figure 6.10. Crystals of this 
size are at the lower limit of feasibility in terms of data collection on a 
microfocus synchrotron beamline. Moreover, crystals of this size are difficult to 
fish from the drop into a loop, can be unstable, and often give poor data. As 
such the microcrystals seen here are unlikely to give good structural data and 
further optimisation is needed before any further steps of data collection are 
taken. 
Looking at the examples given in Figure 6.10 more closely it is possible to draw 
some further observations. The SHG signal seen in Figure 6.10C is initially 
promising, but when the corresponding region of the UV-TPEF image is 
examined there appears to be a decreased signal, with a haze of protein seen 
through the drop accompanied by a dark spot. This indicates that the crystal 
present is likely to be a salt crystal from the well buffer solution, as it does not 
absorb UV. By contrast, Figure 6.10D shows a small crystal next to a ring 
structure, this is present as both a brighter spot in the UV-TPEF and a clear 
signal in the SHG image. This is promising and indicative of a true protein 
crystal. Nevertheless, the size of the crystal and its location within a dust-like 
precipitate make it difficult to see, difficult to isolate, and it is unlikely to prove 
amenable to study. In all, 25 conditions showed some signs of potential hits and 
these conditions are summarised in Table 6.1. The size of potential protein 
crystals that could be visualised by eye and with use of UV-TPEF and SHG 
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imaging was consistently small and generally obscured by precipitation within 
the drop.  
 
Figure 6.10 – Representative examples of potential hits from crystal 
screening.  
The small area of signal is ringed in the SHG images for clarity, and putative 
crystals are in the equivalent position in the Visible and UV-TPEF images. All 
potential hits contain only very small crystals, giving weak signal and are 
generally not clearly visible under normal illumination. Drop size was 0.2 μL 
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Table 6.1 - Table of conditions within the wells of putative hits in crystal 
screen.  
The characters before the hyphen denotes the well (e.g. B8) and the number 
after denotes either drop 1 (1:1 protein:buffer ratio) or drop 2 (2:1 protein:buffer 
ratio) using that condition. No clear pattern of conditions can be drawn out of 
these data.  
 
 
The conditions present in the wells of potential hits (summarised in Table 6.1) 
appear to show no particular pattern of conditions that are represented. The pH 
ranges from 3.4 to 8.5, perhaps reflecting the broad range of stability seen in 
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Section 6.2 over a range of pH values. Similarly, the buffers and additives 
present within the wells covers a broad range of chemical species, and although 
it can be seen that some compounds re-occur in several of the wells, such as 
various PEGs, or sulfate salts, this is more likely to be a reflection of the fact 
that they are present in many of the wells rather than that they are specifically 
good at enhancing the crystallisation of AaeA. Nevertheless, the conditions 
listed in Table 6.1 are a good starting point for further optimisation of 
crystallisation conditions and further screen could be designed to explore a 
range of concentrations of the various PEGs, additives, or salts that are 
highlighted. Additionally, the small crystals seen in the conditions above can be 
used for microseeding experiments, whereby the tiny fragments of crystals are 
added into new crystallisation drops to provide a nucleation site for future 
crystal growth. However, due to time limits it was not possible to perform a 
comprehensive optimisation process and proceed through to potential data 
collection on any crystals that could be grown and so this line of enquiry was 
put on hold.  
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6.5  Electron Microscopy of AaeB  
Although there was not enough purified AaeB sufficient for crystallography, 
there was enough to perform analysis by EM. Negative stain EM provides a way 
to study the structure of AaeB using only μg-amounts of protein in a timescale 
of only a few days and can provide information on complex size and shape, and 
would potentially afford the possibility of assembling a low-resolution model. EM 
negative stain grids were prepared using samples of purified protein, and then 
imaged. 100 micrographs were acquired and from these 13,135 particles were 
picked for further analysis. The EM micrographs showed some patches of 
aggregated and clumped material, but a generally monodisperse and 
homogenous sample (seen in Figure 6.11), which indicates that the EM data 
from this sample should be reliable and is promising for further study. 
 
 
Figure 6.11 - A pair of representative micrographs at 30,000X 
magnification from AaeB negative stain EM grids.  
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6.5.1  EM classes 
The 13,135 particles picked from the micrographs were taken and used to 
create class averages, in order to improve signal-to-noise. Several interesting 
classes are seen from the processed data generated from the first EM imaging 
experiment. It is possible to pick out classes with four regions of electron 
density (Figure 6.12E, G, H, I, J, M): putatively dimers of AaeB, with four sets 
of six helices forming a central pore, seen in Figure 6.12. In addition, there are 
classes that appear to be dimers of the four-lobed density (Figure 6.12B, D, F, 
K). This could be a true tetramer of AaeB, or may be an artefact, with the 
particles merely sat next to each other on the grid. However, the fact that the 
putative dimer-of-dimers is pulled out in the classes indicates it was a relatively 
frequent occurrence. It should also be noted that the possibility of these classes 
being a monomer was eliminated as a protein of 70 kDa would not be visible by 
negative stain EM. 
 
Figure 6.12 - EM class averages of AaeB imaged at 30,000X magnification.  
Classes are seen containing four distinct regions of density in an approximate 
diamond formation.  
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A second set of micrographs were acquired at 50,000X magnification in an 
attempt to acquire higher-resolution data. Class averages from this higher-
magnification data are shown in Figure 6.13A, and a number of the classes 
show a similar four-lobed structure as seen previously (selected in Figure 
6.13B), although many of the classes were very circular and formless, which 
may be expected from a solution containing detergent micelles. The additional 
magnification seemed not to provide any significant greater understanding. 
Moreover, the background noise looks to contain strong features, indicative of a 
poorly aligned particle which is focussed on the background leading to a build-
up of noise. The images looked to contain dominant features consistent with a 
dominant frequency in the image, likely caused by problems with the camera. 
As such this data is not reliable. 
 
Figure 6.13 – A) EM class averages from AaeB taken at 50,000X 
magnification. B) Selected classes that show a more distinct morphology.   
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A second sample of purified AaeB was prepared as before from an independent 
purification and imaged in order to assess the reproducibility of the results seen. 
114 micrographs were taken and from these 13,349 particles were picked. This 
time, as seen in Figure 6.14, significant heterogeneity was seen in the sample 
with a range of particle sizes and with a significantly noisier background.  
 
Figure 6.14 - Example micrographs of AaeB negative stain EM grids 
imaged at 30,000x magnification.  
Larger particles indicated by boxes, smaller particles indicated in circles. 
 
When classes were made from particles picked from this second set of data, 
shown in Figure 6.15, the background looked noisier, as expected. However, 
distinct classes could be picked from the data. Speculatively, these can be 
rationalised as a side view and a top view of a complex of AaeB, with the top 
view showing threefold symmetry and three pores, suggesting a trimer. The 
second sample of AaeB contained a higher proportion of AaeA, so perhaps 
AaeA promotes AaeB to form trimers rather than dimers. Alternatively, AaeB 
could remain as a dimer and AaeA may form a hexamer around AaeB, giving 
the hexagonal shape seen. While distinct classes have been generated by this 
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EM investigation there is not enough data to produce a full 3D model and the 
final model is likely be influenced by the starting model chosen.  
 
Figure 6.15 - Second set of EM class averages from an independently 
prepared sample.  
Below are selected classes. Firstly, a set that have the appearance of a 
“mushroom” which is perhaps a side view of AaeB with a narrow membrane-
embedded region and wider cytoplasmic domain. Secondly, a set that have the 
appearance of a trimer, with an approximately-hexagonal outline and three  
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6.5.2  Gold labelling  
In order to assess the oligomeric state, AaeB was labelled with Ni-NTA-
nanogold, which has affinity for the His-tag268 and has previously been used to 
locate the position of a subunit in the photosystem 2 complex269 in EM 
micrographs. As seen in Figure 6.16, much of the protein is found in large 
aggregated clumps, and the rest of the material is seen in mostly monomeric 
form, although there is some evidence for rare dimers in Figure 6.16C-D. A 
sample of Ni-NTA-nanogold with a smaller diameter of 1.8 nm was also used, 
and as seen in Figure 6.16E-F, a similar pattern of monomers was seen, 
although the nanogold appeared less homogenous. It is noteworthy that the 
micrographs shown in Figure 6.16A-D, in which the EM grids were washed to 
remove excess gold particles before staining, show the clearest background of 
all the samples. This suggests that a washing step is important to produce high 
quality data.  
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Figure 6.16 – EM negative stain images of samples of AaeB labelled with 
gold. 
A-D) 5nm Ni-NTA-nanogold and E-F) 1.8nm Ni-NTA-nanogold. A) large 
aggregated regions are seen. B) smaller aggregates of AaeB are also seen. C-
D) the majority of particles seen on the micrographs are associated with only 
one nanogold particle, rare particles are seen with two nanogold particles 
(circled), which are approximately double in size and so putative dimers.  
 
Overall, the examination of AaeB by EM suggested two potential structures: 
firstly, four-lobed protein particles, rationalised as putative dimers of AaeB, with 
each monomer providing two regions of density, each corresponding to a set of 
6 TM helices; and secondly, a trimer or dimer-with-hexamer structure. The Au 
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labelling showed that dimers were relatively rare, with most monodisperse AaeB 
having only one associated Au label. However, it must be noted that the 
position of the His tags and bulk of the Au label may result in only one His tag 
being labelled through steric clashes. A further problem maybe that the Au 
labelling could force apart multimers which has resulted in the large scale 
aggregation. The monodispersity of the sample on the grid could be improved to 
reduce the clumping seen in some micrographs, perhaps by adjusting the buffer 
used. In addition, the most-likely improvement that could be made is to reduce 
the background on the grids; this is achievable by concentrating the protein 
sample initially before a large-fold dilution in dH2O directly before application 
onto the grid to dilute any interfering buffer components. Due to time constraints 
it was not possible to perform extensive optimisation, although the data 
presented here indicate that washing after sample application helps to reduce 
the background signal.  
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6.6 Studies on the oligomeric state of AaeA and AaeB 
Purified AaeB, solubilised in DDM or DNPG was used to investigate the 
potential complex formed by AaeA and AaeB, multimerisation, and structure. 
When the purified protein was concentrated, an additional band was seen on 
the Coomassie stained SDS-PAGE gels. Seen as the highest band in Figure 
6.17, a band at around the 130 kDa molecular weight marker was identified by 
mass spectrometry as being AaeB, therefore, this is evidence of a dimer of 
AaeB, which persists even in SDS.  
 
Figure 6.17 - Coomassie stained SDS-PAGE gel of 20 μL of IMAC-purified 
AaeB.  
Bands can be seen for AaeA, which co-purifies with AaeB; AcrB, a common 
contaminant during IMAC; and a dimer of AaeB. All bands were identified by 
mass spectrometry, as seen previously.  
 
A similar tight dimer running on SDS-PAGE has been reported for the inner 
membrane protein MacB270, which has been shown to be a dimer in later 
studies271. An example of where a similar co-purification is seen in E. coli is with 
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the AcrA-AcrB-AcrZ complex, which are shown to co-purify together259. No 
outer membrane proteins (OMP) were seen co-purifying with AaeB in this study, 
giving further evidence to the hypothesis that AaeAB does not form a complex 
with an outer membrane channel, although it is possible that if there was such 
an interaction the level of expression of the OMP may merely be too low to be 
detected. This co-purification with an OMP has been seen, for example, in an 
analogous tripartite system MacAB-OmpF with the MacAB pump (in inner 
membrane components), which co-purified with OmpF (the cognate outer 
membrane component)270. 
In addition to this evidence of dimerization of AaeB, purifications of AaeA were 
also seen to contain bands corresponding to dimers of AaeA (as discussed in 
the previous chapter). This is initial evidence that AaeA and AaeB each form 
homomeric assemblies, in addition to the heteromeric interaction between the 
two proteins. However, this leaves many possibilities for the functional state of 
the AaeA-AaeB complex including dimers, trimers, dimers-of-dimers, trimers-of-
dimers, and so on. 
 
6.6.1  Crosslinking of AaeB  
To further investigate the apparent multimeric state seen on gels, chemical 
crosslinking was investigated as a tool to shed light on the multimeric state of 
AaeB in solution. The homo-bifunctional cross-linker glutaraldehyde is widely 
used for crosslinking experiments because it rapidly reacts with amine groups at 
around neutral pH and generates stable covalent bonds272. Purified protein was 
incubated with glutaraldehyde at a range of concentrations (5 mM-100 mM) and 
crosslinking was monitored by SDS-PAGE and Western blotting. 
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Figure 6.18 – Crosslinking of AaeB. 
 A) Western blot of 20 μL samples of crosslinked samples of purified AaeB. 
Arrows indicate the approximate position of a monomer and dimer of AaeB, with 
potential evidence of a band significantly above the size of the MW ladder. The 
well is indicated by arrow with W. B) Coomassie-stained SDS-PAGE gel of the 
same, and C) Blown up and contrast-adjusted section of the coomassie gel. 
Four distinct bands can be seen initially, marked with arrows to the right, but 
upon addition of glutaraldehyde the largest band at >170 kDa becomes the 
major band, becoming the only band at 10 mM glurataldehyde. This band is in 
the region expected for a trimer of AaeB. No crosslinking is seen in the samples 
denatured by SDS, confirming that crosslinking requires higher order structure 
to be intact.  
 
The Western blot of crosslinked samples in Figure 6.18A shows adding 
glutaraldehyde led to a diminishment in the amount of protein in the band at the 
height of an AaeB monomer (70 kDa), and an increase in higher-MW species. A 
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faint band is seen in the non-crosslinked lane at the height expected of a dimer 
(140 kDa) and this increases in intensity when glutaraldehyde is added, along 
with a smear of higher-MW species that continue up to the height of the wells, 
including evidence of a band at a size of a putative trimer (224 kDa). 
Importantly, when the protein sample was first denatured with 1% SDS, no 
crosslinking was seen, indicating that the crosslinking is dependent on correct 
protein secondary structure. The Coomassie stained gel in Figure 6.18C shows 
a band at >170 kDa, approximately in the region expected of a AaeB trimer 
(224 kDa). Some doubt is cast on the Coomassie results, however, as the 
bands seen in the gel appear to match poorly to the expected sizes of AaeB, 
running lower than expected, and lower than seen in other gels. The bands 
shown in the Western blot are closer to the expected sizes and identification is 
aided by the specificity of the anti-His-antibody. 
The crosslinking was repeated on a freshly-purified sample of AaeB (which had 
a greater proportion of AaeA co-purified along with it) using a lower range of 
concentrations of glutaraldehyde, shown in Figure 6.19, and both the 
Coomassie stained SDS-PAGE gel and Western blot showed both monomers 
and dimers but no significant higher bands, and when concentrations of 
glutaraldehyde of 5 mM or higher were employed the protein aggregated and 
was found in the well.  
These crosslinking data provide contrasting evidence for AaeB forming a 
multimeric complex, either in the form of a dimer, or a trimer, but do not appear 
to show any crosslinking between AaeA and AaeB. 
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Figure 6.19 - Crosslinking of AaeB.  
A) Western blot of 20 μL sample of crosslinked samples of AaeB. A monomer 
and dimer size band is seen, but only limited evidence is seen of larger-MW 
species.  B) Coomassie-stained SDS-PAGE gel of crosslinked samples of 
purified AaeB. Also seen is AaeA, which co-purifies with AaeB.   
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6.6.2  Native PAGE Gel of AaeB 
A second approach to investigating the multimeric state of AaeB is a native 
PAGE gel. As native gels do not contain SDS they can assess complexes that 
form between proteins. Evidence is seen in Figure 6.20 for both a monomer 
and dimer in the first lane, plus higher-MW species which tend towards 
aggregates as salt concentration increases. Without addition of NaCl, smeared 
bands are seen at approximately 70 kDa and from 150 kDa up to around 200 
kDa (although this value is above the level of the molecular weight markers) 
and these sizes are approximately consistent with the presence of monomers, 
dimers, and trimers of AaeB. In 250 mM NaCl the protein runs almost entirely in 
a single band at the approximate size of 200 kDa, a putative trimer. At higher 
salt concentrations, the protein appears as high-MW aggregates. These data 
also provide potential evidence for the putative trimer, as they again contain an 
apparent band at >170 kDa.  
 
 
Figure 6.20 – Western blot of a Native PAGE gel. 
20 μL of purified AaeB was run in native sample buffer containing varying 
concentrations of NaCl from 0 – 1000 mM. Increasing salt promoted the 
formation of higher-MW species. Position of the well shown labelled W and MW 
markers shown on the left.  
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6.6.3  Crosslinking of AaeA 
AaeA is likely to form functional multimers similarly to other MFPs and so this 
was tested by crosslinking. Samples of purified AaeA solubilised with DDM 
were treated with freshly-defrosted glutaraldehyde at concentrations up to 250 
μM and, when assessed by Western blotting, bands are seen at molecular 
weights approximately equal to the expected sizes for monomer (34 kDa), dimer 
(69 kDa), trimer (103 kDa), tetramer (138 kDa), pentamer (172 kDa), and 
hexamer (206 kDa), as seen in Figure 6.21. 
 
 
Figure 6.21 - Western blot of 20 μL samples of purified AaeA crosslinked 
with glutaraldehyde for 15 minutes.  
As crosslinking is initiated an increase in the intensity of the dimer, trimer, and 
tetramer bands is seen, when the glutaraldehyde concentration is increased to 
100 μM a band corresponding to the pentamer appears, and at 250 μM there is 
evidence for a hexamer along with smearing of larger-MW species all the way 
up to the size of the well.  
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Figure 6.22 - Crosslinking of purified DDM-solubilised AaeA  
A) B) Coomassie-stained SDS-PAGE gel of 20 μL samples of AaeA alone, and 
after glutaraldehyde treatment; which have been contrast-adjusted to give: C) 
and D). E) F) Western blot of the same, which have been contrast-adjusted to 
give: G) and H). Bands are seen at sizes correcponsing to monomer (M), dimer 
(D), trimer (Tr), tetramer (Te), pentamer (P), and hexamer (H) 
 
 
Glutaraldehyde crosslinking was again employed on a second freshly-purified 
sample of AaeA at a concentration of 100 μM. When assessed by Coomassie 
staining and Western blotting, evidence was seen in Figure 6.22 of monomers 
becoming higher oligomers up to hexamer size. Additionally, each of these 
bands was identified by mass spectrometry to contain AaeA. This is congruent 
with evidence that other MFPs are hexameric in their functional state107, and 
thus it is proposed that AaeA is a hexamer in vivo and the strength of the dimer 
band indicates AaeA is likely to dimerise before these dimers assemble into 
larger multimers.   
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6.7  Assessment of the Oligomeric State of AaeB by SEC-
MALLS 
Size Exclusion Chromatography-Multi Angle Laser Light Scattering (SEC-
MALLS) provides a method for calculation of the molecular weight of solutes 
present in solution, by measurement of the UV absorbance, change in refractive 
index, and light scattering of a sample compared to a reference buffer. This 
enables measurement of particle size and molecular weight of macromolecules 
in solution and as such means that determination of complex stoichiometry is 
possible. Unlike conventional SEC, which is also used for molecular weight 
estimation by reference to known standards, SEC-MALLS is an absolute 
technique and measures molecular weight directly. Furthermore, SEC-MALLS 
is able to distinguish between the protein (which absorbs UV) and the detergent 
surrounding it (which does not), and thus can determine the size of the protein 
specifically. The ability of SEC-MALLS to assess the oligomeric state of any 
species makes it suited to studying AaeA and AaeB complex formation and 
stoichiometry; AaeA is co-purified with AaeB, so samples of this purified 
material were taken to assess oligomerisation and interaction between the two 
proteins.  
For this specific case, this analysis is complicated by the fact that the size of 
AaeB (74 kDa) is approximately equal to the size of a dimer of AaeA (70 kDa), 
this difference is approximately 5%, the expected error in SEC-MALLS 
measurements as quoted by the manufacturer. To give an example, this means 
that it is possible to rationally assign three separate identities to a peak of 
approximately 145 kDa: with AaeA4 (140 kDa), AaeA2AaeB (144 kDa), or AaeB2 
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(148 kDa) all falling at approximately that value. With this caveat, the data are 
presented below.  
Before each SEC-MALLS experiment, a sample of the protein standard 
carbonic anhydrase was run to ensure the equipment was correctly calibrated 
before proceeding with the experiment. An example of one of these runs is 
shown in Figure 6.23; in panel A, the three traces for Light Scattering (LS, red), 
UV absorbance (UV, green), and dynamic refractive index (dRI, blue) overlay 
with the peaks aligned, which they should if the instrument is operating 
correctly. Additionally, panel B shows that when the region of the peak is 
analysed a consistent MW is calculated across the whole peak, and that the 
protein is running as a monodisperse species of a single MW. The calculated 
MW of the protein species is ~ 29 kDa, as expected. These initial tests ensured 
that the equipment was correctly calibrated and aligned.  
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Figure 6.23 - SEC-MALLS analysis of carbonic anhydrase standard to 
assess calibration.  
Light scattering is shown in red line, dRI shown in dotted blue line, and UV 
shown in dotted green. The traces for light scattering (LS), UV absorption (UV), 
and refractive index (dRI) overlay at the peak (A), and the calculated MW is 
consistent across the peak (B) indicating that the equipment is correctly 
calibrated and the protein standard is running as a single monodisperse species 
across the column.  
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6.7.1  SEC-MALLS analysis of AaeB 
AaeB solubilised in DDM and purified by IMAC (co-purified with AaeA) was 
concentrated to approximately 1 mg/mL and 50 μL was injected into the SEC-
MALLS apparatus and run over a Superdex S200 10/300 column (GE 
Healthcare), producing the chromatogram seen in Figure 6.24A. A peak was 
seen at 7 minutes that had a shoulder at 8 minutes, and a third smaller peak 
present at just after 10 minutes. Although these peaks were not well resolved, 
they were analysed and the MW of the species present were calculated as 158, 
117, and 2.48 kDa, respectively (3 s.f.). This can be seen in Figure 6.24B, with 
MWs superimposed as black lines onto the chromatograms. The first two peaks 
were in the expected range for oligomers containing AaeA and AaeB, but the 
final peak was clearly too low to be a protein species of interest, and thus was 
discarded. SEC-MALLS is also able to calculate the amount of detergent 
present in particles within each selected peak by finding the mass of protein 
(which absorbs UV light, unlike detergent) and the total mass of both protein 
and detergent (from light scattering). Peaks 1 and 2 also have approximate 50% 
detergent and 50% protein (Seen as Protein Fraction in Table 6.2), which is the 
expected ratio for membrane proteins solubilised in detergent, indicating that 
these peaks correspond to species of AaeA. The data corresponding to these 
peaks is summarised in Table 6.2. There are two potential assignments for 
Peak 1: AaeA2AaeB (144 kDa), or AaeB2 (148 kDa). Peak 2 may be assigned 
as the heterodimer AaeAAaeB (109 kDa) or a homotrimer AaeA3 (105 kDa).  
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Figure 6.24 - SEC-MALLS analysis of purified AaeB.  
Light scattering is shown in solid black or red line, dRI shown in solid grey or dotted blue line, and UV shown in dotted black or 
dotted green. A) chromatograms and B) peaks with calculated MWs for AaeB run on a Superdex S200 10/300 column. C) 
chromatograms and D) peaks with calculated MWs for AaeB run on a WTC-MP030S5 column. Calculated MWs (indicated by 
the horizontal black lines overlaying the peaks in B and D) are listed in Table 6.2 and Table 6.3. In both cases the peaks are 
relatively poorly resolved from one another.  
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Table 6.2 - Summary of SEC-MALLS results for AaeB on S200 column 
 
 
As the peaks were poorly resolved, a second run was performed on a newly-
purified sample of AaeB, using the WTC-MP030S5 column (Wyatt Technology) 
which is designed for improved resolution when separating membrane proteins 
in detergent. The chromatogram produced can be seen in Figure 6.24C, and 
several peaks could again be identified. Four peaks were selected for analysis, 
indicated in Figure 6.24D. These peaks were calculated to contain 
macromolecules with MW of 245, 129, 64 and 0.6 kDa, respectively. Again, the 
final peak was too low to be relevant. However, the peak of 64 kDa is 
approximately the size of a monomer of AaeB, and thus the three other peaks 
were deemed likely to be appropriate species. The data corresponding to these 
peaks is summarised in Table 6.3.  Peak 1 could be assigned as AaeB3 (222 
kDa), or AaeA2AaeB2 (248 kDa), or AaeA3AaeB2 (253 kDa). Peak 2 may 
represent AaeAAaeB (109 kDa) or AaeA2AaeB (144 kDa). Peak 3 is closest to 
AaeB (74 kDa) or AaeA2 (70 kDa), although as AaeA is present only as a 
consequence of having co-purified along with AaeB and so complexes that 
contain only AaeA are unlikely to be valid species.  
 
 
 
 Peak 1 Peak 2 Peak 3 
MW /kDa 158 (±0.436%) 117 (±0.457%) 2.48 (±0.364%) 
Micelle MW /kDa 173 (±0.928%) 118 (±1.008%) 45 (±0.514%) 
Protein fraction % 47.7 (±0.079%) 49.9 (±0.077%) 5.2 (±0.116%) 
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Table 6.3 - Summary of SEC-MALLS results for AaeB on WTC-MP030S5 
column 
 Peak 1 Peak 2 Peak 3 Peak 4 
MW /kDa 245 
(±6.429%) 
129 
(±6.324%) 
64.0 
(±5.455%) 
0.576 
(±5.002%) 
Micelle MW 
/kDa 
157 
(±17.730%) 
131 
(±14.068%) 
106 
(±10.321%) 
57.6 
(±7.109%) 
Protein 
fraction % 
61.0 
(±0.126%) 
50.0 
(±0.097%) 
38.0 
(±0.081%) 
1.0 
(±0.048%) 
 
The protein fraction in each of these peaks in both experiments was 
approximately half, which is expected for a detergent-solubilised membrane 
protein181 and supports the conclusion that they are relevant species, 
surrounded by DDM. There is evidence to support the existence of AaeB 
monomers (WTC-MP030S5 Peak 3, 64 kDa) and AaeB dimers (S200 Peak 1, 
158 kDa), and AaeB trimers (WTC-MP030S5 Peak 1, 245 kDa), which is in 
agreement with bands seen on SDS-PAGE gels such as Figure 6.17 and 
crosslinking. A range of peaks may also represent various AaeA-AaeB 
heteromers.  
However, although the MWs calculated for the peaks fall within the expected 
range, it is important not to over-analyse the results. The peaks are, in general, 
poorly resolved and generally the line denoting MW is seen to increase or 
decrease across the peak rather than being flat, as would be expected for a 
single monodisperse species. What can be drawn from these data is that the 
species AaeA and AaeB are part of a dynamic, labile complex that does not 
have one clear, dominant species over the conditions of the SEC-MALLS run.  It 
may be possible to extract the entire complex using SMALP-based purification, 
rather than detergent, and run this SEC-MALLS again, which would probe the 
native state of the complex without the disruption caused by detergent 
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purification. Also, perhaps crosslinking the complex may stabilise it in one 
conformation and allow analysis by SEC-MALLS by producing a single peak, 
preventing the complexes falling apart. 
A third examination of the complex AaeA-AaeB was attempted with the WTC-
MP030S5 column. Purified AaeA and AaeB were mixed, ensuring that there 
was an excess of AaeA, before running the SEC-MALLS.  The chromatogram in 
Figure 6.25, and analysis summarised in Table 6.4 show that, again there 
seems to be a dynamic complex, with a MW in the range 112-126 kDa, which is 
broadly what is expected for complexes of AaeB dimers, heteromeric 
complexes of AaeAAaeB, or AaeA trimers or tetramers. Again, the protein molar 
mass lines on the “Results Fitting”, seen in Figure 6.25B, show a curve rather 
than a flat line, suggesting species of higher and lower MW are also present in 
the peak, and there is a labile, dynamic complex.  
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Figure 6.25 - SEC-MALLS analysis of AaeA mixed with AaeB.  
Light scattering is shown in solid black or red line, dRI shown in solid grey or 
dotted blue line, and UV shown in dotted black or dotted green. A) 
chromatogram shows a single major peak in the UV trace with a shoulder.  B) 
analysis of the peak with calculated MW overlaid.  
Table 6.4 - Summary of SEC-MALLS results for AaeA plus AaeB on WTC-
MP030S5 column 
 Peak 1 Peak 2 
MW /kDa 126 (±5.686%)  112 (±5.711%) 
Micelle MW 
/kDa 
72.8 (±16.529%) 
 
72.2 (±15.618%) 
Protein 
fraction % 
63.3 (±0.042%)  60.7 (±0.041%) 
 
6.7.2  SEC-MALLS analysis of AaeA  
Just as was done for AaeB in Section 6.7, purified AaeA was assessed by 
SEC-MALLS. Both the S200 column (Figure 6.26A and B) and WTC-MP030S5 
column (Figure 6.26C and D) were used, and the chromatograms and MW 
estimation is shown in Figure 6.26. For the S200 column, it was possible to 
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calculate the MW of only one peak from the chromatogram, and that peak was 
calculated to be 2.7 MDa, significantly larger than any oligomeric species is 
expected to be, while the detergent micelle was calculated to have a negative 
MW: clearly not physically possible.  
Table 6.5 - Summary of SEC-MALLS results for AaeA on S200 column 
 Peak 1 
MW /kDa 2,718 
(±10.801%)  
 
Micelle MW 
/kDa 
-107 
(±262.313%) 
Protein 
fraction % 
104 
(±0.019%) 
 
Due to this, the experiment was repeated with freshly-purified AaeA using the 
WTC-MP030S5 column. The chromatogram (Figure 6.26C) showed one very 
broad peak, with a shoulder visible on the left hand side of the UV trace. Taking 
several measurements of the MW over the 15-21 minute range it was clear that 
the shoulder contained much higher-MW material, with a calculated MW of 427 
kDa, while the main peak centred around 19.5 minutes was comprised of 
material in the MW range 143-173 kDa. These data are summarised in Table 
6.6. Similarly to the experiment carried out on AaeB, the main peak likely 
represents a complex that is labile and dynamic. The MW lines overlaid in black 
on Figure 6.26D slope downwards, indicating an unstable species. The 
predicted maximum oligomeric state of AaeA is a hexamer, which would have a 
MW of approximately 209 kDa, and the values measured over the peak are a 
small amount below this value. If the analysis of the broad second peak were 
extended to the left, following the upward slope of the line it may plausibly reach 
209 kDa. Interestingly, the shoulder on the peak is approximately the MW of 
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AaeA12 and may represent a pair of hexamers associated together in a DDM 
micelle (or, potentially a dodecamer), although there is no evidence that this is a 
physiologically-relevant state.  
 
Table 6.6 - Summary of SEC-MALLS results for AaeA on WTC-MP030S5 
column 
 Peak 1  Peak 2 Peak 3  Peak 4  Peak 5  
MW 
/kDa 
427 
(±10.014%) 
173 
(±9.082%) 
166 
(±9.063%) 
157 
(±9.097%) 
143 
(±9.025%) 
Micelle 
MW 
/kDa 
340 
(±24.709%) 
99.0 
(±26.549%) 
85.8 
(±28.149%) 
77.2 
(±29.084%) 
73.6 
(±28.017%) 
Protein 
fraction 
% 
55.7 
(±0.013%) 
63.6 
(±0.005%) 
66.0 
(±0.005%) 
67.1 
(±0.005%) 
66.0 
(±0.006%) 
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Figure 6.26 - SEC-MALLS analysis of purified AaeA.  
Light scattering is shown in solid black or red line, dRI shown in solid grey or dotted blue line, and UV shown in dotted black or 
dotted green. A) chromatograms and B) one assigned peak with calculated MWs for AaeA run on a Superdex S200 10/300 
column. C) chromatograms and D) five assigned peaks with calculated MWs for AaeA run on a WTC-MP030S5 column. 
Calculated MWs are listed in Table 6.5 and Table 6.6 
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6.8  Summary and conclusions 
Samples of AaeA and AaeB, produced and purified as seen in the previous 
chapter were used for a variety of biochemical and structural studies. AaeA was 
previously shown to be vital for stability of AaeB in solution, which is in 
agreement with the previously shown requirement for both proteins to confer 
resistance in vivo, and purifications of AaeB showed untagged AaeA co-
purifying, confirming the tight association between these proteins. These data 
suggest that AaeA has a stabilising, chaperone type role with AaeB.  
A homology model of AaeA was constructed in silico based on closely related 
MFP family proteins, and this model contained linearly arranged α-hairpin, 
lipoyl, and β-barrel domains attached an inner-membrane-embedded helix, as 
expected for MFP members. No MPD domain was predicted in the structure, 
which in other MFPs interacts with the periplasmic domains of the cognate inner 
membrane transporters. This is to be expected as AaeA interacts with AaeB, 
which does not have a large periplasmic domain, with the largest globular loops 
being located in the cytoplasm and only minimal presence in the periplasm. This 
model was validated by CD, which showed approximately one third each of α-
helical and β-sheet content, and thermal unfolding was undertaken to give a 
melting temperature of just below 50°C.  
AaeAB may not form an association with TolC, unlike analogous inner-
membrane transporters, and perhaps this absence of interaction is based on a 
single deletion between the bases of the RLS motif in AaeA that is known to be 
vital for interaction with TolC. Thus, the role of their associated MFPs, such as 
AaeA, is open to speculation with their role perhaps being key to promoting 
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stability (supported by the requirement of AaeA to stabilise AaeB) and 
regulating transport activity.   
A survey of buffer conditions was undertaken to optimise the stability of AaeA. 
The protein was shown to be tolerant of a wide range of pH values, while 
increasing the salt concentration provided slightly increased stability, and 
increased glycerol concentration had a strong stabilising effect. This wide pH 
tolerance may reflect the location of AaeA in the periplasm of E. coli, as this is 
likely to experience wide variations in pH as gut bacteria must cope with 
stomach acid as well as a more alkaline intestine. The unfolding temperatures 
measured matched well with the unfolding temperature measured in the CD 
experiments.  
AaeB was studied and evidence was shown for multimerisation by SEC-MALLS 
and crosslinking, with both suggesting that there is a dynamic complex present, 
with AaeB likely a forming a homodimer or -trimer and also evidence was seen 
for heteromeric complexes containing AaeA and AaeB. AaeA alone similarly 
showed evidence of dynamic multimerisation with strong dimerization and the 
likely functional complex hexameric. The mechanism of this multimerisation 
may be explained by the finding that in the model of AaeA opposing faces of the 
molecule are positively and negatively charged, respectively, suggesting a side-
by-side assembly based on electrostatic interactions.  
EM was undertaken to investigate the structure of AaeB complexes and after 
analysis of over 26,000 particles evidence was found for particles that perhaps 
represent dimers of AaeB, in addition to particles that may be trimers of AaeB, 
or alternatively a dimer of AaeB complexed with a hexamer of AaeA, although 
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no 3D model could be constructed from the data collected. Optimisation of 
grids, especially washing, can be undertaken to provide clearer negative-stain 
images, before moving on to cryo-EM in order to generate data at a higher 
resolution, perhaps enough to see a tertiary structure. This is a promising 
approach to study the AaeA-AaeB complex as a whole in addition to homomeric 
complexes. 
For AaeA, enough material could be purified to allow crystallography to be 
done. No clear crystals were formed, but some potential hits containing 
microcrystals that can be followed up by further optimisation to produce crystals 
that can lead to solution of the structure. This optimisation is out of the scope of 
the present study, however, as it is a lengthy process. If production of AaeB is 
optimised, there is hope for crystals of that too, and the complex as a whole.   
In summary, the first in vitro experiments have been performed on AaeA and 
AaeB, a pair of proteins that form a complex within the inner membrane of E. 
coli. An in silico homology model was generated for AaeA, which proved highly 
plausible when considering the literature concerning related MFPs. This model 
was validated by CD and provides a starting point to develop further 
experiments to examine AaeA. In addition, a variety of buffer conditions were 
assayed in order to derive optimal conditions to stabilise AaeA within solution, a 
key step in any structural experiment. A strategy for structural examination of 
AaeA by crystallography and AaeB by EM has been developed in order to 
provide the first structural data for these proteins, or any protein of the PET 
family of which they are a part. Consistent within the EM data and additional 
data from SEC-MALLS and crosslinking on AaeA and AaeB is that they form a 
dynamic, labile complex, likely formed of either dimers or trimers or AaeB and 
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tetramers or hexamers of AaeA. This represents the first biochemical and 
structural data gathered for either of these two proteins, and the first step in 
understanding their structure and mechanism. This understanding may also be 
helpful in understanding the related ALMT family in plants.  
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Chapter 7 
General Discussion and 
Conclusions 
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7  
7.1  Strategies for overexpression of membrane proteins for 
structural studies 
Several approaches were taken in this study in order to attempt to characterise 
ArAE family proteins including ALMTs, a family of membrane proteins which are 
found ubiquitously in plants, and their bacterial members, part of the relatively-
underexplored PET family. Firstly, the C-terminal domain of wheat ALMT1 – 
putatively a soluble domain – was expressed in isolation; secondly, full length 
ALMTs (wheat ALMT1, and Arabidopsis ALMT5 & ALMT9) were expressed 
transiently in the leaves of the model plant Nicotiana benthamiana; and thirdly, 
bacterial proteins were identified from E. coli an S. oneidensis and 
overexpressed in E. coli.  Usually, tens or even hundreds of milligrams of highly 
purified protein are needed in order to undertake detailed structural and 
functional studies, and, unfortunately, the overexpression of membrane proteins 
remains a challenge. Attempts at production of high levels of protein are often 
limited by poor expression levels, misfolded protein, or the formation of 
inclusion bodies, all of which were seen within this project.  
 
7.1.1  The CTD of ALMT1 
In order to study the isolated C-terminal domain of ALMTs, four expression 
constructs were made to express the C-terminal domain of wheat ALMT1 in E. 
coli. Two of these encoded the sequence starting from after the final 
transmembrane helix until the end of the protein, excluding the very C-terminal 
residues, which were predicted to be disordered. These were tagged with either 
a C-terminal or N-terminal His-tag. Two additional truncations were made at the 
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N-terminal end of this construct to remove a further region predicted to be 
disordered and ensure that none of the transmembrane helix was included; 
again these constructs had either N- or C- terminal His-tags. After extensive 
expression trials (encompassing bacterial strain, media, temperature, time, and 
type of induction) it was concluded that it was not possible to express this CTD 
in a soluble form. Attempts at refolding the protein from inclusion bodies were 
similarly not able to produce the soluble, monodisperse protein required, with a 
heavy precipitate forming upon re-folding. An extensive bioinformatics study on 
ALMTs published during this study showed that the CTD of ALMTs contain two 
well-conserved hydrophobic regions, that the authors predicted to be additional 
transmembrane helices45. Thus, it is concluded that the CTD of ALMT1 is not a 
soluble domain and at least one of the hypothesised additional transmembrane 
helices are likely to be present within the CTD. As the CTD is not likely to be the 
independent, globular domain that was initially expected, this line of 
investigation was discontinued. 
 
7.1.2  Full length ALMTs 
The second line of investigation focussed on the full-length plant ALMT 
proteins. Vectors were produced for transient expression of full length ALMTs in 
Nicotiana benthamiana for three family members, TaALMT1, AtALMT5 and 
AtALMT9, which were produced in both C-terminally and N-terminally His-
tagged forms using the pEAQ-HT vector132. This is the first use of transient 
expression of membrane proteins in planta for the purpose of structural studies. 
A proof-of-concept study showed that production of GFP in high yield was 
possible using the system, confirming previously-published work234 and so the 
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target proteins were then expressed. Production of full length ALMTs was 
possible, and expression of all six constructs was seen, but the protein was 
rapidly degraded. This perhaps may reflect the situation in vivo, with the 
proteins being rapidly turned over. In the case of ALMTs involved in stomatal 
opening specifically this is an appealing hypothesis, as stomatal movements 
need to match the diurnal cycle, evidence of which is seen in the expression 
patterns from microarray data (http://www.bar.utoronto.ca/)273. After trialling a 
variety of infiltration conditions and time-points for expression it was concluded 
that it would not be possible to extract protein from the leaves after degradation 
was monitored via SDS-PAGE during extraction.  
 
7.1.3  Bacterial ArAE Proteins 
The third approach concerned investigation of bacterial proteins, including AaeB 
from E. coli, which was originally identified as part of a new protein family 
designated PETs in 200036. Vectors were produced for expression of three 
bacterial proteins: firstly, two inner membrane transporters AaeB from E. coli 
and Q8EKE1 from S. oneidensis, which both have sequence identity to ALMTs; 
and secondly two constructs concerning the MFP AaeA from E. coli, both full-
length and an N-terminal truncation of AaeA to remove the hydrophobic helix 
with the aim of producing a soluble protein. All four of these were expressed in 
E. coli successfully, and AaeB was shown to require co-expression with AaeA in 
order to be solubilised, supporting the previous physiological study that showed 
both components were required to form a functional complex38. AaeAΔTM was 
only expressed as an insoluble aggregate, despite attempts at optimisation of 
culture conditions (including strain, media, and temperature). The S. oneidensis 
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protein was produced and purified successfully, however, the amount of protein 
was low and, as such, further investigations were not continued with this. But, if 
expression levels could be optimised and increased then this protein shows 
promise for use in further experiments as a strategy for its solubilisation and 
purification has already been developed. Both AaeA and AaeB were expressed 
in sufficient amounts, solubilised by detergents, and purified successfully and so 
were used for a range of biochemical and structural experiments.  
The finding that the solubility of AaeB requires co-expression with AaeA 
supports previous studies that showed a requirement for both proteins for 
physiological function and the pull-down of AaeA during the purification of AaeB 
is the first direct evidence of a direct interaction between AaeA and AaeB in 
vitro. This provides strong evidence that AaeA and AaeB form a functional 
complex in the inner membrane in vivo.  
AaeA was subjected to crystallography, and some evidence of microcrystals 
was seen, although there was not sufficient time to follow up this discovery and 
fully optimise the crystallisation conditions. Nevertheless, the development of a 
strategy to express, solubilise, and purify AaeA to the point of being able to 
obtain microcrystals is a significant step on the path to obtaining high resolution 
structural data.  
In the absence of any experimental structure, homology modelling has become 
an important tool in structural biology to predict secondary and tertiary structure 
of membrane proteins. The models that result can be used to guide 
experimental approaches, such as mutagenesis, that are aimed at shedding 
light on mechanisms of activity, for example examination of transport in the 
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case of channels and transporters. The first homology model for the protein 
AaeA was generated in this study, based on several MFPs that form complexes 
with inner membrane transporters from the RND, ABC, and MFS families. This 
model contained three of the canonical domains identified in other MFPs, 
alongside the transmembrane helix that anchors the protein into the inner 
membrane. This membrane localisation was supported by experimental data. 
Overexpressed AaeA segregated with the membrane fraction when produced in 
E. coli, and the protein could not be washed from the membrane into the soluble 
fraction with either addition of NaCl, or NaCO3 pH 11.5, indicating that AaeA 
was a true integral membrane protein, not merely membrane-associated. The 
bioinformatics analysis of AaeA also drove the production of a construct to 
express a truncated version of AaeA (designated AaeAΔTM) that aimed to 
exclude the N-terminal transmembrane helix. Unfortunately, (in contrast to other 
studies on related MFPs that also took this approach254) expression of this 
truncated protein produced only aggregated protein in inclusion bodies that 
could not be re-folded into a soluble form. It is possible that the exact location of 
the truncation was not optimal, perhaps leaving a disordered or untethered N-
terminus. If so, then expression of a range of constructs with serial deletions 
from the N-terminus may identify a specific construct that is both well-expressed 
and correctly-folded. The high expression levels seen for both AaeA and 
AaeAΔTM and previous success seen by other groups in expressing N-
terminally-truncated MFPs253,254 leads to the conclusion that this approach is a 
promising route, although time constraints dictated that this was not possible to 
investigate this in the course of the present study.  
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The homology model and sequence analysis also presented several interesting 
avenues of investigation and provide new insights into the AaeA-AaeB complex 
and wider family members. And the validation of the model using CD 
spectroscopy provides confidence in the model and allows such predictions to 
be made using it. The finding that AaeA has opposing faces that are positive 
and negative, respectively, suggests a potential mode of side-by-side 
multimerisation and is the first description of such a mechanism for AaeA. 
Additionally, the conserved “RLS motif”, found within MFPs to be vital for 
interaction with TolC in the outer membrane107, was identified in the model of 
AaeA at the tip of the α-hairpin with a single residue deletion, which appears to 
be conserved in the MFPs known to be expressed in operons with PET/AraE 
family inner membrane transporters. This deletion is a possible explanation for 
the previous observation that TolC is not required by the AaeAB transporter38. 
As such, the homology model and sequence alignment have shown how the 
AaeAB exporter may have become adapted to extrusion into the periplasm 
rather than past the outer membrane. 
Data was gathered by crosslinking and SEC-MALLS in order to investigate the 
complex formed by AaeA and AaeB, along with potential multimerisation of the 
individual subunits. The data gathered, in toto, show that AaeA and AaeB forms 
a dynamic complex, with AaeA being necessary to stabilise AaeB. Both AaeA 
and AaeB appear to form homodimers readily, and the most likely configuration 
of the final complex is a 6:3 configuration similar to AcrA-AcrB, with evidence 
seen for dimers and trimers of AaeB, and multimers up to hexamers of AaeA.   
Overall, this study has developed a strategy for expression and purification of 
two bacterial genes from S. oneidensis and E. coli that have homology to 
- 250 - 
ALMTs, as well as an accessory protein that forms a complex with the E. coli 
gene. A variety of biochemical and structural approaches have been applied to 
investigate the E. coli genes, AaeA and AaeB, alongside the production of the 
first homology model of AaeA. This is the first in vitro study of any PET family 
member or its associated MFP as well as the first EM study, showing a possible 
arrangement of the complex. A schematic view of the proposed arrangement of 
AaeAB is shown in Figure 7.1. In the absence of an interaction with an outer 
membrane channel, the MFP AaeA may have a role as a “funnel” or “chimney” 
to help channel and deposit substrates further away from the inner membrane.  
 
 
Figure 7.1 - Overall schematic proposed for the complex AaeAB as 
compared to AcrAB-TolC 
In the canonical description of a tripartite efflux system the complex contains a 
trimeric inner membrane transporter connected to a trimeric outer membrane 
channel via a hexameric periplasmic membrane fusion protein. It is proposed 
that AaeAB similarly forms a complex with either dimeric or trimeric AaeB as the 
inner membrane component with hexameric AaeA. No connection to an outer 
membrane protein has thus far been demonstrated for AaeAB as so AaeA may 
represent a “chimney” to deposit substrate away from the inner membrane.  
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7.2   Future work  
7.2.1  Continuation of work on AaeA-AaeB 
The next aim for studies of AaeA and AaeB would be to move forward with 
further structural studies. Microcrystals of AaeA were seen in several 
crystallisation conditions, and further optimisation of the well solutions should 
provide larger crystals suitable for X-ray diffraction. Once obtained, a structure 
would be able to provide the ultimate validation of the model presented herein. 
However, it should be noted that the refinement of microcrystals to form well-
diffracting crystals can take several months, if not years. Beyond this structure, 
a structure of AaeA in complex with AaeB would provide further insights into the 
nature of their interaction. To achieve this, optimisation is required to improve 
expression levels of AaeB, and material can be produced with a scale up to 
fermenter scale. This will allow sufficient amounts of protein to be made in order 
to undertake crystallographic studies, either alone, or as part of a complex with 
AaeA. The commercially available ProPlex screen is particularly designed for 
assessment of protein complexes and may be of specific interest for such a 
study. Additionally, once greater expression is obtained it would be worthwhile 
to perform screening of buffer conditions to find the optimal conditions for 
complex stability, as done with AaeA. Additionally, production of a soluble 
fragment of AaeA would also be beneficial for crystallographic studies. 
Unfortunately, there was insufficient time in the study presented herein to 
produce and screen the required range of constructs with deletions in order to 
find a soluble construct. However, if a soluble version of AaeA were able to be 
produced it would have advantages for the various biochemical and structural 
characterisations of interest, especially as detergents or other reagents would 
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not be required to solubilise and stabilise the protein in solution, crystallisation is 
also likely to be easier without the presence of detergents. 
Beyond crystallography, more work can be done with the EM. Optimisation of 
grids coated with AaeB, particularly washing to improve the background would 
likely produce significant improvement in aligning the classes against one 
another, with the aim of producing a preliminary 3D model from the data. Once 
negative stain EM has provided this initial model, cryo-EM can be used to follow 
up and provide higher-resolution data. Another interesting avenue would be to 
examine AaeA in isolation by EM. If it forms higher-order oligomers such as 
hexamers, then they should be visible by negative stain. A hexamer with six-fold 
symmetry should be particularly clear, and gold labelling would provide further 
direct evidence. Additional techniques could be used following the approach of 
Janganan et al. (2011)274 who used crosslinking followed by both atomic force 
microscopy  and EM to visualise the hexamer of a MFP and mass spectrometry 
to measure the mass of the intact complex.  
Although no interaction with TolC is predicted from physiological data, a 
biochemical investigation would be of interest; in particular, an assessment 
could be made to if any evidence of binding between AaeAB and outer 
membrane proteins known to associate with inner membrane transporters in 
tripartite complexes such as TolC, MtrE, and OprM via binding studies. 
Perticularly of interest would be SdsP, as this protein is found in an operon with 
another AeAE family member (the SdsQRP operon). Highly-conserved residues 
identified from the model could also be investigated by mutagenesis, in order to 
assess their role. Mutation of residues vital for oligomerisation should abolish 
the interaction when mutated, for example, and this can be measured with 
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binding studies such as isothermal titration calorimetry or microscale 
thermophoresis.  
7.2.1.1 An alternative to detergent 
It could be beneficial to attempt solubilisation of AaeA-AaeB in styrene maleic 
acid co-polymer (SMA) to form styrene maleic acid co-polymer lipid particles 
(SMALPs) containing both AaeA and AaeB. This may allow isolation of the 
entire complex as a single unit by wrapping around it in the membrane, enabling 
analysis of the complex as a whole. Extraction of whole complexes has been 
shown, with for example, the entire SecYEG complex, which was co-extracted 
with SecA275. A key benefit of SMALPs over other techniques is that it extracts 
proteins directly from the membrane without the need for detergents that may 
destabilise the complex or individual polypeptides276. As well as this improved 
stability, later experiments are often improved when SMALPs are used rather 
than detergent. SMALPed protein appear much better looking in EM compared 
to detergent-solubilised proteins, when tested on the related AcrB175, with 
significantly improved background. SMALPs have also been used to obtain 
improved data for EPR spectroscopy277, CD and NMR experiments278. Similarly, 
SMALPed AaeAB could be assessed by NativePAGE, SEC-MALLS, 
crosslinking, and EM, as seen in this study and the ability to extract and 
stabilise the whole complex would be extremely beneficial for study of the true 
native state. SMALPs do have the drawback – shared with detergents – of not 
being suitable for functional studies to test transport, as this experiment requires 
a closed system with membrane across which substrate can be transported, so 
they are not appropriate for every experiment, but they do provide a useful tool.   
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7.2.2  Study of ALMTs 
Given the unpromising nature of expression in planta shown in Chapter 4, 
alternative expression systems are needed. Several approaches suggest 
themselves, the first of which is the possibility of using engineered plants that 
lack proteases, which would promote the stability of the expressed 
ALMTs279,280. Alternatively, it may be possible to prevent the action of proteases 
with addition of a greater variety of protease inhibitors, but as inhibitors were 
used in the extraction buffers in this study it is not clear what additional 
components would prove suitable. Bacterial expression presents a lower-cost 
system that lends itself well to screening a large number of constructs, with the 
caveat that eukaryotic proteins have a low rate of success in bacterial 
expression systems and as such it is likely to not provide success without a very 
wide-ranging set of constructs to be tested. Recent developments in plant-
based cell free expression systems also are an attractive proposition due to 
their similarity to the native system. Systems based on tobacco BY2281 and 
Arabidopsis callus282 have joined the wheatgerm system that has been in use 
for over 30 years283. Additionally, a benchmarking of several systems showed 
that HeLa- and Leishmania-based systems produced protein that was highly 
monodisperse284, significantly expediting structural studies, though it should be 
noted that these proteins were globular rather than membrane proteins. 
Possibly the best choice is expression in Sf9 insect cells, from which have been 
produced a significant proportion of membrane protein structures deposited in 
the PDB. Here, again, screening of as large a range of candidate genes and 
fusion tags as possible is the best approach to finding an eventual high-
expressing, readily-solubilised protein that is amenable to structural study.  
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Isolation of specific eukaryotic cDNA sequences is somewhat more difficult 
compared to bacterial sequences, due to the presence of introns in the genomic 
DNA and thus the need to prepare it from mRNA, but this should not cause a 
major problem when compared to the challenges of membrane protein 
structural biology. Two additional cDNA have now become available to order 
from ABRC in addition to those studied in Chapter 4 (AtALMT9 and 
AtALMT12), and it is also possible to order cDNA libraries for Arabidopsis, from 
which can be amplified the genes of interest. For other species, cDNA can be 
produced from plant material, as long as they are expressed in the tissues in 
question. In particular, the sequence for ALMT1 could be extracted from root 
tissue of plants grown in Al-containing media, and the coding sequences of 
ALMT6, ALMT9, and ALMT12 can be extracted from leaves, where they are 
known to be expressed in the stomata. Of course, another approach is to have 
the cDNA of interest chemically synthesised, which can be a fast and 
economical choice, with Genscript offering synthesis from 99 USD per gene. 
This approach also allows sequences to be codon-optimised, which can often 
prove helpful for heterologous expression by allowing faster translation, 
although, paradoxically, this can also lead to problems as rapid overexpression 
of membrane proteins can then overwhelm downstream processing machinery. 
In addition to starting with a larger number of sequences, it is likely to be a good 
idea to set up a range of vectors that have a variety of different tags for 
example, MBP fusion, GFP fusion, His-tag, Strep-tag, and combinations 
thereof. It is known that the location of type of fusion tags can affect the 
expression and stability of proteins and so screening several gives a greater 
chance of finding a construct that expresses well167. A recent example in the lab 
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involved re-engineering an expression vector to incorporate a larger flexible 
linker and a GFP fusion, which led to a significant improvement in both 
expression levels and yield after purification and thus a larger yield of the target 
protein was obtained, accelerating biochemical studies.    
A potential further line of enquiry would be to renew analysis of the CTD of 
TaALMT1. New constructs designed to encode the CTD while deleting the two 
predicted TM regions, either both or individually could be created, and their 
solubility assessed. The region between the two putative TM helixes is 
approximately 75 residues long, and expressing this alone, presuming that this 
region folds as an independent soluble domain, could enable the study of it by 
crystallography, binding studies, and crosslinking. Production of this region from 
homologues such as AtALMT1, which also is Al-activated, and AtALMT6, 9, and 
12, which are not, may produce comparisons that can elucidate the structural 
basis of differences between the proteins. Additionally, if either of the two 
putative TM regions can be left in the construct yet still produce soluble protein 
then this could provide evidence that either of the regions is not actually a TM 
helix, gaining further evidence for topology and architecture of ALMTs.  
 
7.2.3  Study of Bacterial Homologues 
In the absence of an experimental structure for ALMTs, acquisition of a 
structure of a related bacterial protein, such as AaeB, would enable insights to 
be drawn by homology modelling. This is of course in addition to the knowledge 
gained about the bacterial protein, which is important in itself. Similar to the 
discussion for ALMTs above, it would be advantageous to clone all of the PETs 
identified in E. coli, as well as SmFuaA, which has a known function, and other 
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similar proteins from other bacterial species (Prof. Stephen Baldwin identified 9 
additional genes from species whose DNA was not available in the lab, for 
example). Once a great number of proteins has been identified, these should be 
fused to a variety of tags before screening all of the constructs created in order 
to screen to find best-expressing, as discussed above. In addition, it is 
worthwhile recommencing study on the S. oneidensis gene investigated in 
Chapter 5 as the expression and purification of this protein has already shown 
promise and further optimisation of fusion tags and culture conditions could well 
provide sufficient material for structural studies. Once a sufficient yield is 
obtained for any construct, the expression can be scaled up and produced 
protein can be used for crystal trials and EM. A crystal structure obtained for 
any individual family member is likely to provide a good template for homology 
modelling of any other member of the family, and proteins showing high 
sequence identity to ALMTs can similarly be used to guide the production of a 
homology model for ALMTs.  
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7.3  Summary 
At the outset of this study the aim was to structurally and biochemically 
characterise ALMT family members, which have not been subject to such study 
thus far despite their vital biological importance in plants, and bacterial PET 
family members which are related to ALMTs and equally understudied. In 
particular, ALMTs are anion channels found throughout all plant species, and 
have key roles in acid soil tolerance, stomatal movements, and fruit flavour, with 
many more likely roles yet to be elucidated. Yet despite this clear importance, 
little headway has been made with discovering their three-dimensional 
structure, hampering the design of and interpretation of the results of any 
biochemical investigations. As such this study aimed to express and 
characterise both full-length ALMT channels and the isolated C-terminal domain 
of TaALMT1 and while a set of strategies was developed to produce members 
of this difficult family it was not possible to isolate protein fopr the studies 
intended. However, a great deal was learnt about the challenges of expressing 
these targets in E. coli and Nicotiana benthamiana. To overcome the problems 
with production of the plant proteins a shift was made to study of the related 
AaeB from E. coli, which is also poorly characterised. This work has shown the 
interaction between AaeA and AaeB and that they likely form a complex in vivo. 
Additionally, AaeA has been shown to be an integral membrane protein and a 
homology model has been developed, which was validated by CD 
spectroscopy. This was used to draw conclusions about AaeA such as 
identifying a potential mechanism for side-by-side homo-oligomerisation. The 
oligomeric state has been shown to be likely to be hexameric, and although 
stoichiometry of the overall AaeA-AaeB complex is difficult to determine, there 
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is evidence to support a 6:2 or 6:3 ratio. And finally EM analysis has shown the 
first structural evidence for the organisation of the complex, albeit at a low 
resolution. Overall this work has provided a significant development in our 
understanding of this bacterial family of proteins.  
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